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One of the most prevalent pollutants in urban cities is diesel exhaust particulate 
(DEP).  Air pollution has been linked with increased risk of recurrent myocardial 
infarction (MI) and MI related death
 
(Brook, 2008).  This may be due, in part, to 
effects on atherosclerotic plaque stability and blood clotting tendency.  Whether 
exposure to DEP changes the response of the heart to ischaemia, resulting in 
increased damage after MI is less well documented.  The work described in this 
thesis was designed to investigate the hypothesis that pulmonary instillation of DEP 
would increase vulnerability of the heart to subsequent myocardial reperfusion injury 
secondary to activation of a systemic inflammatory response, endothelial dysfunction 
and triggering of transient receptor potential vanilloid 1 (TRPV1) mediated 
autonomic reflexes in the lung. 
 
Examination of bronchoalveolar lavage (BAL) fluid revealed pulmonary 
inflammation 6 h after exposure to DEP, characterised by neutrophil infiltration, 
raised levels of the inflammatory mediator interleukin-6 (IL-6) and an increase in 
alveolar permeability demonstrated by increased levels of  protein in the lavage fluid.  
Pulmonary inflammation was largely resolved 24 h after exposure.  While there was 
no indication of systemic inflammation at 6 h after DEP instillation, the levels of two 
inflammatory mediators, IL-6 and tumour necrosis factor alpha (TNFα) were 
increased in the plasma by 24 h after exposure.  DEP had no affect on blood flow 
responses to the endothelium dependent dilator acetylcholine (ACh) in rat hind-limb 
vasculature in vivo at 6 or 24 h.  In summary, while exposure of rats to DEP can 
induce both pulmonary and systemic inflammation, it does not modify endothelium-
dependent vasodilatation. 
 
Ischaemia-reperfusion (I/R) was induced in vivo in anaesthetised rats and ex vivo in 
buffer perfused hearts from rats that had received DEP in vivo 6 h earlier.  In both in 
vivo and ex vivo I/R models, infarct size (unstained by triphenyltetrazolium choride) 
iv 
 
was significantly increased in hearts from DEP-instilled rats relative to hearts from 
saline-instilled or non-instilled rats.  Baseline oxidant stress, determined by electron 
paramagnetic spin resonance (EPR) in heart perfusate, was also significantly higher 
in perfusate of hearts from DEP-instilled rats.  In summary, a single exposure of the 
lung to DEP leads to priming of the myocardium for I/R injury. 
 
As the results cited above illustrated, priming of hearts appeared unlikely to be due to 
either coronary vascular endothelial dysfunction or systemic inflammation.  At 6 h 
post exposure, DEP was associated with increased blood pressure and myocardial 
hypersensitivity to ischaemia-induced arrhythmias, both suggestive of sympathetic 
activation.  The beta 1 (β1) selective blocker metoprolol was used to investigate the 
role of the sympathetic nervous system (SNS) in transmitting the influence of DEP in 
the lung to the myocardium via β1 adrenoceptor activation.  Administration of 
metoprolol (10 mg/kg, intraperotineal) at the time of DEP instillation into the lung 
was found to protect the heart from potentiation of ex vivo reperfusion injury.  
Metoprolol was also effective in reducing oxygen free radical generation from these 
hearts.  The TRPV1 antagonist AMG 9810 was also used to study the role of TRPV1 
receptors in mediating the priming influence of pulmonary DEP to the myocardium 
since activation of sensory receptors have been reported to modify sympathetic 
output via feedback to the central nervous system (Widdicombe et al., 2001).  Co-
administration of AMG 9810 (30 mg/kg) in vivo with DEP into the lung was found to 
prevent enhancement of ex vivo reperfusion injury associated with DEP instillation 
alone. 
 
Collectively these results have demonstrated that a single exposure of the lung to 
DEP leads to priming of the myocardium for I/R injury.  Furthermore, this priming 
occurs via activation of a pulmonary sensory reflex that is likely to involve 
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1.1 Atmospheric pollution 
1.1.1 Air pollution and mortality: Historical perspective 
The detrimental effects of air pollution were recognised as early as 1872 when the 
Scottish chemist, Angus Robert Smith wrote a book detailing air pollutants as 
hazardous components of urban air (Smith RA, 1872).  The excess deaths noted 
during foggy conditions (through industrial and domestic combustion of solid fuels) 
in the Meuse Valley, Belgium in 1930 (Nemery et al., 2001), Donora, Pennsylvania 
in 1948 (Helfand et al., 2001) and London in 1952 (Bell et al., 2001; Davis et al., 
2002) further increased public awareness of air pollution related health problems.  
Increased consensus on the health impacts of air pollution saw the enforcement of 
legislation (such as the United Kingdom Clean Air Act of 1956) focussed on 
reducing air pollution.  Despite these laws having been largely successful in reducing 
levels of air pollutants, air pollution continues to pose a significant threat to health.  
The World Health Organisation (WHO) has estimated that the number of deaths 
attributable to air pollution has risen 16.5% between 2004 and 2008 to 1.34 million 
deaths per year (WHO Statistics: 
http://www.who.int/phe/health_topics/outdoorair/databases/burden_disease/en/index.
html).  Moreover, air pollutants appear to have no demonstrable safe level or 
threshold for significant adverse health effects (Ware, 2000). 
1.1.2 Components of atmospheric pollution 
Air pollution is a heterogeneous, complex mixture of gases and particulate matter 
(PM).  Gaseous pollutants include carbon monoxide (CO), carbon dioxide (CO2), 
nitrogen oxides (NOx), ozone (O3) and sulphur oxides (SOx) (Brook et al., 2004).  
Both gaseous and particulate components have been associated with a spectrum of 
health effects, including increases in mortality due to cardiovascular and respiratory 
disease, as well as hospital admissions and ill health related to these diseases 
(Burnett et al., 1997; Dockery et al., 1993; Miller et al., 2007; Pope et al., 2004; 
Sunyer et al., 2003).  However, as well as in having an independent effect on health, 
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components of air pollution can interact giving rise to antagonistic, additive or 
synergistic effects (Chitano et al., 1995).  The work described in this thesis focuses 
on the PM component of air pollution.  PM constitutes only 2% of the total mass of 
air pollution (Brook et al., 2010), yet is considered the major perpetrator of ill health 
caused by air pollution (Brook, 2008; Mills et al., 2009). 
 
PM itself is a heterogeneous amalgam of solids and liquids with its concentration, 
size and chemical composition varying both temporally and spatially (Brook et al., 
2004).  PM originate from a variety of sources, being either man-made (eg, fuel 
combustion in motor vehicles and industrial sources) or natural (eg, windblown dust, 
sea salt and forest fires) (Brook et al., 2004; Harrison et al., 2000; Simkhovich et al., 
2008).  In addition to these primary sources of PM, secondary particulates such as 
nitrates and sulphates can form as a result of gas-to-particle conversion in the 
atmosphere (Brook et al., 2004). 
 
PM is often categorised by aerodynamic diameter.  The term PM10 includes all 
particles with a diameter less than 10 µm.  PM10 are also called thoracic particles 
since they can be inhaled into, and accumulate in, the respiratory system.  PM10 is 
commonly classified into three further size groupings: coarse particles (PM2.5-PM10, 
diameter 2.5-10 µm), fine particles (PM2.5, diameter < 2.5 µm) and ultrafine particles 
(UFP, diameter < 0.1 µm) (Figure 1.1) (Brook et al., 2004).  Current health-based air 
quality standards for PM are mass-based but other factors such as surface area, 
deposition within the respiratory system, chemical composition and source may be 
important for predicting health risks (Brook et al., 2004).  Indeed, UFP are believed 
to pose greater health risks than larger size particles due a higher surface-area-to-
mass ratio that permits these particles to carry greater amounts of toxins as well as 
greater total lung deposition (Oberdorster, 2001).  The primary contributors of UFP 
are combustion products found in motor vehicle exhaust (Cyrys et al., 2003).  The 
work described in this thesis focuses on diesel exhaust particulates (DEP) generated 
by the combustion process in diesel engines since these engines generate more UFP 
than petrol engines (Donaldson et al., 2005).  Typically, combustion-derived DEP 
consists of a carbon core onto which different chemical constituents are adsorbed 
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(Figure 1.2).  Components include inorganic compounds (eg, nitrates and sulphates), 
metals (eg, iron, copper and nickel), organic compounds (eg, polycyclic aromatic 
hydrocarbons) and biological compounds (eg, endotoxin, cell fragments) (Brook et 
al., 2004).  Acute exposure to DEP in animals increases platelet aggregation and 
thrombosis formation (Yokota et al., 2004; Yokota et al., 2008a), causes oxidative 
stress in the myocardium (Yokota et al., 2008b) and increases the risk of ventricular 





Figure 1.1 Schematic representation of the aerodynamic size distribution of 
particulate matter (PM) in air pollution in the range of 0.1 – 10 micrometre 










Figure 1.2 Generalised chemical composition of combustion-derived diesel 
exhaust particulate (DEP). 
The particles are composed of spherical elemental carbon cores onto which various 




1.1.3 PM exposure methods used in the assessment of health effects 
A number of ex vivo and in vivo exposure models have been applied to gain 
understanding of potential adverse health effects of air pollution.  Ex vivo models of 
PM exposure, however, make the assumption that PM can definitely translocate to 
extra-pulmonary tissues.  As will be discussed in more detail in Section 1.3.4, a 
potential role of PM translocation remains somewhat controversial.  The latter is also 
a limitation of animal studies delivering particles by injection (e.g., intravenous and 
intraperitoneal).  The lung is one of the principal ports of entry for all air pollutants.  
The two most widely used techniques for the introduction of PM into the lungs of 
experimental animals are inhalation and intra-tracheal instillation.   There are 
advantages and disadvantages of both delivery methods.  The studies described in 
this thesis delivered DEP to the lungs of rats by intra-tracheal instillation.  Instillation 
was selected, in part, for practical reasons as we are not equipped with inhalation 
facilities in Edinburgh.  Instillation has been used successfully in investigating the 
health effects of DEP on the cardiovascular system (Madden et al., 2000; Murphy et 
al., 1998; Yan et al., 2008; Yokota et al., 2004; Yokota et al., 2008a; Yokota et al., 
2005; Yokota et al., 2008b).  Although intra-tracheal instillation is less physiological 
than inhalation, it has been widely accepted as a reliable technique to administer 
particles directly to the respiratory tract in a quantitative and reproducible manner 
(Driscoll et al., 2000; Miyabara et al., 1998).  In comparison to inhalation exposure, 
instillation results in better dispersion of particles throughout the lobes of rodent 
lungs and across the alveolar surface (Driscoll et al., 2000; Miyabara et al., 1998).  
The nasal passages of rodents are more complex than humans and serve as a filter for 
the inhaled particles.  This filtering of particulates conversely reduces the quantity of 
particles able to reach the alveoli and limits dose reproducibility (Driscoll et al., 
2000; Miyabara et al., 1998).  Additionally, PM has been reported to induce similar 
increases in bronchoalveolar lavage (BAL) fluid cell counts for both methods of 
exposure (Driscoll et al., 2000; Henderson et al., 1995; Miyabara et al., 1998).  
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1.2 Air pollution and cardiovascular disease 
1.2.1 Epidemiological evidence of the cardiovascular effects of 
atmospheric pollution 
Numerous epidemiological studies conducted worldwide (and summarised in a series 
of reviews) have in general yielded positive and statistically significant associations 
between PM exposure and cardiovascular mortality and morbidity (Brook, 2008; 
Pope et al., 2006a; Simkhovich et al., 2008).  Such associations have been reported 
after short-term and long-term exposure to PM (Brook, 2008; Pope et al., 2006a; 
Simkhovich et al., 2008).  The work described in this thesis focuses on the health 
effects of short-term exposure to PM.  For this reason the major findings from 
epidemiological studies documenting adverse effects of PM after short-term 
exposure are discussed here. 
 
Data from a large multi-city study in Europe (APHEA2, Air Pollution and Health: A 
European Approach) demonstrated a 0.7% increase in acute all-cause mortality in 
response to a 10 µg/m
3
 increase in PM10 (Katsouyanni et al., 2001).  Increases in 
mortality related to short-term PM exposures have been reported in several other 
well acknowledged single-city and multi-city studies (Dominici et al., 2005; Jerrett et 
al., 2005; Wietlisbach et al., 1996; Wong et al., 2008). 
 
Cardiovascular events such as myocardial infarction (MI), heart failure, arrhythmia 
and peripheral arterial disease have all been associated with increased all-cause 
mortality and hospitalisations after elevated PM (Dominici et al., 2006; Peters et al., 
2001a; Peters et al., 2004; Pope et al., 2006b; Sullivan et al., 2005).  Indeed, Peters 
et al. (2004) reported that residents of Augsburg had a three-fold increased risk of MI 
as little as one hour after traffic exposure.  Increases in PM2.5 concentrations over a 
24 hour sampling period have also been reported to increase susceptibility to 
ventricular arrhythmias among patients with implantable cardioverter defibrillators 
(Rich et al., 2005).  In general, studies have reported stronger exposure-response 
relationships on cardiovascular outcomes for fine (PM2.5) than for coarse (PM10) 
9 
 
particles (Brook et al., 2004; Peng et al., 2008).  The increase in daily hospital 
admissions for cardiovascular disease associated with a rise in PM2.5-10 levels were 
lost after adjustment for PM2.5 (Peng et al., 2008).  The magnitude of risk estimates 
for the short-term exposure has also been shown to vary depending on the source of 
pollutant(s), with more consistent or stronger effects observed for traffic-related 
pollution (Maynard et al., 2007; Peters et al., 2004).  Section 1.1.2 addressed the 
potential toxicity of UFP.  However, few epidemiological studies have been 
conducted for UFP (Delfino et al., 2005; Nel et al., 2006) partly due to the lack of 
routine monitoring of these particles in the atmosphere.  In a review of the 
epidemiological evidence, specific groups within the population have been identified 
to be more sensitive to pollutants (Brook et al., 2004).  A case-crossover study 
reported that the risk of death associated with short-term increases in PM10 was 
higher among older individuals (Zeka et al., 2006).  Other groups that have been 
identified to be more sensitive include children, males, those of lower socio-
economic status and those with pre-existing medical conditions (Calderon-
Garciduenas et al., 2007; Goldberg et al., 2001; Granados-Canal et al., 2005; Laden 
et al., 2000; Pope et al., 2006b; Zeka et al., 2006). 
 
A number of epidemiological studies have also linked PM exposure with changes in 
a variety of sub-clinical physiological end-points that relate to cardiovascular health 
(Simkhovich et al., 2008).  PM exposure has been linked to increased levels of 
various circulating mediators, such as C reactive protein (CRP) (Chuang et al., 2007; 
Riediker et al., 2004), interleukin-6 (IL-6) (Riediker, 2007; Ruckerl et al., 2007b) 
and tumour necrosis factor alpha (TNFα) (Calderon-Garciduenas et al., 2008).  
Indeed, short-term increases in vehicle-derived PM2.5 were associated with an 
increase in serum levels of CRP in nine healthy male North Carolina Highway Patrol 
troopers (Riediker et al., 2004).  PM-related changes in blood coagulation, 
fibrinolytic factors, blood pressure, vascular reactivity and heart rate variability 
(HRV; defined as the temporal variation between sequences of consecutive heart 
beats (Task Force of the European Society of Cardiology 1996)) have also been 
reported (see review by Simkhovich et al., 2008).  Given the burden of 
epidemiological evidence, a few of the key findings will be highlighted here with 
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particular emphasis placed on blood pressure and HRV.  The general consensus 
seems to be that PM exposures lead to an elevation of blood pressure (Brook et al., 
2009a).  Short term exposures to elevated concentrations of PM2.5 (mean 
concentration 10.5 µg/m
3
) among cardiac rehabilitation patients were associated with 
increases of approximately 2.7 mmHg for both systolic and diastolic blood pressures 
(Zanobetti et al., 2004).  Contrary to this, however, daily changes in PM in Finland, 
Germany and the Netherlands were not associated with increases in blood pressure in 
adults with coronary heart disease (Ibald-Mulli et al., 2004).  Epidemiological 
evidence for associations between short-term exposure to PM and cardiac autonomic 
indexes such as HRV have generally been inconsistent (Peretz et al., 2008a; Peters et 
al., 2000; Pope et al., 2004; Pope et al., 1999; Riediker et al., 2004; Wheeler et al., 
2006).  Short-term exposure to PM has been variously shown to decrease (Pope et al., 
1999) and to increase (Riediker et al., 2004) HRV in healthy volunteers.  Apart from 
different sources and chemical properties of pollutants, differences in monitoring 
methods and degree of individual susceptibility may, in part, explain the 
inconsistencies among findings (Brook et al., 2004).  Potential mechanisms for 
regulation of HRV and autonomic function will be discussed further in Section 1.3.3. 
1.2.2 Air pollution and vascular function 
1.2.2.1 Normal vascular function 
Vascular endothelial cell injury and dysfunction plays an important role in the 
pathogenesis of many cardiovascular disorders including atherosclerosis, coronary 
vasoconstriction and myocardial ischaemia (Celermajer, 1997).  Exposure to PM has 
been associated with a number of adverse cardiovascular health effects (see review 
by Brook et al., 2004 and Section 1.1).  Taken together, these findings could indicate 
a potential deleterious effect of pollution on normal vascular endothelial cell function.  
Here an overview is given of normal endothelial cell function.  A clear understanding 





The vascular endothelium, a single cell layer separating blood and vascular smooth 
muscle, is involved in the regulation of multiple processes, including the control of 
vascular tone, coagulation, fibrinolysis, inflammation and platelet and leukocyte 
interactions with the vessel wall (Figure 1.3) (Celermajer, 1997).  These multiple 
responses are mediated by the production and release of various autocrine and 
paracrine substances (Table 1) in response to physical stimuli, such as shear stress 
and in response to a variety of endogenous substances, such as bradykinin and 
thrombin (Celermajer, 1997).  The work described in this thesis evaluates vascular 
relaxant responses to the endothelium-dependent vasodilator acetylcholine (ACh) 
and the endothelium-independent vasodilator sodium nitroprusside (SNP) in rats 
following DEP exposure. 
 
ACh increases intracellular calcium (Ca
2+
) concentration by M3 muscarinic receptor 
(member of the superfamily of G-protein coupled 7 transmembrane (TM) receptors) 
activation on endothelial cells (Furchgott et al., 1980).  The subsequent increase in 
intracellular Ca
2+ 
then stimulates the release of substance(s) (e.g., nitric oxide (NO), 
prostacyclin (PGI2) and endothelium-derived hyperpolarising factors (EDHFs)) that 
causes relaxation of the vascular smooth muscle (Figure 1.4) (Furchgott et al., 1980).  
It should be noted that the contribution of these vasodilators largely depends on the 
origin of the vessel being analysed.  NO is the principal contributor to endothelium-
dependent relaxation in conduit vessels (eg, aorta), whereas the contribution of 
EDHF predominates in smaller resistance vessels (eg, mesenteric vessels) (Graff et 
al., 2004). 
 
The best characterised EDRF is NO (Palmer et al., 1987).  An increase in 
intracellular Ca
2+ 
activates the endothelial constitutive nitric oxide synthase (eNOS), 
which catalyses the oxidation of L-arginine to L-citrulline and NO (Marletta, 1993).  
This eNOS-catalysed reaction occurs in two steps and requires the presence of 
molecular oxygen and a number of co-factors (eg, nicotinamide adenine dinucleotide 
phosphate (NADPH) and tetrahydrobiopterin (BH4)) (Govers et al., 2001).  
Endothelium-derived NO exerts its smooth muscle vasodilator effect by diffusing to 
subjacent smooth muscle cells where it primarily activates soluble guanylate cyclase 
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(sGC) to convert guanosine trisphosphate (GTP) into cyclic 3’, 5’ guanosine 
monophosphate (cGMP; Figure 1.4) (Lloyd-Jones et al., 1996).  NO donor 
compounds such as SNP and glyceryl trinitrate (GTN) cause relaxation of the 
vascular wall, independently of the endothelium, directly releasing NO and thereby 
activating sGC (Katsuki et al., 1977).  The mechanisms by which cGMP causes 
smooth muscle relaxation include reduction of cytosolic Ca
2+
 and stimulation of 





Figure 1.3 Normal human coronary artery. 
The arterial wall is composed of a single layer of endothelial cells surrounded by 




                  
Vasodilators NO, prostacyclin, EDHF, bradykinin, adrenomedullin, C-natriuretic peptide     
Vasoconstrictors ET-1, angiotensin-II, thromboxane A2, oxidant radicals, prostaglandin H2     
Antiproliferative 
NO, prostacyclin, transforming growth factor-β, heparin 
sulphate      
Proproliferative 
ET-1, angiotensin-II, oxidant radicals, platelet-derived growth factor, basic fibroblast growth factor, insulin-like growth factor, 
interleukins 
Antithrombotic NO, prostacyclin, plasminogen activator, protein C, tissue factor inhibitor, von Willebrand factor    
Prothrombotic 
ET-1, oxidant radicals, plasminogen-activator inhibitor-1, thromboxane A2, fibrinogen, tissue 
factor    
Inflammatory 
markers CAMs (P- and E selectin, ICAM, VCAM), chemokines, nuclear factor κ-B     
Permeability Receptor for advanced glycosylation end-products, VEGF      
Angiogenesis Vascular endothelial growth factor             
Table 1.1 Autocrine and Paracrine Substances Released From the Endothelium (Adapted from Verma et al., 2002) 
Abbreviations: NO = nitric oxide, EDHF = endothelium-derived hyperpolarising factor, ET-1 = endothelin-1, CAM = cell adhesion 
























Figure 1.4 Schematic diagram describing endothelium-dependent relaxation of 
vascular smooth muscle. 
Endothelial cells respond to various chemical and physical stimuli to cause an 
increase in intracellular calcium (Ca
2+
) concentrations.  The resulting increase in 
intracellular Ca
2+
 activates endothelial nitric oxide synthase (eNOS) to release nitric 
oxide (NO).  Increased Ca
2+
 also promotes the release of arachidonic acid (AA) by 
activation of phospholipase A2 (PLA2) as well as several endothelium-derived 
hyperpolarisation factors (EDHF).  The released AA is converted to prostacyclin 
(PGI2).  After release, NO, PGI2 and EDHFs diffuse to the smooth muscle cell and, 
through different intracellular pathways, decrease cytosolic Ca
2+
 concentrations, 
resulting in hyperpolarisation and vascular relaxation.  NO decreases cytosolic Ca
2+
 
via activation of soluble guanylate cyclase (sGC) that synthesises cyclic 3’, 5’ 
guanosine monophosphate (cGMP) from guanosine trisphosphate (GTP).  In contrast, 
PGI2 causes relaxation by activating adenylyl cyclase (AC), and stimulating the 
conversion of adenosine triphosphate (ATP) to 3’, 5’ cyclic adenosine 
monophosphate (cAMP).  Figure adapted from (Cohen et al., 1995). 
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1.2.2.2 Pollution and vascular dysfunction 
As discussed above, NO released from the endothelium plays an important role in the 
control of vascular tone.  Reduced NO bioavailability therefore decreases the ability 
of endothelial cells to execute their function in regulating vascular tone and shifts the 
vasoactive balance towards vasoconstrictive pathways.  This section summarises the 
current literature associating air pollution with reduced NO bioavailability and 
impaired endothelial cell vasomotor function.  Controlled inhalation studies with 
volunteer subjects revealed impaired endothelium-dependent and –independent 
dilatation of forearm resistance arteries after short-term exposure to diesel exhaust 
(DE) (Mills et al., 2005; Tornqvist et al., 2007).  However, this is not always the case.  
In the study by Brook et al. (2002), endothelium-dependent vasodilation (induced by 
ACh) of intact human conduit vessels was unaltered by PM exposure.  It is important 
to note that these clinical studies are generally limited in their ability to investigate 
the mechanisms underlying endothelial cell dysfunction. 
 
Inhalation of DE in animals has been reported to alter vascular tone ex vivo in 
isolated blood vessels (coronary and mesenteric arteries) in an NO-dependent 
manner (Cherng et al., 2009; Knuckles et al., 2008).  Diminished bioavailability of 
NO has also been reported after pulmonary exposure to fine PM or nanosized 
titanium dioxide (TiO2) ex vivo in rat skeletal muscle arterioles (Nurkiewicz et al., 
2004; Nurkiewicz et al., 2009).  Although the precise mechanism of this reduced NO 
bioavailability remains unclear, several ex vivo studies have suggested that functional 
uncoupling of the NOS protein and increased free radical generation may be 
important following ex vivo (Miller et al., 2009) and in vivo (Knuckles et al., 2008; 
Nurkiewicz et al., 2009) PM exposures.  Nurkiewicz et al. (2009) detected increased 
levels of reactive oxygen species (ROS), by hydroethidine oxidation, in isolated rat 
skeletal muscles after TiO2 nanoparticle exposure in vivo.  A causative role of ROS 
was further supported by observations that scavenging ROS ex vivo partially restored 
agonist-mediated dilatation after TiO2 nanoparticle exposure in vivo (Nurkiewicz et 
al., 2009).  In other experiments, however anti-oxidant treatment ex vivo did not 
protect against impairment of NO-dependent relaxation induced by PM (Courtois et 
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al., 2008).  The same investigators suggested that a systemic inflammatory 
mechanism may be responsible for the reduced NO-dependent relaxation seen in 
pulmonary arteries from rats exposed to PM (Courtois et al., 2008).  Indeed, it was 
demonstrated that NO-dependent relaxation could be reversed when treated ex vivo 
with the anti-inflammatory drug dexamethasone (Courtois et al., 2008).  Furthermore, 
the release of TNFα from pulmonary arteries was higher in rats exposed to PM 
(Courtois et al., 2008).  This cytokine has been postulated to be a key player in 
alterations of the NO signalling pathways in the vasculature (Park et al., 1999).  It is 
important to note that not all studies have reported pulmonary exposure to PM to 
effect ex vivo vasorelaxation responses despite the high doses of particulate 
employed (Bagate et al., 2004a; Hansen et al., 2007).  Similarly negative findings 
may be under-represented due to the tendency not to report negative data.  
Nevertheless, overall, there seems to be a general assumption that pulmonary 
exposure to PM, by either inhalation or instillation, attenuates vascular function ex 
vivo.  However, these studies on ex vivo vessels remove the vessel from 
neurohumoural control in vivo.  To date, studies on air pollutions effects on 
vasomotion in vivo remains uncertain and has yet to be definitively established. 
 
Although this section has focussed on NO, exposure to pollutants is likely to alter the 
release, turnover or receptor activity of other vasoactive factors such as endothelin-1 
(ET-1) to affect reactivity (Batalha et al., 2002; Brook et al., 2002; Cascio et al., 
2007; Peretz et al., 2008b).  Increased levels of ET-1, a potent vasoconstrictor 
released from endothelial cells has been associated with alterations in vascular tone 
due to PM exposure in man (Peretz et al., 2008b) and in animals (Batalha et al., 
2002).  However, no increase in plasma ET-1 was detected 2 hours after controlled 
exposures (1 hour with intermittent exercise) of healthy volunteers to dilute DE 
(Langrish et al., 2009a). 
 
As discussed in Section 1.1.2, diesel combustion exhaust is a major source of 
atmospheric UFP.  To date there have only been a limited number of published 
studies relating specifically to the effects of DEP exposure on vasomotor function.  
In vitro application of DEP suspension to thoracic aortas from rats has shown loss of 
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endothelium-dependent vasodilatation (Ikeda et al., 1995; Miller et al., 2009; Muto 
et al., 1996; Sagai et al., 1993).  Excessive production of ROS has been proposed to 
be responsible for the alterations in vasomotor function due to DEP (Miller et al., 
2009; Tzeng et al., 2003).  However, these observations are likely to be of limited 
biological significance as this assumes particles can be translocated from the lung 
into the circulation and thus directly interact with and influence the vasculature.  
While studies have demonstrated that translocation of nanoparticles is feasible 
(Brown et al., 2002; Kreyling et al., 2002; Oberdorster et al., 2004), as discussed 
later in Section 1.3.4, there remains considerable uncertainty over whether this 
mechanism underlies the health effects of combustion-derived PM (Brook et al., 
2004; Mills et al., 2006).  Only one animal study has evaluated endothelial cell 
vasomotor function following pulmonary exposure to DEP (Hansen et al., 2007).  
The study found that a single in vivo exposure to DEP blunted endothelium-





)) mice (Hansen et al., 2007).  However, wild-type mice 
were resistant to DEP-induced alterations in vasomotor function.  Moreover, there 
are no pre-clinical studies assessing vasomotor function in vivo following pulmonary 
exposure to DEP. 
1.2.2.3 Pollution, plaque formation and thrombogenicity 
Epidemiological studies have demonstrated short-term exposures to air pollution to 
be associated with triggering of MI (see Section 1.2.1).  It has been suggested that 
the pulmonary inflammation induced by exposure to environmental air pollutants 
may lead to changes in blood coagulation parameters, as well as measures of 
systemic inflammation.  Epidemiological studies have shown an association between 
short-term increases in air pollution exposure and coagulation promotors such as 
fibrinogen (Peters et al., 1997; Ruckerl et al., 2007a; Schwartz, 2001), which plays a 
key role in thrombotic events within atherosclerotic plaques (Koenig, 2003).  
Circulating levels of fibrinogen were shown to be increased in response to elevated 
air pollution levels in a large cohort of MI survivors across Europe (Ruckerl et al., 
2007a).  Animal (Gardner et al., 2000) and human (Ghio et al., 2000) toxicology 
studies have also reported increases in plasma fibrinogen levels after acute exposure 
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to air pollutants.  Thrombosis formation is a central pathologic mechanism 
contributing to MI (Libby, 1995).  Increased plasma levels of fibrinogen have been 
associated with an increase in the incidence of ischaemic events (Sweetnam et al., 
1996; Thompson et al., 1995).  Furthermore, inhalation of DE in humans has been 
shown to enhance thrombus formation in an ex vivo clinical model of arterial injury 
(Lucking et al., 2008).  The enhanced thrombogenicity 6 hours after DE inhalation 
was suggested to be mediated by platelet-leukocyte activation (Lucking et al., 2008).  
Tracheal instillation of DEP has also been shown to enhance platelet aggregation and 
thombosis within 1 hour of exposure in a murine model of vascular injury (Nemmar 
et al., 2003a; Nemmar et al., 2003b).  What is not clear is the mechanism underlying 
the effects of environmental air pollutants on platelet aggregation.  However, 
Nemmar and co-workers did demonstrate that these pro-thrombotic events were not 
solely a result of the inflammatory response in the lungs after air pollution (Nemmar 
et al., 2003b).  Pulmonary inflammation and peripheral thrombotic complications 
were correlated at 6 and 24 hours but not at 1 hour after DEP instillation (Nemmar et 
al., 2003b). 
1.2.3 Pollution and blood pressure  
Several epidemiological studies have examined associations between short-term 
exposure to PM and blood pressure (Brook et al., 2009a).   The general consensus 
seems to be that PM exposures lead to an elevation of blood pressure (Brook et al., 
2009a).  In contrast, controlled human and animal exposure studies evaluating the 
effects of PM on blood pressure have yielded somewhat inconsistent results (Bartoli 
et al., 2009b; Cheng et al., 2003; Mills et al., 2008; Mills et al., 2005; Vincent et al., 
2001).  This may be partly explained by differences in the methodologies of 
exposure.  Vincent et al. (2001) reported an increase in blood pressure 2-48 hours 
after nose-only inhalation exposure to diesel soot in rats.  Nemmar and co-workers, 
on the other hand, assumed that particles could translocate from the lungs into the 
circulation and demonstrated circulating DEP (24 hours after intravenous injections) 
to be associated with lower blood pressure in rats (Nemmar et al., 2007).  
Inconsistencies may also result from using different blood pressure measurement 
techniques and different PM characteristics and sources. 
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Investigators have suggested several possible explanations for the positive or 
negative associations between short-term exposure to PM and blood pressure.  Some 
researchers have suggested that the rapid onset of blood pressure changes with PM 
exposure might be due to an imbalance in autonomic nervous system (ANS) activity 
(Bartoli et al., 2009b; Brook et al., 2009b).  Healthy volunteers exposed for 3 hours 
at rest to a controlled concentration of PM2.5 showed increased blood pressures and 
decreased HRV; indices of parasympathetic ANS withdrawal (Brook et al., 2009b).  
A recent observational study conducted by our clinical team members at the 
University reported that systolic blood pressure (SBP) was significantly less in 
healthy subjects wearing a facemask during a 2 hour walk in Beijing (Langrish et al., 
2009b).  The magnitude of the SBP decrease was strongly associated with increases 
in HRV, reflecting an autonomic regulation of blood pressure (Langrish et al., 
2009b).  The role of the ANS is further supported by Bartoli et al. (2009) who 
demonstrated that the raised diastolic blood pressure (DBP) during a 5 hour exposure 
to concentrated ambient particles (CAP) was significantly attenuated by prazosin, a 
selective alpha 1 (α1) adrenoceptor antagonist.  As will be discussed in more detail in 
Chapter 1.3.3, PM-evoked activation of sensory nerve endings in the airway lining 
leads to reflexes involving both the sympathetic and parasympathetic branches of the 
ANS, lending further support to a neural contribution (Widdicombe et al., 2001).  
Other studies have suggested that the later onset of blood pressure changes is likely 
elicited by particle-induced oxidative stress within the lung and/or systemically and 
subsequent inflammation-induced vascular dysfunction (Brook et al., 2002; Sun et 
al., 2005; Sun et al., 2008).  Lastly, it has also been suggested that alterations in the 
biological activity of the potent vasoconstrictor peptide ET-1 underlie PM exposure-
induced changes in blood pressure (Bouthillier et al., 1998; Calderon-Garciduenas et 
al., 2007; Peretz et al., 2008b; Vincent et al., 2001). 
1.2.4 Air pollution and the heart 
1.2.4.1 Pollution, cardiotoxicity and arrhythmia 
As mentioned above, acute exposure to PM has been reported to influence vascular 
function, blood pressure, coagulation, and thrombosis.  All of these events may act as 
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triggers for a MI.  There is also increasing evidence to suggest that short-term 
exposure to PM is followed by changes in the electrical, mechanical, ionic and 
energetic state of the myocardium itself. 
 
Epidemiological studies in healthy adults (Riediker et al., 2004) or in subjects with 
known underlying heart disease (Peters et al., 2000; Rich et al., 2005) have 
demonstrated that the prevalence of ventricular arrhythmias increases after short-
term exposure to PM (see Section 1.2.1).  Laboratory studies of PM exposure via 
inhalation or instillation in animals have generally supported these epidemiological 
results (Anselme et al., 2007; Farraj et al., 2009; Godleski et al., 2000; Gordon et al., 
1998; Muggenburg et al., 2000; Muggenburg et al., 2003; Watkinson et al., 1998; 
Wellenius et al., 2002).  Cardiac arrhythmias after acute exposure to PM have been 
reported in healthy animals (Muggenburg et al., 2000) but mostly in animal models 
of vascular and myocardial injury (Godleski et al., 2000; Gordon et al., 1998; 
Muggenburg et al., 2000; Muggenburg et al., 2003; Watkinson et al., 1998; 
Wellenius et al., 2002).  These investigations reinforce epidemiological studies 
showing stronger associations between PM and health effects among those with pre-
existing diseases (Daigle et al., 2003; Pope, 2000).  The key findings of controlled 
animal exposure studies investigating the acute effects of PM on arrhythmia are 
summarised in Table 2.  Using an anaesthetised model of acute myocardial ischaemia 
(induced by coronary artery occlusion), Wellenius and colleagues demonstrated that 
exposure to residual oil fly ash (ROFA) (Wellenius et al., 2002), but not to CAP 
(Wellenius et al., 2004), increased the frequency of arrhythmias.  These changes 
were associated with decreased HRV, suggesting that particulate-mediated changes 
in cardiac autonomic balance may be responsible (Wellenius et al., 2002).  
Decreased HRV has been associated with increased risk for the development of fatal 
arrhythmias among acute post-MI patients (Bigger et al., 1992; Kleiger et al., 1987).  
Other studies have, however, shown the pro-arrhythmic effects of air pollutants not 
to be mediated by changes in HRV (Anselme et al., 2007).  Exposure to PM has been 
associated with systemic inflammation (see Section 1.3.2), which in turn may trigger 
cardiac arrhythmias (Hatzinikolaou-Kotsakou et al., 2006).  Intravenous injections of 
UFP suspensions from DE engines have also been reported to induce ventricular 
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premature beats (VPB) in healthy rats in vivo (Wold et al., 2006).  However, this 
study assumes the particulate, or its soluble constituents, triggers arrhythmias 
through direct electrophysiological effects on cardiac myocytes.  Whether particles 
enter the systemic circulation is a matter of intense debate (see Section 1.3.4) and it 
is currently unknown whether these direct effects on induction of arrhythmia will 
apply when animals are exposed to DEP via inhalation or instillation.  More recently, 
a study by Hazari et al. (2009) reported the potential for a single exposure of ROFA 
to sensitise the heart to a subsequent dysrhythmic stimulus.  24 hours after exposure, 
ROFA-exposed spontaneously hypertensive (SH) rats developed arrhythmias at 
lower doses of aconitine than air exposed SH rats (Hazari et al., 2009).  This 
suggestion that a single exposure to PM may render the heart more sensitive to 




       
Animal Model 
Route of 





occlusion Inhalation CAPs 
85-1056 µg/m3 x 
6h/d x 3d Increased 




abnormalities Inhalation ROFA 
50 µg/m3 x 3h/d x 
3d No effect 
Muggenburg et al., 
2003 
Dog Healthy Inhalation Metals 
3 mg/m3 x 3h/d x 
3d No effect 




hypertension Instillation ROFA 0.25, 1.0, 2.5 mg Increased 
Watkinson et al., 
1998 
Rat 
Prior left ventricular 
MI Inhalation ROFA 3 mg/m3 x 1h Increased 




hypertension Inhalation CAPs >360 µg/m3 x 3h Increased 
Gordon et al., 
1998 
Table 1.2 Overview of animal exposure studies investing the acute effects of particulate exposure on arrhythmia. 





Changes in QT interval and T-wave morphology have been reported both in humans 
(Henneberger et al., 2005) and in animals (Ghelfi et al., 2008; Godleski et al., 2000) 
following PM exposure.  These parameters, indicative of possible changes in ion 
channel function, have recently been attributed, in part, to vagal sensory receptors 
and their reflex effects (Ghelfi et al., 2008; see Section 1.3.3 for a more detailed 
discussion).  Ion channel modulation may account for impaired left ventricular 
diastolic performance reported in rats following in vivo exposure to DEP (Yan et al., 
2008).  It is important to note, however, that not all animal studies have found PM to 
affect the heart’s electrical conduction system (Muggenburg et al., 2000; 
Muggenburg et al., 2003).  These conflicting results may reflect different sources and 
chemical properties of pollutants. 
 
As will be discussed in more detail in Section 1.3.1, oxidative stress in the lungs, 
resulting from exposure to PM, has been shown to induce and/or augment the 
pulmonary inflammatory response that arises following exposure to air pollution 
particles.  It has also been suggested that this oxidative stress extends beyond the 
lung.  Gurgueira et al. (2002) demonstrated for the first time particle-driven 
increased production of oxidants in the heart in vivo.  Inhalation of CAPs in rats 
resulted in 300% increases in the levels of oxidants in the heart, as measured by 
chemiluminescence (CL) (Gurgueira et al., 2002).  There have been some recent 
attempts to elucidate potential mechanisms linking particle deposition in the lung to 
oxidative stress in the heart.  The increase in oxidative stress in rat hearts 12 hours 
after intra-tracheal instillation was found to be associated with elevated peripheral 
neutrophil counts (Yokota et al., 2008b).  Other investigators have, however, 
suggested that particle exposure alters the ANS leading to oxidative stress in the 
heart (Rhoden et al., 2005).  Pre-treatment with either atenolol (beta 1 (β1) 
adrenoceptor antagonist, 5 mg/kg) or glycopyrrolate (muscarinic receptor antagonist, 
0.30 mg/kg) abolished the oxidative stress in hearts of rats after inhalation of CAPs 
(Rhoden et al., 2005).  Lastly, increased superoxide production was reported in 
isolated neonatal rat cardiac myocytes exposed to DEP for up to 24 hours (Okayama 
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et al., 2006).  However, similar to the study by Wold et al. (2006), as described 
above, this study assumes that DEP can be translocated from the lung into the 
circulation, which remains an unsolved and controversial issue. 
1.2.4.2 Pollution and myocardial infarction (MI) 
Timely restoration (reperfusion) of blood flow, either by percutaneous coronary 
intervention (PCI) or fibrinolytic therapy, has been successful in salvaging ischaemic 
myocardium and improving clinical outcome.  Despite this, reperfusion itself may 
lead to accelerated and additional myocardial injury beyond that generated by 
ischaemia alone (Yellon et al., 2007).  This phenomenon has been termed 
“reperfusion injury” (Jennings et al., 1960) and may manifest as arrhythmias, 
contractile dysfunction, endothelial dysfunction, and ultimately cell death (Yellon et 
al., 2007).  The molecular and cellular events involved in myocardial I/R injury are 
complex, and not fully understood.  A pivotal feature of reperfusion is that 
neutrophils are quickly recruited into the ischaemic myocardium following 
reperfusion releasing inflammatory mediators (eg, proteases, cytokines and ROS) 
(Jordan et al., 1999).  Mitochondrial damage leading to increasing membrane 
permeability is also recognised as a contributing factor in the development of I/R 
injury (Di Lisa et al., 2006). 
 
Exacerbation of reperfusion-induced arrhythmias and increased reperfusion-related 
mortality has been reported in rats 24-48 hours after intra-tracheal instillation of DEP 
(Yokota et al., 2004; Yokota et al., 2008a).  The same group of investigators also 
noted that the circulating neutrophil count was significantly elevated among those 
animals receiving DEP.  Furthermore, pre-treatment with superoxide dismutase 
(SOD) abolished the exacerbation of arrhythmias (Yokota et al., 2004).  Based on 
these observations, the investigators suggested that increased neutrophil infiltration 
and subsequent ROS generation greatly increases the susceptibility to arrhythmias.  
Indeed, infiltration and activation of neutrophils into the ischaemic myocardium is 
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known to play an important role in the genesis of arrhythmias (Jordan et al., 1999).  
Alternatively, myocardial ischaemia may increase the susceptibility to arrhythmias.  
In a conscious canine model, CAP inhalation significantly augmented ischaemia-
induced electrocardiogram (ECG) changes (ST-segment elevation) compared to the 
filtered air-exposed control animals (Godleski et al., 2000; Wellenius et al., 2003).  
A follow-up study implicated impaired myocardial blood flow as contributing to the 
response (Bartoli et al., 2009a).  However, the mechanisms responsible for the 
observed effects of CAPs on myocardial blood flow have not been identified.  
Studies conducted by the clinical research department at the University of Edinburgh 
reported inhalation of dilute DE to exacerbate myocardial ischaemia during exercise 
in males with stable coronary heart disease (Mills et al., 2007).  Only one 
experimental study has assessed the effects of PM exposure on myocardial ischaemia 
and reperfusion-induced tissue injury in vivo.  In that study, the investigators found 
the infarct size to be larger in mice 24 hours after pulmonary exposure to CAP.  
However, the mechanism by which pulmonary exposure to pollution is associated 
with enhanced reperfusion injury is currently unclear. 
1.2.5 Summary 
In summary, considerable research attention has been devoted to short-term increases 
in particulate levels sparking a cascade of harmful effects on the heart and circulatory 
system.  Reported adverse cardiovascular events include cardiac arrhythmia, ECG 
changes, blood coagulation and vascular injury.  Furthermore, there is some limited 
evidence to suggest that exposure to PM may render the heart more susceptible to 
subsequent ischaemic injuries, such as arrhythmias and infarction.  However, the 
mechanism by which pulmonary exposure to pollution is associated with injury in 
other parts of the body is currently unclear.  It is also unknown whether pulmonary 
exposure to DEP exacerbates ischaemic injury during acute vessel obstruction. 
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1.3 Biological mechanism 
Although it is clear that PM has adverse cardiovascular health effects (refer to 
Sections 1.1 and 1.2), the underlying biological mechanism(s) remain unclear.  
Proposed biological mechanisms linking PM to cardiovascular disease include: 1) 
Systemic inflammation as a consequence of “spill-over” of inflammatory mediators 
(e.g., cytokines) from the lungs to the systemic circulation, 2) ANS imbalance, and 
3) Direct toxic cardiovascular effects through the ability of particles (or their 
associated constituents) to gain direct access into the systemic circulation (Brook et 
al., 2004).  The following section explores each of these in more detail.  
1.3.1 Pulmonary inflammation 
A number of in vivo (animal) and in vitro (cell culture) studies have shown that 
various particles (including carbon black (CB), CAP and DEP) can induce lung 
inflammation (Boland et al., 1999; Chang et al., 2005a; Li et al., 2002; Madden et al., 
2000; Nemmar et al., 2003b; Rhoden et al., 2008; Rhoden et al., 2004; Shaw et al., 
2009).  PM is taken up by phagocytic alveolar macrophages and bronchial epithelial 
cells in vitro and, in turn, up-regulates production of pro-inflammatory cytokines 
(Fujii et al., 2001; Mukae et al., 2000; van Eeden et al., 2001).  Moreover, in vitro 
inflammatory responses to particulates are amplified by interactions between alveolar 
macrophages and epithelial cells (Fujii et al., 2002).  With regard to DEP, incubation 
of human bronchial epithelial cells with DEP increased the release of the pro-
inflammatory cytokines interleukin-8 (IL-8) and granulocyte-macrophage colony-
stimulating factor (GM-CSF) (Boland et al., 1999).  An inflammatory response in the 
airways, characterised by an increased number of neutrophils in sputum, has also 
been reported after 2 hour exposure of healthy volunteers to inhaled DEP 
(Nightingale et al., 2000) or whole DE in humans (Salvi et al., 1999). 
 
Several studies have shown PM to induce oxidative stress in alveolar epithelial cells 
in vitro (Baeza-Squiban et al., 1999; Li et al., 2002; Stringer et al., 1998) and in lung 
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in vivo (Gurgueira et al., 2002; Rhoden et al., 2004).  For example, rats exposed by 
inhalation to CAPs increased oxidised lipid levels (indicative of oxidative stress) in 
the bronchoalveolar lavage (BAL) fluid 24 hours after exposure (Rhoden et al., 
2004).  ROS may be generated by the particles themselves through their redox ability 
or released by alveolar macrophages or epithelial cells after particle up take 
(Donaldson et al., 2003).  As mentioned briefly in Section 1.2.4.2, particulate-
induced oxidative stress has been reported to mediate some of the inflammatory 
responses to PM (Becker et al., 1996; Grimm et al., 2010; Kvetnansky et al., 1978; 
Li et al., 2002; Rhoden et al., 2008; Rhoden et al., 2004).  In vitro cell culture 
models have shown exposure to PM to up-regulate activation of redox-sensitive 
transcription factors (eg, nuclear factor (NF)-ĸβ) involved in the production of pro-
inflammatory cytokines induced upon in vivo exposure to PM (Kvetnansky et al., 
1978; Shukla et al., 2000).  Further supporting ROS as mediators of the effects of 
particulates, N-acetylcysteine (NAC) pre-treatment prevented the DEP-mediated 
potentiation of IL-6 release in THP-1 cells (a macrophage cell line) (Li et al., 2002).  
Pre-treatment with the anti-oxidant NAC also effectively attenuated the influx of 
neutrophils in BAL fluid from rats after inhalation exposure to CAP (Rhoden et al., 
2004).  It is important to note that mechanisms other than ROS have been implicated 
in the regulation of inflammatory responses to PM exposure.  Elevated BAL 
histamine and neutrophil levels have been reported after exposure to DEP in rats 
(Nemmar et al., 2003a) and humans (Salvi et al., 1999).  Moreover, pre-treatment 
with the histamine receptor antagonist diphenhydramine prevented the increase in 
neutrophils seen in BAL fluid from DEP-exposed rats (Nemmar et al., 2003a). 
1.3.2 Systemic inflammation 
It has been proposed that PM deposited in the lung may affect the cardiovascular 
system indirectly through the release of inflammatory mediators from the lung into 
the systemic circulation (Seaton et al., 1995). Terashima et al. (1997) demonstrated 
that alveolar macrophages, on exposure to inert fine carbon particles, release 
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inflammatory mediators to stimulate polymorphonuclear leukocytes (PMN) release 
from the bone marrow, as well as shortening of the transit time of PMN through the 
marrow.  Similar results have been observed in animals exposed to other well-
characterised PM (Mukae et al., 2000), as well as in humans during episodes of acute 
high-level PM exposure (Tan et al., 2000).  Moreover, instillation into rabbit lungs of 
supernatants from alveolar macrophages cultured with PM produced a bone marrow 
response similar to that produced by instilling the particles themselves (Mukae et al., 
2000; Terashima et al., 1997).  Significant positive correlations between blood 
neutrophil count and neutrophil mobilising cytokines (including IL-6 and 
granulocyte-colony stimulating factor (G-CSF)) levels in BAL fluid 12 hours after 
the intra-tracheal instillation of DEP in rats further supports the hypothesis that 
mediators released from the lung contribute to the systemic response (Yokota et al., 
2005).  Of note, high levels of circulating leukocytes have been associated with an 
increased mortality (Friedman et al., 1974). This in turn, may be a factor in the 
cardiovascular mortality that has been associated with air pollution.  A recent in vitro 
study in Edinburgh has also supported the potential for airborne particulates to 
adversely affect the cardiovascular system through indirect pathways (Shaw et al., 
2009).  In this study, supernatants recovered from DEP-laden monocyte-derived 
macrophages potentiated pro-inflammatory cytokine release from human umbilical 
vein endothelial cells (HUVEC) and may serve as a plausible mechanistic link 
between the previously described association of PM exposure and vascular 
dysfunction (Shaw et al., 2009). 
 
Increases in circulating levels of CRP, an acute-phase protein produced in the liver, 
have also been reported after acute exposure to air pollutants both in animals (Lei et 
al., 2005) and in humans (Peters et al., 2001b; Sandhu et al., 2005).  Peters and co-
workers showed that elevated serum levels of CRP were positively associated with 
episodes of increased air pollution in healthy men (Peters et al., 2001b).  Increased 
circulating levels of CRP are associated with systemic inflammation (Rattazzi et al., 
2003).  In addition, this inflammatory marker may predict the risk of MI among 
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healthy individuals, as well as among patients with ischaemic heart disease (Berton 
et al., 2003; Morishima et al., 2002; Ridker et al., 1997).  It is important to note, 
however, that while the pulmonary responses to PM appear to be relatively consistent, 
results have been notoriously variable regarding systemic inflammation (Mills et al., 
2008; Mills et al., 2005; Swiston et al., 2008).  Indeed, Mills and colleagues have 
reported no systemic inflammation in humans following short-term exposure to CAP 
(Mills et al., 2008) or DE (Mills et al., 2005).  Differences in the type and 
composition of the particulate or co-pollutant may explain these discrepancies. 
1.3.3 Imbalance of ANS activity 
1.3.3.1 HRV 
The potential role of the ANS in mediating the acute cardiovascular responses to 
particulate air pollution has already been referred to in previous sections.  HRV 
analysis has been widely used as a non-invasive measurement of cardiac autonomic 
function (Malik et al., 1990; Pomeranz et al., 1985).   Whilst there are some 
inconsistencies in epidemiological studies (as mentioned in Section 1.2), the general 
consensus is that HRV is decreased following exposure to PM (Gold et al., 2000; 
Liao et al., 1999; Pope et al., 1999).  Depressed HRV may reflect an increase in 
sympathetic activation and/or decrease in parasympathetic activation.  Low HRV has 
been associated with increased cardiovascular mortality, even in relatively healthy 
individuals, and with lowering of the threshold for arrhythmia (Algra et al., 1993; 
Dekker et al., 2000; Hohnloser et al., 1997; Tsuji et al., 1996).  Changes in HRV 
may therefore to some extent explain the ECG abnormalities and arrhythmias 
reported in animals and humans after short-term pollution exposures (Godleski et al., 
2000; Kodavanti et al., 2001; Mills et al., 2007; Watkinson et al., 1998).  It is, 
however, important to note that in contrast to epidemiological studies, human and 
animal exposure studies have been less conclusive.  While some studies have 
reported a decreased HRV (Chang et al., 2005b; Devlin et al., 2003; Frampton et al., 
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2004; Wellenius et al., 2002) after PM exposure, others have reported an increase 
(Elder et al., 2007; Elder et al., 2004; Gong et al., 2003; Tankersley et al., 2004) or 
no change in HRV (Fakhri et al., 2009; Muggenburg et al., 2003; Routledge et al., 
2006). 
1.3.3.2 How does pulmonary exposure to pollution modify ANS activity 
To date, how pulmonary PM exposure would modulate autonomic functions remains 
unclear.  This modulation may be a secondary, downstream effect caused indirectly 
by the release of inflammatory mediators and/or ROS into the systemic circulation 
(Brook et al., 2004; Rhoden et al., 2005).  Rhoden et al. (2005) showed that pre-
treatment of rats with the anti-oxidant NAC (50 mg/kg i.p.) could prevent PM-
dependent changes in heart rate (HR) and HRV.  The particles themselves may also 
modulate cardiac electrophysiology by interacting with ion channels in the 
myocardium (Brook et al., 2004; Graff et al., 2004).  However, it remains in doubt 
whether particles in the systemic circulation reach a concentration high enough to 
exert biological effects (see Section 1.3.4).  An alternative, and perhaps more likely 
explanation, is that receptors expressed in airway afferent C-fibres sense pollutants 
deposited in the respiratory system and, in turn, initiate cardiac autonomic reflexes.  
Pollutants including, O3 (Lee et al., 2001), sulphur dioxide (SO2) (Wang et al., 1996), 
wood smoke (Lai et al., 1998) and DE (Wong et al., 2003) have all been shown to 
stimulate pulmonary C-fibre afferents.  What is not clear is the mechanism 
underlying the activation of these lung sensory receptors in response to air pollution.  
Data have linked the activation of sensory receptors to the surface charge carried on 
the PM (Oortgiesen et al., 2000).  On the other hand, others have shown activation of 
sensory receptors in the airways by ROS that are produced in the lung when 
inflammation accompanies exposure to PM (Bessac et al., 2008).  Finally, receptor 
transactivation or crosstalk between different classes of sensory receptors following 
PM exposure has also been reported (Skrzypiec-Spring et al., 2007). 
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1.3.3.2 Transient receptor potential (TRP) channels 
The TRP channels are a group of ion channels, located on a large number of tissues 
and cell types, that often function as cellular sensors to perceive and respond to a 
wide range of stimuli, including chemical irritants, pain, protons, temperature, 
mechanical force, taste and osmolarity (Johnson et al., 2006; Moran et al., 2004).  
This class of ion channel was first described in Drosophila in 1977, where 
photoreceptors carrying TRP exhibited a transient response to continuous light 
(Minke, 1977).  To date, 28 mammalian TRP channels have been identified and are 
divided into six sub-families based on amino acid sequence identity: TRPV 
(Vanilloid), TRPC (Classical), TRPM (Melastatin), TRPML (mucolipin), TRPP 
(polycystin) and ANKTM1 (ankyrin transmembrane protein 1) (Moran et al., 2004).  
Most TRP channels are tetrameric calcium-permeable non-selective cation channels 
with six TM spanning domains, a pore region situated between helices five and six 
and intracellular carboxy and amino termini (Clapham et al., 2001)(Figure 1.5).  





Figure 1.5 Topological model of transient receptor potential (TRP) channel 
structure. 
The typical TRP channel consists of six transmembrane domains (TM1-TM6), an 
intracellular pore loop between TM5 and TM6 and an intracellular carboxy and 
amino termini.  Figure adapted from Clapham et al., 2001. 
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To date, only one study has reported TRP activation by PM in vivo to be damaging to 
the heart (Ghelfi et al., 2008).  These investigators reported that the pharmacological 
TRPV1 inhibitor capsazepine (CPZ) prevented the cardiac oxidative stress and 
electrophysiological changes in rats following exposure to CAP (Ghelfi et al., 2008).  
Chapter 6 evaluates whether pulmonary TRPV1 blockade afects the ability of the 
hearts from DEP exposed rats to withstand subsequent ischaemic injury.  The 
TRPV1 ion channel was first cloned and characterised in 1997 by functional 
expression from rat dorsal root ganglia (DRG) tissue on the basis of capsaicin (the 
pungent component of chilli pepper) sensitivity (Caterina et al., 1997).  Besides 
capsaicin, TRPV1 is activated by noxious heat (<42°C) and, acidic pH, as well as by 
locally-generated peptides and inflammatory mediators (Caterina et al., 1997; 
Johnson et al., 2006; Moran et al., 2004).  Immunohistochemical studies have 
localised TRPV1 receptors in non-myelinated (C-fibre) afferents originating from 
DRG neurons projecting to the airways and lungs (Groneberg et al., 2004; Seki et al., 
2006; Watanabe et al., 2005).  As discussed above (see Section 1.3.3.1) many 
different air pollutants have been reported to activate pulmonary C-fibre afferents.  
Activation of pulmonary C-fibres evokes bursts of action potentials that are 
conducted to the nucleus tractus solitarius (NTS), in turn leading to reflex changes in 
autonomic, cardiovascular and respiratory systems (Coleridge et al., 1984) (Figure 
1.6).   
 
Vagal afferents can also give rise to an inflammatory airway response (neurogenic 
inflammation) through local antidromic axon reflexes, releasing neuropeptides such 
as substance P (SP) and calcitonin gene-related peptide (CGRP) (Figure 1.6) (Julius 
et al., 2001).  The released neuropeptides can initiate or amplify inflammation in the 
airways by acting on both immune (eg, neutrophils and macrophages) and non-
immune (eg, epithelial, endothelial and smooth muscle) cells to release inflammatory 
cytokines (Veronesi et al., 2000).  Using a cultured human bronchial epithelial cell 
line, BEAS-2B, Veronesi and colleagues demonstrated release of IL-6, IL-8 and 
TNFα cytokine protein 6 hours after exposure to SP or CGRP (Veronesi et al., 
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1999a).  Importantly, TRPV1 has been identified in a range of cell types other than 
C-fibre sensory neurons, such as airway epithelial cells and mast cells (Biro et al., 
1998; Veronesi et al., 2006).  Indeed data from numerous in vitro studies have shown 
that TRPV1 activation by capsaicin increases calcium influx and cytokine release in 
human respiratory epithelial cell lines (Reilly et al., 2003; Seki et al., 2007).  In vivo 
studies in rats exposed to capsaicin by inhalation have also reported respiratory 
inflammation (Reilly et al., 2003).  As was discussed in Section 1.3.1, many studies 
have shown that exposure to inhaled PM induces a pulmonary inflammatory 
response.  Attention has been given to the role of TRPV1 in mediating the 
inflammatory responses to PM exposure, but the results reported to date have been 
inconsistent (Oortgiesen et al., 2000; Veronesi et al., 1999b; Witten et al., 2005; 
Wong et al., 2003).  Using a cultured human bronchial epithelial cell line, BEAS-2B 
release of IL-6 after exposure to ROFA was blocked by the TRPV1 antagonist CPZ 
(Veronesi et al., 1999b).  Involvement of TRPV1 receptors in airway inflammatory 
responses to PM have also been reported on isolated mouse vagal pulmonary sensory 
neurons (Oortgiesen et al., 2000).  Others have, however, concluded that lung C-fibre 
activation does not play a dominant role in pollution-induced pulmonary 
inflammation and injury (Witten et al., 2005; Wong et al., 2003).  There has also 
been little experimental evidence to illustrate the molecular mechanism behind the 
observed sensitising effect of PM on TRPV1 receptors.  Agopyon et al. (2003) and 
others (Oortgiesen et al., 2000) have demonstrated that the effect of PM on TRPV1 
is strongly dependent on PM carrying a net-negative surface charge.  Neutral 
synthetic polymer microspheres (SPM) was markedly less effective than their 
charged counterparts in increasing intracellular Ca
2+
 and IL-6 in the mouse DRG 
(Oortgiesen et al., 2000).  TRPV1 receptors can also be activated by ROS that are 
produced in the lung when inflammation accompanies exposure to PM (Bessac et al., 
2008).  In cultured DRG (Story et al., 2003) and trigeminal ganglia (TG) (Jordt et al., 
2004) cells, TRPA1 has been shown to co-localise with TRPV1.  Moreover, it has 
been reported that TRPV1 is activated secondary to TRPA1 perhaps due to Ca
2+
 
influx or cytokine production (Skrzypiec-Spring et al., 2007). 
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Consideration of the role of TRPV1 in tissues other than the lung (such as, pancreas, 
liver and heart (O'Neil et al., 2003; Zahner et al., 2003)), is beyond the scope of this 
thesis.  However, it is worth mentioning that both pharmacological and gene 
knockout studies have demonstrated activation of TRPV1 receptors on the epicardial 
surface of the heart to elicit a local cardioprotective feedback loop (Hu et al., 2002; 
Rang et al., 2004; Wang et al., 2005).  For example, Wang and colleagues 
demonstrated TRPV1 gene deletion to impair post-ischaemic recovery in isolated 




Figure 1.6 Schematic of central and local axon reflex responses of 
bronchopulmonary C-fibres. 
A number of exogenous and endogenous stimuli can stimulate C-fibre afferents of 
the airways.  Action potential are generated and transmitted to the nucleus tractus 
solitarius (NTS), where they are integrated and ultimately influence the autonomic 
output to effector organs (e.g., heart).  Vagal afferents can also give rise to an 
inflammatory airway response (neurogenic inflammation) through local antidromic 
axon reflexes, releasing neuropeptides such as substance P (SP) and calcitonin gene-




Another potential mechanism is that the PM can be translocated from the lung into 
the circulation and thus exert direct effects on the heart and vessels.  Studies in rats 
with 
99
Tc-labelled nanocolloid albumin particles (Nanocoll) by Nemmar et al. (2001) 
found particles to be translocated across the respiratory epithelium to the blood 
circulation with subsequent uptake in the liver.  Other animal studies using inhalation 
or instillation techniques have reported the translocation of radio-labelled particles 
from the lungs to extra-pulmonary organs via the blood circulation (Chen et al., 
2006; Kreyling et al., 2002; Oberdorster et al., 2002).  UFP inhaled and deposited in 
the lungs has also been reported to enter the central nervous system (CNS) via 
neuronal pathways (Oberdorster et al., 2004).  In theory, the translocation of particles 
may explain the reported associations between UFP and cardiac events through 
effects on the ANS and/or initiation of a cascade of reactions involving plaque 
rupture and thrombosis (Knol et al., 2009).  However, the extent of this translocation 
and its pathological impact is likely to be governed by particle size and surface 
chemistry (Peters et al., 2006).  It is also important to note that the studies cited 
above, suggesting particle translocation from the lungs detected minute particle 
translocation ranging from 1% to 6% of the deposited particles (Chen et al., 2006; 
Kreyling et al., 2002; Nemmar et al., 2001; Oberdorster et al., 2004; Oberdorster et 
al., 2002).  Moreover, of the human studies conducted to date, the majority have 
detected no or very low levels of UFP outside the lungs (Brown et al., 2002; Mills et 
al., 2006; Nemmar et al., 2002).   DEP translocation has not yet been confirmed.  
Based on the existing evidence, it is reasonable to assume that if DEP did translocate, 
it would be unlikely to account for the full biological effects of DEP entering the 
lung. 
1.3.5 Summary 
Although a number of mechanisms have been proposed to explain the adverse health 
impact of PM, the issue remains unsolved.  Inflammation has been implicated in 
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many of the actions of DEP and other particles, including actions on the 
cardiovascular system.  However, many other adverse effects have been associated 
with activation of sensory receptors in the airways leading to alterations in 
autonomic balance.  Furthermore, it has been proposed that the particles may 
translocate from deposition sites within the lung into the blood circulation with the 
potential to have direct effects on extrapulmonary organs, but the evidence for this is 
limited.  It is also unlikely that particles would reach high enough concentrations in 
the circulation to account for the full biological effect. 
1.4 Hypothesis 
The work described in this thesis addressed the hypothesis that: 
Intra-tracheal instillation of diesel exhaust particulate (DEP) in rats renders the heart 
more sensitive to ischaemia/reperfusion (I/R)-induced damage secondary to 
activation of a systemic inflammatory response, endothelium dysfunction and altered 
cardiac autonomic reflexes. 
1.4.1 The specific aims were to: 
 Establish the influence of pulmonary exposure to DEP on endothelial cell 
function in vivo, following development of a suitable in vivo method for 
assessing endothelial cell function. 
 Establish the extent of pulmonary and systemic inflammation following intra-
tracheal instillation of DEP. 
 Establish the contribution of in vivo neurohormonal activation by pulmonary 
DEP to myocardial injury following I/R by comparing I/R outcomes in vivo 
with those ex vivo in isolated perfused hearts. 
 Investigate the mechanisms by which pulmonary exposure to DEP in vivo 
might ‘prime’ the heart for subsequent injury ex vivo, in particular the 
potential roles of a pulmonary sensory reflex involving activation of transient 
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receptor potential vanilloid 1 (TRPV1) receptors in the lung and beta 1 (β1) 








All experiments were performed according to the guidelines of the Animals 
(Scientific Procedures) Act 1986 (U.K. Home Office).  Licensed procedures were 
carried out under project licence PPL 60/4247 and personal licence PIL 60/11646.  
All experiments were approved by the ethical review committee for animal research 
at the University of Edinburgh.  Adult male Wistar rats (250 – 350 g; Charles River, 
Margate, UK), were housed under controlled environmental conditions (21 ± 2°C; 
12-hour light/dark cycle) and received ad-libitum access to tap water and to standard 
laboratory rat chow.  All animals were allowed to acclimatise to the environment for 
at least one week before commencing any surgical or experimental procedures. 
2.2 Preparation of diesel exhaust particulate (DEP) 
Suspensions of DEP (Standard Reference Material (SRM) 2975; National Institute of 
Standards and Technology (NIST), USA) were prepared in 0.9% sterile saline at a 
concentration of 1 mg/ml and then sonicated for 5 minutes in an ice bath using a 
probe-type sonifier (US70; Philip Harris Scientific, Lichfield, U.K.) set at 70% 
power (5 Hz).  The particle size analyser (Brookehaven PS90, Brookhaven 
Instrument Corporation, New York, USA) estimated the mean diameter of the DEP 
to be ~ 150 nanometres (nm).  Previous data from our laboratory demonstrate DEP 
suspensions to be endotoxin free (Shaw et al., 2009). 
2.3 Intra-tracheal instillation protocol 
Rats were anaesthetised using 5% isoflurane (Meriol, Essex, UK) delivered in 100% 
oxygen, and then positioned on an incline board at a 45 angle with the head upwards.  
With the tongue held out, a paediatric laryngoscope was used to visualise the vocal 
cords.  A 2 mm Luer port cannula (Portex, Kent) was inserted into the trachea and 
used to administer 0.5 ml DEP suspension (0.5 mg/rat), or an equivalent volume of 
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0.9% sterile saline, into the lungs.  The dose used is comparable to previous studies 
(Madden et al., 2000; Murphy et al., 1998; Yan et al., 2008; Yokota et al., 2008b) 
and experiments in this laboratory have shown this dose of DEP to induce systemic 
effects without acute toxicity (McQueen et al., 2007).  Non-instilled rats were 
included to ensure that the instillation procedure itself had no notable effects on the 
parameters studied. 
2.4 Collecting whole blood and plasma 
Blood was collected in heparinised syringes (100 IU.ml
-1
 final concentration; 
Multiparin® CP Pharmaceuticals, Wrexham, UK) via the abdominal aorta (whole 
blood cell (WBC) counts and measurements of plasma pro-inflammatory cytokine 
concentrations) or in heparinised tubes (100 IU.ml
-1
 final concentration) after 
decapitation (measurements of plasma catecholamine concentrations).  Whole blood 
was used immediately for basic haematological parameters (Chapter 2.5.4).  
Cytokine concentrations (Chapter 2.5.3) were measured in plasma obtained after 
centrifugation of whole blood at 1500 g for 5 minutes at 4°C.  Catecholamine 
concentrations (Chapter 2.6) were measured in plasma obtained after centrifugation 
of whole blood at 1000 g for 15 minutes at 4°C.  All plasma samples were stored at -
80°C until time of analysis. 
2.5 Assessment of pulmonary and systemic inflammation  
2.5.1 Bronchoalveolar lavage (BAL) 
A BAL was performed to assess pulmonary inflammation 6 and 24 hours after DEP 
instillation.  Briefly, the trachea was exposed and cannulated (0.3 mm outer diameter 
(o.d.), stainless steel) through which the lungs were lavaged with 8 ml of physiologic 
saline.  The fluid was retrieved by gentle syringe aspiration and this procedure was 
repeated four times.  The last three aspirated lavage fluids were pooled and 
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immediately placed on ice.  The recovered lavages were centrifuged at 2000 x g for 5 
minutes.  The supernatant from the first lavage was separated into 1 ml aliquots and 
stored at -80C until required for biochemical determination.   The supernatants 
fraction from the subsequent lavages were decanted and discarded.  All the cells 
were re-suspended in 1 ml of physiologic saline.  The total cell number in the BAL 
fluid was measured using an automatic cell counter (Sartorius Steadman, 
Chemometec, Nuclecounter®, Gydevang, Denmark (941-0002)).  Cytospin 
preparations of 10,000 cells in 300 μl phosphate buffered saline (PBS) containing 
0.1% bovine serum albumin (BSA) were prepared by cytocentrifugation (Shandon 
cytospin 3 centrifuge) onto glass slides (Superfrost Plus, 75 mm x 25 mm, VWR 
International Ltd., Leicestershire, UK) for 3 minutes at 300 rpm.  After air-drying, 
the cytospin preparations were fixed in 100% methanol for 1 minute and then stained 
using Diff-Quik physiological stain (Raymond A. Lamb, London, UK).  The 
differential cell count was performed using a hemocytometer (Sigma-Aldrich, Dorset, 
UK) under 100x magnification.  Results were expressed as absolute number of 
macrophages, neutrophils and other leukocytes.  A representative picture of a BAL 
cytospin slide from a rat 6 hours after the instillation of DEP is shown in Figure 2.1. 
2.5.2 Bicinchoninic acid (BCA) assay 
Increased lung permeability has been associated with airway inflammation 
(Henderson, 2005).  Increased lung permeability is usually accompanied by 
increased protein leakage into the lungs (Henderson, 2005).  Total protein levels in 
BAL fluid were determined using a standard bicinchoninic acid kit (BCA, Thermo 
Scientific Pierce, Northumberland, UK) to assess alveolo-capillary permeability as 
an indicator of lung inflammation.  The principle of the BCA method is based on the 
reduction of copper (II) to copper (I) upon reaction of protein with an alkaline 
solution.  The amount of reduction is proportional to the protein present.  Protein 
concentrations were determined from a standard curve generated using BSA at 
concentrations from 0.125 to 2 mg/ml.  Briefly, the BCA solution and copper (II) 
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sulphate solution were mixed in a 1:50 volume ratio.  190 μl of the BCA/copper mix 
was added to 10 μl of the sample or standard and the plates were incubated at 37C.  
Duplicates of each standard and sample were assayed.  After 30 minutes, the plate 
was placed in a spectrophotometer set at a wavelength of 570 nm (MRX plate reader.  




Figure 2.1 Representative Diff-Quick stained cytospin (x40 magnification) from 
a rat 6 hours after intra-tracheal instillation of diesel exhaust particulate (DEP). 
Microscopic image showing macrophages (large circular shape and single membrane 
bound nucleus) and neutrophils (smaller cells with a multi-lobed nucleus). 
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2.5.3 Quantification of cytokines 
The concentrations of interleukin-6 (IL-6), tumor necrosis factor alpha (TNF, and 
C reactive protein (CRP) in plasma and BAL fluid were quantified using enzyme-
linked immunosorbent assay (ELISA) (R & D Systems, Abingdon, UK) according to 
the manufacturs instructions.  Briefly, ninety-six well flat bottomed plates were 
coated overnight at room temperature with 100 μl per well of capture antibody 
(mouse anti-rat IL-6, or mouse anti-rat TNF, or mouse anti-rat CRP, all from R & 
D Systems, Abingdon, UK) diluted to a final concentration of 4 μg/ml in PBS.  The 
plates were then washed four times with 300 μl of washing buffer (0.05% Tween 20 
in PBS, pH 7.2-7.4, 0.2 μm filtered) and blocked by adding 300 μl of reagent diluent 
(1%BSA in PBS, pH 7.2-7.4, 0.2 μm filtered) to each well and incubating for a 
minimum of 1 hour at room temperature.  After a further washing step, 100 μl of 
standards in reagent diluent together with samples and controls were added in 
duplicate to wells.  The plates were incubated for 2 hours at room temperature and 
then washed with washing buffer.  Next, wells were incubated for 2 hours at room 
temperature with 100 μl of a cytokine-specific detection antibody (biotinylated goat 
anti-rat IL-6, or biotinylated goat anti-rat TNF, or biotinylated mouse anti-rat CRP, 
all from R & D Systems, Abingdon, UK) diluted to a concentration of 4 – 400 ng/ml 
in reagent diluent.  Thereafter, wells were washed and 100 μl of conjugated 
Streptavidin-horseradish peroxidase (HRP) (diluted 1/200 in reagent diluent) was 
added to detect the bound biotinylated detection antibody.  After 20 minutes at room 
temperature, wells were washed and 100 μl of the 3, 3’, 5, 5’ tetramethylbenzidine 
(TMB) liquid substrate (Sigma-Aldirich, Dorset, UK) was added.  The bound 
conjugated Streptavidin-HRP reacts with the TMB liquid substrate to generate a blue 
colour directly proportional to the concentration of cytokine present.  Plates were 
incubated in the dark at room temperature and after 20 minutes, the colour 
development was stopped by adding 50 μl of stop solution containing 2 N sulphuric 
acid (H2SO4) to each well. 
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Plasma interleukin-8 (IL-8) concentrations were quantified using the rat IL-8 ELISA 
kit (CUSABIO BIOTECH Co, Newark, USA) according to the manufacture’s 
instructions 6 hours after DEP instillation.  Briefly, 100 μl of standards in sample 
diluent together with samples were added in duplicate to a 96 well polystyrene 
microplate pre-coated with an antibody specific to IL-8.  The plates were incubated 
for 2 hours at 37°C and then the liquid contents carefully removed before adding 100 
µl of biotin-antibody (diluted 1/100 in biotin-antibody diluent).  After 1 hour at 37°C 
plates were washed three times with 200 µl wash buffer with a 30 second soak period 
and then 100 μl of HRP-avidin (diluted 1/100 in HRP-avidin diluent) was added to 
detect the bound biotinylated antibody.  Plates were incubated for 1 hour at 37°C.  
After a further washing step, 90 μl of the TMB liquid substrate was added.  The 
bound HRP-avidin reacts with the TMB liquid substrate to generate a blue colour 
directly proportional to the IL-8 concentration present.  Plates were incubated in the 
dark at 37°C and after 20 minutes, the colour development was stopped by adding 50 
μl of stop solution to each well. 
 
Following the addition of stop solution, all plates were gently mixed to ensure 
complete and uniform colour change from blue to yellow.  Finally, the plates were 
read at single wavelength at 450 nm (IL-8) or dual wavelength at 450-540 nm (IL-6, 
TNF, and CRP) in a Dynatech MXR microplate reader (Dynatech Laboratories; 
USA).  The lower limits of detection were 31.25, 15.63, 39.06 and 18.75 pg/ml for 
IL-6, TNF, CRP and IL-8 respectively.  A standard curve was generated for each 
assay performed of absorbance versus protein concentration.  The protein 
concentration of each sample was interpolated from the standard curve.  An example 
of a standard curve conducted for the IL-6 ELISA is shown (Figure 2.2). 
2.5.4 Haematological assays 
Blood was collected as detailed in Chapter 2.4.  The mean values of different 
haematological parameters; white blood cells (WBC), red blood cells (RBC) and 
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platelets; were measured with the Coutler®A
c
.T series analyser (Coutler Corporation, 
Miami, USA). 
2.6 Plasma corticosterone levels 
Plasma corticosterone concentrations were quantified using a commercial ELISA 
(CUSABIO®BIOTECH, USA) according to the manufacture’s instructions 6 hours 
after DEP instillation.  Briefly, 100 μl of standards in sample diluent together with 
samples (diluted 1/200 in sample diluent) were added in duplicate to a 96 well 
polystyrene microplate pre-coated with an antibody specific to corticosteroids.  The 
plates were incubated for 2 hours at 37°C and then the liquid contents carefully 
removed before adding 100 µl of biotin-antibody (diluted 1/100 in biotin-antibody 
diluent).  After 1 hour at 37°C plates were washed three times with 200 µl wash 
buffer with a 30 second soak period and then 100 μl of HRP-avidin (diluted 1/100 in 
HRP-avidin diluent) was added to detect the bound biotinylated antibody.  Plates 
were incubated for 1 hour at 37°C.  After a further washing step, 90 μl of the TMB 
liquid substrate was added.  The bound HRP-avidin reacts with the TMB liquid 
substrate to generate a blue colour directly proportional to the corticosterone 
concentration present.  Plates were incubated in the dark at 37°C and after 20 
minutes, the colour development was stopped by adding 50 μl of stop solution to 
each well.  The plates were then gently mixed to ensure complete colour change from 
blue to yellow.  Finally, the plate was read at dual wavelength 450/540 nm in a 
Dynatech MXR microplate reader (Dynatech Laboratories; USA).  The lower limit 
of detection was 6.25 pg/ml.  A standard curve was generated of absorbance versus 
protein concentration.  The protein concentration of each sample was interpolated 




Figure 2.2 Standard curve for interleukin 6 (IL-6) protein ELISA 
Standard curve for IL-6 ELISA using linear regression analysis.  The linear equation 
between IL-6 protein concentration (x-axis) and absorbance (y-axis) is shown.  The 
R-squared value estimates how well the regression line approximates real data points.  
R-squared of 1.0 indicates perfect fit. 
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2.7 Myocardial ischaemia/reperfusion (I/R) models 
2.7.1 In vivo induction of ischaemia 
The effects of DEP instillation on myocardial damage were investigated using a 45 
minute occlusion of the proximal left anterior descending coronary artery followed 
by reperfusion for 120 minutes as previously described (Jeanes et al., 2008). 
 
Rats were anaesthetised with an intra-peritoneal (ip) injection of sodium 
pentobarbital (60 mg.kg
-1 
body weight; Sagital, Rhone Merieux, UK) 6 hours after 
instillation. Animals were placed on a thermostatically-controlled under-blanket 
(Homeothermic Blanket Control Unit, Harvard Apparatus, UK) to maintain 
normothermia (37°C). 
 
A small midline incision was made in the ventral surface of the neck and the trachea 
exposed by blunt dissection of the sternothyroid muscle.  A 1.8 mm o.d. stainless 
steel cannula (Portex, Harvard Apparatus, UK) was then inserted into the trachea 
through a small transverse incision between the fourth and fifth tracheal rings.  The 
lungs were mechanically ventilated at a rate of 60 strokes/min and a stroke volume of 
1.5 ml/100 g body weight (Harvard rodent ventilator model 683; Harvard Apparatus, 
Kent, UK) to maintain pH, pO2 and pCO2 within physiological limits.  The right 
internal jugular vein was cannulated (0.8mm o.d., 0.5mm inner diameter (i.d.); 
Portex, Jencons Scientific Ltd, Bedfordhire, UK) for supplemental anesthetic if 
required. 
 
The left carotid artery was cannulated with polyethylene tubing (0.8mm o.d., 0.5mm 
i.d.; Portex, Jencons Scientific Ltd) filled with heparinised saline (100 IU.ml
-1
 final 
concentration; Multiparin® CP Pharmaceuticals, Wrexham, UK).  Care was taken to 
avoid damaging surrounding veins or vagal nerve.  The cannula was secured in place 
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with three 5-0 braided silk ligatures (InterFocus Ltd, England) and connected to a 
fluid filled pressure transducer (Powerlab/4SP, ADInstruments, UK) for continuous 
monitoring of the arterial blood pressure (systolic, diastolic and mean) and heart rate.   
A representative recording trace of arterial blood pressure is shown below (Figure 
2.3).  Electrocardiograms (ECG) were continuously monitored using subcutaneous 
wires in a three lead configuration (right arm, left leg, and right leg leads).  ECG 
signals were generated by connecting the lead wires to a Powerlab (Powerlab/4SP, 
ADInstruments, UK) via a Bridge Amplifier.  All data were collected on a 
MacLab/4e data acquisition system (AD instruments, Sussex, UK) and analysed 
using Chart™ software (AD Instruments, Sussex, UK) on a Macintosh computer 
(Power PC G3). 
 




 rib and dissection was 
continued down through the intercostal muscles and the ribs were gently spread with 
an adjustable screw retractor to expose the heart. To prevent lung injury during 
surgery, the left lung was temporarily collapsed by placing a saline-soaked gauze 
swab over the lung and gently pressed away from the heart.  The pericardial sac was 
then opened and the heart was exteriorised by gently lifting with a cotton bud placed 
on the underside.  A piece of 5-0 braised silk suture (11-mm round bodied, 
InterFocus Ltd) attached to a needle holder was placed around the left anterior 
descending (LAD) coronary artery.  The suture was then threaded through a 
polyethylene tube and the heart was immediately replaced in the chest cavity.  After 
a stabilisation period of 10 minutes, the coronary artery was occluded by tightening 
the ligature using the polyethylene tube and clamping in place.  Occlusion was 
verified by the appearance of epicardial cyanosis and a transient drop in arterial 
blood pressure.  Experiments where the procedure produced a sustained decrease in 
blood pressure of less than 60 mmHg were discontinued.  After a 45 minute period of 
coronary occlusion, reperfusion was initiated by gently releasing the clamp and then 
monitored for 2 hours under continued anaesthesia.  All cardiovascular parameters 
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were monitored continuously, noting the responses every 15 minutes during the 
ischemic-reperfusion period.  At the end of the 2 hour reperfusion period, the LAD 
coronary artery was re-occluded and Evans blue (1% w/v in 1 ml PBS) was injected 
into the right jugular vein catheter to differentiate between the ischaemic area at risk 
(AAR) and non-ischaemic heart tissue (Figure 2.4).  The heart was then rapidly 
removed, rinsed with PBS and stored at -20C until analysis. 
2.7.1.1 Quantification 
The mean arterial pressure was computed as diastolic pressure plus one third of the 
difference of systolic blood pressure (SBP) minus diastolic blood pressure (DBP).  
Heart rate (HR) was measured as the period of time between successive systolic 
peaks.  At each time point, all haemodynamic parameters were calculated as the 




Figure 2.3 Typical arterial blood pressure waveform recorded from the carotid 
artery of anesthetised non-instilled rats before the induction of cardiac 
ischaemia. 
The trace displays arterial pressure in millimeters of mercury (mmHg) versus time in 
seconds (s) recorded from a pressure transducer connected to the left carotid artery.  
The peak pressure is defined as the systolic pressure and the minimum pressure is 
defined to as the diastolic pressure. 
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Figure 2.4 Isolated rat heart showing area at risk of cardiac ischaemia. 
Representative heart collected after 45 minutes of cardiac ischaemia and 2 hours of 
reperfusion.  Evans blue (1% w/v in 1 ml PBS) was injected as a bolus into the 
jugular vein.  The area left unstained by Evans blue was defined as the area at risk 
(AAR), and the blue stained region was the well-perfused (non-ischaemic) area. 
56 
 
2.7.2 Induction of ischaemia ex vivo (Langendorff) 
The effect of particle instillation on myocardial damage was also investigated ex vivo 
using a Langendorff perfusion system (Figure 2.5).  Animals were anaesthetised by 
inhalation of 5% isoflurane delivered in 100% oxygen.  The hearts were removed 
and immediately arrested in ice-cold HEPES buffer (composition: 5 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid, 140 mM NaCl, 4 mM KCl, 1 mM 
MgCl2, 11 mM glucose 11.1; pH 7.4; 4°C).  Immediately before anaesthesia animals 
received an ip injection of heparin (100 IU.ml
-1
 final concentration; Multiparin® CP 
Pharmaceuticals, Wrexham, UK) to prevent the formation of thrombi in the excised 
heart.  Following removal of excess connective tissue, the aorta was held below the 
cannula for a few seconds allowing it to fill with Tyrodes solution (composition: 116 
mM NaCl, 20 mM NaHCO3, 0.4 mM Na2HPO4, 1 mM MgSO4, 4 mM KCl, 11 mM 
glucose, 2.5 mM CaCl2; 37 ± 1°C), making sure all air bubbles were removed.  The 
cannula was then inserted into the ascending aorta, secured in place and perfused at a 
constant flow of 10 ml/min (delivered via a ML172 Minipuls 3 Peristaltic pump, AD 
Instruments, Sussex, UK) for the duration of the experiment.  The heated glass 
chamber of the Langendorff apparatus was placed around the heart in order to 
provide a warm (37°C) and humid environment.  Coronary perfusion pressure (CPP) 
was measured using a fluid-filled pressure transducer (Powerlab/4SP) attached to a 
side port immediately above the level of the heart.    Following a stabilisation period 
of 10 minutes, a piece of 5-0 braised silk suture was placed around the LAD 
coronary artery and ischaemia was initiated using the threaded polyethylene tube as 
described for in vivo experiments (Chapter 2.6.1.1).  After 30 minutes of ischaemia, 
the clamp was released to allow reperfusion for 2 hours.  At the end of the 2 hour 
reperfusion period, the LAD coronary artery was re-occluded and Evans blue (1% 
w/v in 1 ml PBS) was injected into the aortic cannula to differentiate between the 
ischemic (AAR) and non-ischemic heart tissue.  The heart was then rapidly removed, 




Figure 2.5 Photograph showing the components of the Langendorff heart 
preparation. 
Hearts are attached to the Langendorff perfusion system through a cannula in the 
ascending aorta.  Perfusate buffer is pumped through a water jacketed coil.  This 
fluid is then delivered in a retrograde direction down the aorta at a constant flow rate 
(delivered via a Peristaltic pump).  A side port in the junction block is used to 




2.8 Tissue sampling 
Hearts were removed from rats 6 hours after DEP instillation and placed immediately 
in 0.9% saline.  After thoroughly rinsing in 0.9% saline, the atria, large vessels and, 
connective tissue were trimmed and the heart was cut either longitudinally or 
transversely, approximately half way between the apex and base to expose the inside 
of the left and right ventricles.  The hearts were fixed for 24 hours in 10% neutral 
buffered formalin prior to further processing and paraffin wax embedding.  The first 
step of processing involves the removal of water from the tissue by immersion in 
increasing concentrations of ethanol.  Next, as ethanol is not miscible with the 
paraffin wax, the ethanol from the tissue is removed prior to wax impregnation.  This 
is achieved by transfer of the tissue to a wax miscible agent, also referred to as a 
clearing agent.  Finally, the tissue is embedded in paraffin wax to form tissue blocks.  
The blocks were stored at room temperature until ready for sectioning. 
2.9 Histology 
2.9.1 Triphenyltetrazolium chloride staining 
Infarct size was determined by 2, 3, 5-triphenyltetrazolium chloride (TTC) (Sigma-
Aldrich, Dorset, UK) staining as previously described by Jeanes et al. (2006) with 
minor modifications.  The heart was sliced into 2-3 mm thick transverse sections 
from apex to base.  The slices was then immersed in a 1% w/v solution of TTC in 
saline (0.9% w/v) at 37C and stained for 30 minutes.  This technique differentiates 
between viable (viable ischaemic tissue) and infarcted (necrotic ischaemic tissue) 
tissue within the AAR as identified previously by the absence of Evans blue staining.  
TTC is reduced to TTC-formazan, an insoluble brick-red precipitate, by 
dehydrogenase enzymes present in viable myocardial tissue.  Thus, significantly 
lower levels of dehydrogenase enzymes in infarcted myocardial tissue leaves this 
59 
 
tissue unstained (white) by TTC.  A representative Evan’s blue/TTC-stained section 
of a rat heart is shown in Figure 2.6.  After TTC staining, the slices were immersed 
for 10 minutes in 10% formalin (Sigma-Aldrich, Dorset, UK) in PBS to enhance the 
contrast of the stain and then rinsed for 10 minutes in saline (0.9% w/v).  Total left 
ventricle (LV), AAR and infarct were separated by careful dissection and weighed.  
The AAR was expressed as a percentage of the LV and infarct size as a percentage of 
either LV or the AAR. 
2.9.2 Haematoxylin and eosin (H & E) staining 
Paraffin wax-embedded hearts were sectioned at 5 μm using a retractable rotary 
microtome (Leitz Weltslar 1512 microtome) and floated onto a water bath 
maintained within 40-45C.  After a few minutes to allow any wrinkles to smooth 
out, the sections were mounted on SuperFrost® Plus glass slides (VH Bio, Tyne and 
Wear). The slides were then left to air-dry for a minimum of 10 minutes before being 
placed in a humid chamber at a temperature of 37C overnight. 
 
For H & E staining, the sections were completely de-waxed by placing in xylene for 
1 minute (2 changes of 30 seconds).  After de-waxing, sections were re-hydrated 
through descending grades of alcohol (100% ethanol for 1 minute, 74% ethanol for 1 
minute twice) to running tap water.  Sections were then placed in Harris 
haematoxylin (Shandon) to stain cell nuclei dark-blue.  After incubation for 
approximately 5 minutes, the sections were gently rinsed with running tap water (1 
minute) and then immersed in alkaline tap water (2-3 drops of ammonia in 400 ml 
tap water for 1 minute) to stop the reaction.  Sections were differentiated in acid 
alcohol (1% hydrochloric acid in 74% ethanol) for 5 seconds and then immediately 
washed well with running tap water.  Sections were then counterstained in alcoholic 
Eosin Y (Sigma) for 30 seconds followed by a wash in running tap water and 
dehydration through a graded series of alcohol (74% ethanol for 1 minute twice, 
100% ethanol for 1 minute).  Finally, sections were cleared in xylene (2 changes of 2 
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minutes) and a cover slipped was mounted using DPX mounting media.  Neutrophils 
were viewed with an Image Pro6.2, Stereologer Analyser 6 MediaCybernetics 
(Buckinghamshire, UK).  For quantification, sections were tiled at x100 
magnification (using a 100x objective).  The entire LV was identified as the area of 
interest using the Image Pro6.2 computer programme after image acquisition.  
Neutrophils were identified by their distinct morphological nature showing multi-
lobed nuclei at x100 magnification.  Cells were counted in the LV from 15 randomly 







Ischaemic, non-necrotic tissue 
(area at risk)
 
Figure 2.6 Section of an infracted heart after ischaemia and reperfusion. 
Representative photograph of heart section stained with Evans blue and 2, 3, 5-
triphenyltetrazolium chloride (TTC).  Tissue stained blue by Evans blue represents 
normal perfused myocardium.   TTC stains the ischemic but viable tissue brick red 
whereas the necrotic ischemic tissue (infarct) is unstained (white) by TTC. 
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2.10 Assessment of neutrophil activation status by flow 
cytometry 
2.10.1 Flow cytometry 
Whole blood flow cytometry was used to assess granulocyte activation status 
following DEP exposure by quantifying the expression of the two cell surface 
molecules CD11b and L-selectin (CD62L) (Cozzi et al., 2006).  Flow cytometry is a 
method routinely used to identify cell populations based on light scatter and 
fluorescence.  Light scattered by the cells is measured in the forward and sideways 
directions.   Forward scatter (FS) is a measure of cell size, whereas side scatter (SS) 
is a measure of cell granularity (Ibrahim et al., 2007).  When activated, cells show an 
increase in CD11b expression and a decrease in expression of L-selectin.  We 
hypothesised that exposure to DEP would induce activation of neutrophils.  Primed 
neutrophils would be more likely to adhere to the endothelium causing increased 
damage during myocardial I/R.  Initial attempts at staining of neutrophils with a 
neutrophil specific antibody (phycoerythrin (PE)-conjugated mouse anti-rat IgG2a 
mAb, clone RP-1, BD Pharmingen, Oxford, UK) were unsuccessful.  Many attempts 
were made to develop and optimise the protocol including testing various blood anti-
coagulants as well as checking for variation between antibody batches.  Therefore the 
expression of CD11b and L-selectin were assessed on all granulocytes (neutrophils, 
basophils and eosinophils). 
 
Whole blood was withdrawn into a heparin (100 U/ml final concentration, 
Multiparin®, CP Pharmaceuticals, Wrexham, UK) rinsed 10 ml aspiration syringe 
and immediately placed on ice.  As a positive control a subset of blood samples were 
stimulated with formyl-Met-Leu-Phe-OH (fMLP) which has previously been shown 
to increase leukocyte adhesion ex vivo (Shen et al., 1999).  To determine the optimal 
concentration of fMLP, heparinised whole blood was treated with increasing 
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concentrations (0.001 – 10 µg/ml) for 30 minutes at 37°C with gentle shaking.  1 
µg/ml was used for all subsequent studies.  After 30 minutes, non- and fMLP-
stimulated blood was placed on ice for 15 minutes and then stained with saturating 
concentrations of fluorochrome-conjugated antibodies directed against CD11b 
(Fluorescein Isothiocyanate (FITC)-conjugated mouse anti-rat mAb, clone OX-42, 
10 µg/ml, AbD serotec, Oxford, UK) or CD62L (FITC-conjugated mouse anti-rat, 
clone OX-85, 0.1 mg/ml, AbD serotec, Oxford, UK).  All antibodies were titrated in 
preliminary experiments to determine the optimum antibody concentration.  
Following incubation in the dark at room temperature for 20 minutes, erythrocytes 
were lysed by adding 2 ml of AbD Serotec’s Erythrolyse diluted 1:10 in distilled 
water.  After 10 minutes, samples were centrifuged for 5 minutes at 400 g and the 
supernatant discarded.  Cells were then washed in 2 ml PBS containing 1% BSA and 
centrifuged for 5 minutes at 400 g.  Finally, the supernatant was decanted and the cell 
pellet re-suspended in 200 µl of PBS containing 1% BSA.  Unstained cells were also 
included as a negative control to detect any autofluorescence or background staining.  
FITC-conjugated mouse IgG2a mAb (10 μg/ml, AbD serotec, Oxford, UK) was used 
as an isotype control for the test antibodies to estimate non-specific binding. 
2.10.2 Acquisition and analysis 
Fluorescence was detected in the FL-1 channel.  The granulocytes were identified 
and gated based on their distinct forward- and sideways-scatter profiles.  Data were 
presented as the median fluorescence intensity (MFI) for each peak after deduction 
of the isotype control.  All data were collected on a FACS-Calibur (BD Pharmingen, 
Oxford, UK) flow cytometer and analysis performed using FlowJo Data Analysis 
Software.  Five thousand events were collected from each single sample.  A forward 
versus side scatter dot plot of lysed whole rat blood is shown in Figure 2.7. MFI 





Figure 2.7 Representative dot plot of forward scatter (FSC-H) versus side 
scatter (SSC-H). 
Region 1 (R1) is expected to contain cellular debris and dead cells.  Lymphocyte, 
monocyte and granulocyte populations were identified on bases of their forward and 
sideward scatter properties.  A gate (red circular box) was set around the granulocyte 











Figure 2.8 Fluorescence intensity histograms of both stained and unstained 
granulocytes. 
 (a) Fluorescence histogram of unstained granulocytes collected 6 hours following 
instillation of saline.  The peak within the first log decade of the x-axis corresponds 
to unstained control cells.  (b) Fluorescence histogram of CD11b stained 
granulocytes collected 6 hours following instillation of saline.  CD11b antibody 
showed two fluorescence peaks in the histogram with low (LF) and high 
fluorescence (HF).  Histogram overlay indicates istoype matched control antibody 
(IgG2a, red histogram).  The isotype control showed a similar pattern to unstained 
cells.  Cells within region 1 (R1) are negative for CD11b protein; cells within region 
2 (R2) are positive. 
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2.11 Electron paramagnetic resonance (EPR) 
Hearts from rats pre-treated 6 hours earlier with intra-tracheal instillation of DEP or 
saline were isolated and mounted on a Langendorff perfusion apparatus with constant 
flow as described (Chapter 2.7.2).  Oxygen free radical generation from the 
myocardium was assessed in perfusate using spin-label electron paramagnetic 
resonance (EPR) (Jeanes et al., 2008; Miller et al., 2009).  Chemical spin-traps are 
molecules that react with highly unstable primary radical species to form a more 
stable secondary radical that can be detected by EPR.  Coronary effluent was 
collected in 1 ml aliquots (9 drops) into tubes containing the spin trap 1-hydroxy-3-
carboxy-pyrolidine (CP-H; Axxora Ltd, Nottingham, UK) to achieve a final 
concentration of 10
-3
M.  CP-H has previously been demonstrated to detect oxygen-
centred free radicals (Dikalov et al., 1997).  Upon reaction with oxygen-centred 
radicals, CP-H is oxidised to 3-carboxy-proxy (CP˙; Figure 2.9).  The stable radical 
gives rise to a characteristic 3-line EPR spectrum that can be quantitatively assessed.  
Pyrogallol was used as a positive control to generate superoxide radicals (Taylor et 
al., 2004).   Hearts were subjected to 30 minutes of coronary occlusion followed by 2 
hour reperfusion as described previously (Chapter 2.7.2).  Perfusion effluent was 
collected at baseline, after 0 and 30 minutes of ischaemia and after 0, 1 and 2 hours 
of reperfusion.  All samples were incubated at 37°C for 5 minutes.  50 µl of the 
sample solution was then drawn up into a glass capillary tube (Scientific Laboratory 
Ltd, Coatbridge, UK), sealed with claylike sealant (Cristaseal, VWR International, 
Lutterworth, UK) and placed in an X-band EPR spectrometer (Magnettech MS-200, 
Berlin, Germany).  The EPR spectrum settings were as follows: microwave power, 
20 mW; modulation frequency, 100 kHz; modulation amplitude, 1500 mG; center 
field, 3365 G; sweep width, 43.95 G; sweep time, 30 sec; number of passes, 1.  
Relative radical concentrations (in arbitrary units, AU) were recorded as the signal 







Figure 2.9 Schematic illustration of the concomitant oxidation of spin-trap CP-
H to CP 
The hydroxylamine spin probe 1-hydroxy-3-carboxy-pyrolidine (CP-H) reacts with 
superoxide radical (O2
.-
) to form the stable 3-carboxy-proxy (CP˙) radical.  Adapted 
from supplier website (www.axxora.com). 
2.12 Drug dosing 
For some experiments (described in Chapter 6) the beta 1 (β1) adrenoreceptor 
antagonist, metoprolol, was used to investigate the role of the sympathetic nervous 
system (SNS) in the action of DEP on I/R injury.  Metoprolol (dissolved in 0.9% 
sodium chloride) was given as a single 10 mg/kg ip injection at the time of 
instillation.  Studies in rats have used higher (Beique et al., 2000) or lower doses 
(Beril Gok et al., 2007); therefore, a dose between these concentrations was selected 
to ensure an active dose was given, yet minimise non-specific effects.  In an 
additional group, hearts from DEP-instilled animals underwent ex vivo I/R while 
being perfused with Tyrodes buffer containing metoprolol (10 µM final 
concentration, Kovacs et al., 2009), to control for any direct ex vivo influence of the 
drug on injury. 
The transient receptor potential (TRP) ion channel super family has been reported to 
participate in the detection of various sensory stimuli (Eid et al., 2009).  Sensory 
responses following exposure to DEP were evaluated using a TRP vanilloid 1 
(TRPV1) receptor antagonist, AMG 9810 ((2E)-N-(2, 3-Dihydro-1, 4-benzodioxin-6-
yl)-3-[4-(1, 1-dimethylethyl) phenyl]-2-propenamide, Tocris bioscience, Bristol, UK).  
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30 mg/kg AMG 9810 was dispersed with the vehicle or DEP-suspension and 
administered by intra-tracheal instillation (see above; Chapter 2.3).  Gavva et al. 
(2005) reported blockade of capsaicin-induced eye wiping after an intraperitoneal 
injection of 3, 10 and 30 mg/kg AMG 9810.   The highest dose was selected in the 
study because of the relatively short half-life of AMG 9810.  The selectivity of action 
was determined by perfusing the rat hearts with 1 µM AMG 9810 (final 
concentration). 
2.13 Drugs and reagents 
Unless otherwise stated all pharmacological agents were obtained from Sigma 
Aldrich (Dorset, UK) and all basic salts were obtained from VWR (Leicestershire, 
UK).  All drugs were dissolved in sterile 0.9% saline, with the exception of CP-H 
[dissolved in 0.01 M ethylenediaminetetraacetic acid (EDTA; final concentration, 0.1 
mM) to minimise metal-ion-induced auto-oxidation]. 
2.14 Statistical analysis 
Statistical analyses were performed using GraphPad Prism software (V5.0; GraphPad 
Software Inc, USA).  In each chapter all data are expressed as mean ± SEM.  
Comparisons were performed by unpaired Student’s t test and one-way or two-way 
analysis of variance (ANOVA) as appropriate.  For full details, please see individual 
chapters.  P values less than 0.05 were considered to be statistically significant. 
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Chapter 3  
Development of an in vivo pre-clinical model for 
investigating endothelial cell function: drug dosing 




Vascular endothelial cell injury and dysfunction plays an important role in the 
pathogenesis of many cardiovascular disorders including atherosclerosis, coronary 
vasoconstriction and myocardial ischaemia (Celermajer, 1997; Endemann et al., 
2004; Lerman et al., 2005).  In a normal physiological state, healthy endothelium 
regulates numerous blood vessel functions including the control of vascular tone, 
coagulation, cell adhesiveness, fibrinolysis, and inflammation (Celermajer, 1997).  
This is achieved through the synthesis and release of various factors in response to 
chemical and physical stimuli such as acetylcholine (ACh), bradykinin, thrombin and 
shear stress (Celermajer, 1997).  One of the most important and best characterised 
substances released from the endothelium is nitric oxide (NO), a potent vasodilator 
produced through oxidation of L-arginine by endothelial nitric oxide synthase 
(eNOS) (Furchgott & Zawadski, 1980).  Endothelial dysfunction encompasses a 
range of abnormalities, the most extensively studied being impairment of 
endothelium-dependent relaxation, mainly as a result of loss of NO bioavailability 
(Boomsma et al., 1993; Davignon et al., 2004).  Under normal conditions, NO 
produced by endothelium diffuses into vascular smooth muscle where it binds to 
soluble guanylate cyclase (sGC), increasing cyclic 3’, 5’ guanosine monophosphate 
(cGMP) and causing relaxation (Davignon et al., 2004). 
 
In humans, endothelium-dependent vasomotion has been studied in both the coronary 
and peripheral circulations by measuring changes either in vessel diameter or in 
regional blood flow in response to vasoactive influences (Wegesser et al., 2008).  
Forearm venous occlusion plethysmography with local brachial artery infusion has 
become widely recognised as the ‘gold standard’ for endothelial cell function testing 
(Webb & Hand, 1995).  First described over 100 years ago by Hewlett and von 
Zwaluweburg, this approach is less invasive than measurements of coronary 
endothelial cell function and allows administration of subsystemic doses of 
71 
 
vasoactive factors, thus minimising disturbances to systemic physiology (Hewlett & 
von Zwaluweburg, 1909). 
 
Previous work from this laboratory has shown both short- and long-term impairment 
of endothelium-dependent dilation in humans after exposure to diesel exhaust (DE) 
(Mills et al., 2007; Mills et al., 2005; Tornqvist et al., 2007).  These studies are 
limited, however, in their ability to investigate the mechanisms underlying 
endothelial cell dysfunction.  More recent data from this laboratory have suggested 
that superoxide radicals contribute significantly to the endothelial cell dysfunction in 
isolated blood vessels exposed to diesel exhaust particulate (DEP) (Miller et al., 
2009).  However, this experimental approach assumes that a considerable number of 
the particles are able to translocate from the lung to the circulation.  Whilst studies 
have demonstrated that such translocation of nanoparticles is feasible (Brown et al., 
2002; Kreyling et al., 2002; Oberdorster, 2004) there remains considerable 
uncertainty over whether this mechanism underlies the health effects of combustion-
derived nanoparticles (Brook et al., 2004; Mills et al., 2006). 
 
Given the limitations cited above, there is a need to introduce a model to study the 
effects of DEP exposure on endothelial cell vasomotor function in the physiological 
environment under the influence of neuronal, circulatory and local mediators.  The 
work described in this chapter aimed to develop a suitable model for studying 
endothelial cell vascular function in vivo.  In general, intravenous administration of 
vasodilators causes a drop in blood pressure leading to a reflex vasoconstriction 
which rapidly restores the blood pressure (Dabisch et al., 2008; Takahashi et al., 
1996).  These vasodilator-induced alterations in blood pressure make changes in 
blood flow difficult to interpret.  This complication can be avoided in studies using 
decerebrate or pithed animals.  An alternative, less technically challenging approach 
is to inject vasodilators locally into a vascular bed.  The clinical studies discussed 
above assessed endothelial cell function by measuring forearm blood flow responses 
to endothelium-dependent and –independent vasodilators.  In this study we 
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developed a model to assess rat hind-limb endothelial cell function by measuring 
femoral artery blood flow (FBF) responses to intra-arterial injections of vasodilators.  
In support of such a model for endothelial function testing, Dabsich and colleagues 
successfully demonstrated intra-arterial vasodilator agents to increase rat hind-limb 
blood flow (HBF) without decreasing systemic blood pressure (Dabisch et al., 2008). 
3.1.1 Hypothesis 
The work described in this chapter addressed the hypothesis that it was possible to 
study endothelium-dependent and –independent vasodilator responses in the hind-





Adult male Wistar rats (250-350g; Charles River Laboratories) were used in all 
experiments. 
3.2.2 Development of a model for studying endothelial cell function 
in vivo in the rat hind-limb 
3.2.2.1 Rat hind-limb preparation 
All rats were anesthetised with isoflurane (induced at 5%, maintained at 2% in 100% 
oxygen).  The left carotid artery was cannulated and connected to a fluid-filled 
pressure transducer for continuous monitoring of arterial blood pressures (systolic, 
diastolic and mean) and heart rate (HR) as described in Chapter 2.7.1.1. 
 
A midline incision was performed in the abdominal wall and the right iliac artery just 
distal to the aortic bifurcation was carefully isolated from surrounding tissue.  Once 
the artery was isolated, the tip of a Transonic flow probe (type 0.7V; Transonic 
Systems Inc.) was covered with lubricating jelly (Surgical lubricant sterile 
bacteriostatic, Fougera) and the probe was placed around the isolated vessel.  FBF 
(millimeters per minute) was monitored continuously throughout the study via a 
Transonic TS420 flowmeter (Transonic System Inc.).  Steady state levels of blood 
flow were attained before the beginning of the experimental protocol (Figure 3.1). 
 
At the end of the experiment all rats were killed by exsanguination. 
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3.2.2.2 Intravenous administration of endothelium-dependent and –independent 
vasodilators 
The left jugular vein was cannulated in the anaesthetised rat as described in Chapter 
2.7.1.1.  All studies used ACh as an endothelium-dependent vasodilator and sodium 
nitroprusside (SNP) to assess endothelium-independent, cGMP-mediated relaxation.  
Upon attaining a steady blood flow, animals were subjected to single intravnous 
injections of either ACh (0.4 and 1.8 µg/kg) or SNP (0.30 and 3.0 µg/kg) or an 
equivalent volume of saline.  These doses were based on previous injection 
experiments in the rat (Dabisch et al., 2004; Dabisch et al., 2008). 
3.2.2.3 Intra-arterial administration of endothelial-dependent and –independent 
vasodilators 
A left groin incision was made in the anaesthetised rat to gain access to the femoral 
vessels.  The fine connective tissue connecting the left femoral artery, vein and 
saphenous nerve was carefully cleared by blunt dissection.  After isolating the 
femoral artery, a polyethylene cannula (0.61mm outer diameter (o.d.), 0.28mm inner 
diameter (i.d.), Portex, Jencons Scientific Ltd, Bedfordshire, UK) was inserted and 
gently advanced until its tip reached the bifurcation of the abdominal aorta, allowing 
drug to be administered as it entered the femoral artery of the limb where flow was 
assessed (Figure 3.1).  The cannula was secured in place with three 5-0 braided silk 
ligatures. 
 
Upon attaining a steady-state blood flow ACh (0.07, 0.7 and 7 µg) and the saline 
vehicle were delivered in a volume of 10 µl via a microsyringe (25 µl Hamilton) 
attached to the right femoral artery cannula, followed by increasing doses of SNP 
(0.09, 0.9 and 9 µg).  The doses were calculated to be equivalent to those used for 
intravenous administration. Each animal received all three doses of ACh, SNP or the 
saline vehicle administered at random.  Blood flow was allowed to return to a new 




All values are expressed as mean ± SEM.  The mean arterial pressure (MAP) was 
computed as diastolic pressure plus one third of the difference of systolic blood 
pressure (SBP) minus diastolic blood pressure (DBP).  HR was measured as the 
period of time between successive systolic peaks.  Blood flow responses to 
vasodilators were compared using one-way ANOVA followed by Bonferroni post-
hoc test.  Changes in haemodynamic parameters in response to different 
concentrations of vasodilators were analysed by two-way ANOVA using the 





Figure 3.1 Illustration showing the positioning of cannulae and flow probe. 
Cannulae were inserted into one carotid artery (blood pressure measurements), one 
jugular vein (acetylcholine (ACh) or sodium nitroprusside (SNP) injections) and one 
femoral artery (ACh or SNP injections).  A transonic flow probe was positioned 
around the right femoral artery.  (Adapted from Mahajan et al., 2004). 
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3.3 Results  
3.3.1 Baseline blood pressure, HR and FBF 
The baseline MAP, HR and FBF were 102.4 ± 5.0 mmHg (n=5), 365 ± 10 beats/min 
(n=5) and 2.6 ± 0.4 ml/min (n=6) respectively. 
3.3.2 Hind-limb vasodilator responses to intravenous injections of 
ACh and SNP 
The administration of ACh (0.4 µg/kg single iv bolus) did not affect blood flow 
compared with baseline (Figure 3.2a).  Increasing the dose of intravenous ACh to 1.8 
µg/kg induced a transient decrease in flow (17% reduction in baseline flow) but this 
did not reach statistical significance (Figure 3.2a).  The response recorded in the 
hind-limb vascular bed after administration of SNP (0.3-3.0 µg/kg single iv bolus) 
was similar to that produced by ACh (Figure 3.2b).  The two vasodilators caused a 
temporary significant drop in systemic arterial pressure (Figures 3.3a & b).  
Intravenous administration of ACh or SNP produced minimal change in HR (Figures 
3.3c & d).  Saline administered intravenously had no effect on FBF or 
haemodynamic parameters (data not shown). 
3.3.3 Hind-limb vasodilator responses to intra-arterial injections of 
ACh and SNP 
The intra-arterial injections of ACh in doses of 0.07 to 7 µg significantly increased 
FBF over baseline (Figure 3.4a).  The administration of 0.07 or 0.7 µg ACh had no 
significant effect on systemic arterial pressure, whereas 7 µg ACh significantly 
decreased arterial pressure (Figure 3.5a).  Intra-arterial injections of SNP (0.09 and 
0.9 µg) into the hind-limb vascular bed significantly increased blood flow over 
baseline with minimal changes in arterial pressure (Figures 3.4b & 3.5b).  Increasing 
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the dose to 9 µg SNP also significantly increased FBF (Figure 3.4b) but caused a 
significant drop in arterial pressure (Figure 3.5b).  Intra-arterial administration of 
ACh or SNP produced minimal change in HR (Figures 3.5c & d).  The 
haemodynamic and regional blood flow responses to ACh or SNP were not dose-
dependent.  Intra-arterial administration of 10 µl saline had no effect on FBF or 






















































Figure 3.2 Intravenous administration of acetylcholine (ACh) and sodium 
nitroprusside (SNP) did not affect femoral artery blood flow (FBF). 
FBF before (filled columns) and after (diagonally striped columns) intravenous 
injections of (a) ACh (0.4 and 1.8 µg/kg) or (b) SNP (0.3 and 3.0 µg).  Columns 
























































































































Figure 3.3 Intravenous administration of acetylcholine (ACh) and sodium 
nitroprusside (SNP) decreased blood pressure and had no effect on heart rate 
(HR). 
Mean arterial blood pressure (MAP, a & b) and HR (c & d) before (filled columns) 
and after (diagonally striped columns) intavenous injections of ACh (0.4 and 1.8 
µg/kg) or SNP (0.3 and 3.0 µg).  Columns represent mean ± SEM (n=3-4).  *P<0.05; 
***P<0.001, compared to pre-injection value, two-way ANOVA using the 




























































Figure 3.4 Femoral artery blood flow (FBF) increased in response to intra-
arterial administration of acetylcholine (ACh) and sodium nitroprusside (SNP). 
FBF before (filled columns) and after (diagonally striped columns) intravenous 
injections of (a) ACh (0.07, 0.7 and 7 µg) or (b) SNP (0.09, 0.9 and 9 µg).  Columns 
represent mean ± SEM (n=6).  *P<0.05; **P<0.01, compared to pre-injection value, 




















































































































Figure 3.5 Acetylcholine (ACh) and sodium nitroprusside (SNP) administered 
intra-arterially did not alter systemic blood pressure, except at the highest dose. 
Mean arterial blood pressure (MAP, a & b) and heart rate (HR, c & d) before (filled 
columns) and after (diagonally striped columns) intra-arterial injections of ACh (0.07, 
0.7 and 7 µg) or SNP (0.09, 0.9 and 9 µg).  Columns represent mean ± SEM (n=5).  
***P<0.001, compared to pre-injection value, two-way ANOVA using the 




The purpose of this study was to develop a model, and assess its reproducibility, for 
measuring drug-induced changes in blood flow to allow evaluation of endothelial 
function in the rat hind-limb.  This was driven by the need for an in vivo approach to 
study the effects of DEP exposure on endothelial cell vasomotor function.  The data 
presented here confirm that it was possible to administer vasodilators intra-arterially 
into the regional vascular bed to cause vasodilatation and thus increase blood flow. 
In the current study two routes of administration were compared: intravenous and 
intra-arterial.  Single intravenous bolus doses of 0.4-1.8 µg/kg ACh induced a rapid 
and transient drop in systemic blood pressure.  The results of this study showed that 
intravenously administered SNP (0.3-3 µg/kg) had the same blood-pressure-lowering 
effect to that of ACh.  Analogous results have been reported in rats after intavenous 
administration of ACh in a dose range of 0.1-3 µg/kg (Dabisch et al., 2008).  
Intravenous administration of SNP has also been shown to produce dose-dependent 
decreases in MAP in rats (Takahashi et al., 1996).  It is well recognised that 
baroreceptors in the vessel walls detect the resulting drop in blood pressure causing 
vasoconstriction which increases blood pressure back to normal range (Dabisch et al., 
2008; Saeed et al., 2005; Takahashi et al., 1996). These vasodilator-induced 
alterations in blood pressure make changes in blood flow difficult to interpret.  Thus, 
it seems likely that reflex vasoconstriction blunted the dilator responses to 
intravenous ACh and SNP in the current study.  Baroreceptor reflex function has 
been assessed by measuring resultant changes in HR in response to changes in blood 
pressure induced by vasoactive drugs (Brook et al., 2009a).  In the present study, 
intravenous drug administration had little or no effect on HR.  Future studies 
assessing heart rate variability (HRV) may provide a more sensitive measure for 




In the present study, experiments were performed to investigate whether vasodilators 
administered locally into the hind-limb vascular bed may avoid the above-mentioned 
haemodynamic limitations associated with intravenous administration.  The results 
presented here show, in rats, that intra-arterial injection of the endothelium-
dependent vasodilator ACh (0.07 and 0.7 µg) caused an increase in FBF.  These 
results are in agreement with those of previous studies in the rat hind-limb vascular 
bed (Dabisch et al., 2008).  ACh given intra-arterially at doses of 0.0075, 0.075 and 
0.75 µg caused significant increases in blood flow in the rat hind-limb (Dabisch et al., 
2008).  In the present study intra-arterial administration of 7 µg ACh increased blood 
flow through the femoral artery but a significant decrease in systemic blood pressure 
was also seen.  This is most probably due to ACh entering the systemic circulation.  
Intra-arterial administration of the endothelium-independent vasodilator SNP (0. 09 
and 0.9 µg) was also capable of increasing hind-limb blood flow without altering 
systemic arterial pressures.  This is important for studies evaluating vascular 
responses in rats following pulmonary exposure to DEP in the next chapter.  Using 
both endothelium-dependent and –independent vasodilators will provide a better 
knowledge of the cellular mechanisms underlying vascular responses to DEP.  
 
To summarise, this study has shown that it is possible to administer vasodilators into 
the hind-limb vascular bed to cause local vasodilatation without major effects on the 
systemic circulation.  This protocol was applied in Chapter 4 of this thesis to evaluate 




In vivo assessment of endothelial cell function after 




Previous studies from this laboratory have shown both short- and long-term 
impairment of endothelium-dependent dilation in humans after exposure to diesel 
exhaust (DE) (Mills et al., 2007; Mills et al., 2005; Tornqvist et al., 2007).  
Furthermore, ex vivo exposure of blood vessels to DEP inhibits nitric oxide (NO)-
mediated vasodilatation via generation of superoxide free radicals (Miller et al., 
2009).  Thus, DEP can directly alter endothelial cell function but this assumes that a 
considerable number of the particles are able to translocate from the lung to the 
circulation.  Whilst studies have demonstrated that such translocation of 
nanoparticles is feasible (Brown et al., 2002; Kreyling et al., 2002; Oberdorster et al., 
2004) there remains considerable uncertainty over whether this mechanism underlies 
the health effects of combustion-derived nanoparticles (Brook et al., 2004; Mills et 
al., 2006). 
 
An alternative suggestion is that inflammation induced by particulate matter (PM) in 
the lung develops into a systemic inflammatory response, causing indirect 
cardiovascular changes (Seaton et al., 1995).  Clinical and experimental studies have 
reported pulmonary inflammation to peak ~ 6-12 hours after exposure to DEP 
(Madden et al., 2000; Nemmar et al., 2003b; Salvi et al., 1999).  Several different 
types of particulate have been shown to induce pulmonary inflammation (Madden et 
al., 2000; Nemmar et al., 2003b), but the occurrence and potential role of systemic 
inflammation following pulmonary exposure to particulates is often inconsistent 
(Mills et al., 2008; Mills et al., 2005; Swiston et al., 2008).  The work described in 
this chapter was designed to evaluate whether instillation of DEP will cause 
endothelium dysfunction in rats as a consequence of pulmonary and systemic 
inflammation.  Currently, there are limited studies investigating the potential adverse 
systemic vascular effects after pulmonary exposure to PM (Cozzi et al., 2006; 
Hansen et al., 2007; Tamagawa et al., 2008).   Moreover, in almost all studies 
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endothelial cell function was assessed in isolated aortic rings after PM exposure 
(Cozzi et al., 2006; Hansen et al., 2007; Tamagawa et al., 2008).  However, isolated 
vessels are removed from the influence of circulating neurohormonal factors.  In the 
present study, endothelium-dependent relaxation was assessed in vivo in the rat hind-
limb vascular bed following intra-tracheal instillation of DEP. 
4.1.1 Hypothesis 
Intra-tracheal instillation of DEP in healthy rats causes pulmonary and systemic 
inflammation, which in turn leads to vascular endothelial cell dysfunction. 
4.1.2 Aims 
The aims of the work described in this chapter were to determine whether intra-
tracheal instillation of DEP: 
i. causes endothelial vasomotor dysfunction in vivo 
ii. generates pulmonary inflammation 
iii. generates systemic inflammation 
iv. alters haemodynamic parameters, including arterial blood pressure and 




4.2.1 Pulmonary instillation of DEP 
Adult male Wistar rats (250-350 g; Charles River Laboratories) were used for all 
experiments.  Rats were intra-tracheally instilled with either DEP (0.5 mg in 0.5 ml 
saline) or vehicle (saline 0.5 ml).  For details of the preparation and instillation 
process please refer to Chapters 2.2 and 2.3.  To ensure that saline instillation itself 
had no notable effects on the parameters studied, an additional group of rats received 
no instillation.  Animals were sacrificed 6 and 24 hours after instillation by 
exsanguination. 
4.2.2 Assessment of rat hind-limb endothelial cell function in vivo 
Rats underwent anaesthesia and the right carotid artery was catheterised for 
measurement of arterial blood pressures (systolic, diastolic and mean) and HR as 
described in Chapter 2.7.1.1.  The vasomotor response of the rat hind-limb to intra- 
arterial injections of endothelium-dependent (acetylcholine, ACh) and –independent 
(sodium nitroprusside, SNP) vasodilators was studied as described in Chapter 3.2. 
4.2.3 Assessment of pulmonary inflammation  
A bronchoalveolar lavage (BAL) was performed as described in Chapter 2.8.  Total 
and differential cell counts were performed on the BAL fluid.  Total protein was 
detected using a bicinchoninic acid (BCA) kit (Thermo Scientific Pierce).  
Interleukin-6 (IL-6), tumour necrosis factor alpha (TNFα) and C reactive protein 
(CRP) levels in BAL fluid were assayed by enzyme-linked immunosorbent assay 




4.2.4 A complete blood count and plasma pro-inflammatory 
cytokine levels 
Blood samples were collected after the 6 and 24 hour study period as described in 
Chapter 2.4.  A complete blood count was performed on heparinised blood with the 
use of a Coulter®A
c
.T series analyser, as described in Chapter 2.5.4.  Circulating 
levels of IL-6, TNFα and CRP were measured by ELISA (R & D Systems) in plasma 
generated by centrifugation of whole blood for 5 minutes at 1500 g and 4°C, as 
described in Chapter 2.5.3. 
4.2.5 Measurement of plasma catecholamine  
A commercially available ELISA (CUSABIO®BIOTECH, USA) was used to 
measure the total catecholamine (adrenaline and noradrenaline) concentrations in the 
plasma of decapitated rats as described in Chapter 2.6. 
4.2.6 Statistics 
All values are expressed as mean ± SEM.  The mean arterial pressure (MAP) was 
computed as diastolic blood pressure (DBP) plus one third of the difference of 
systolic blood pressure (SBP) minus DBP.  HR was measured as the period of time 
between successive systolic peaks.  Vasomotor responses were expressed as changes 
in femoral vascular conductance (FVC).  This was done to minimise any alterations 
in arterial pressure in response to ACh and SNP (discussed in detail in Chapter 3).  
The FVC was calculated by femoral artery blood flow (FBF) divided by MAP.  
Haemodynamic and inflammatory indices between the groups were compared by 
one-way ANOVA followed by Bonferroni post-hoc test.  Changes in FVC and 
haemodynamic parameters in response to different concentrations of vasodilators 
within a group and between DEP instillation and control groups were compared by 





4.3.1 Effect of DEP instillation on resting HR and blood pressure 
There was no difference in resting HR between the groups (358 ± 8 bpm for non-
instilled, 341 ± 22 bpm for 6 hour saline,  373 ± 13 bpm for 6 hour DEP, 337 ± 5 
bpm for 24 hour saline and 348 ± 13 bpm for 24 hour DEP (Table 4.1).  Resting 
arterial blood pressure (both systolic and diastolic) remained constant at both time 
points after saline instillation compared to the non-instilled group.  However, in 
DEP-instilled rats mean resting systolic and diastolic pressures were greater (31% 
and 37% respectively) than saline-instilled rats 6 hours after DEP (Table 4.1).  Blood 
pressures had almost returned to control values by 24 hours after instillation (Table 
4.1).  The resting rate pressure product (RPP, HR multiplied by systolic arterial 
pressure) was calculated to provide an indication of myocardial demand.  There was 
no difference in RPP in rats that received saline instillation compared to non-instilled 
rats (Table 4.1).  However, RPP was significantly higher 6 hours after instillation of 
DEP (P<0.05 compared to 6 hour saline), an effect that was no longer evident at 24 
hours post-instillation. 
4.3.2 Effect of DEP instillation on femoral arterial responses to 
vasodilator agents in vivo 
There was no difference in resting blood flow between the groups (2.5 ± 0.4 ml/min 
for non-instilled, 2.4 ± 0.4 ml/min for 6 hour saline, 2.1 ± 0.3 ml/min for 6 hour DEP, 
2.7 ± 0.2 ml/min for 24 hour saline and 2.6 ± 0.3 ml/min for 24 hour DEP).  In non-
instilled rats, FVC rose by 75 and 125% following intra-arterial injections of 0.07 
and 0.7 µg ACh, respectively (Figures 4.1a & b).  Responses to ACh were not 
significantly different in saline, compared to non-instilled or DEP-instilled rats at 
either 6 hours (Figure 4.1a) or 24 hours (Figure 4.1b) after instillation.  Recovery 
time (time for vascular tone to return to that before ACh injection) was prolonged 
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and more variable 6 hours after DEP instillation compared to saline control (60.1 ± 
24.8 versus 24.5 ± 5.9 seconds after intra-arterial injection of 0.7 µg ACh).  However, 
these changes did not reach statistical significance, perhaps due to the relatively high 
variation in the DEP group.  Recovery time following ACh was not different 
between saline- and DEP-instilled rats at the 24 hour time point (22.4 ± 3.1 versus 
27.4 ± 7.8 seconds after intra-arterial injection of 0.7 µg ACh).  Intra-arterial 
injection of ACh (0.07 and 0.7 µg) produced minimal change in HR or arterial 
pressure (Table 4.3).  Responses were not significantly different in saline- or DEP-
instilled rats either 6 hours or 24 hours (Table 4.2). 
  
SNP increased vascular conductance at both doses in the non-instilled animals 
(Figures 4.1c & d) to an extent that was similar in rats both 6 and 24 hours after 
saline instillation.  6 hours after instillation of DEP, femoral arterial responses to 0.9 
µg SNP were suppressed compared to saline controls (3.0 ± 0.6 versus 0.2 ± 0.5 
ml/min, P<0.01; Figure 4.1c).  A similar result was also obtained at 24 hours after 
instillation (-0.5 ± 0.8 ml/min, P<0.05; Figure 4.1d).  Unlike ACh, it was not 
possible to evaluate the time course of the SNP response in DEP-instilled rats at 
either time point as these animals failed to restore a stable blood flow.  Intra-arterial 
injection of SNP (0.09 and 0.9 µg) produced minimal change in HR or arterial 
pressure (Table 4.3).  Responses were not significantly different in saline- or DEP-
instilled rats at either 6 hours or 24 hours (Table 4.2). 
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  Group 
  Non-instilled Saline DEP 
    6 h 24 h 6 h 24 h 
HR (beats/min) 342 ± 12 341 ± 44 328 ± 24 373 ± 13 348 ± 13 
SBP (mmHg) 103.9 ± 5.7 105.1 ± 5.2 101.3 ± 2.4 138.8 ± 13.0** 116.9 ± 5.9 
DBP (mmHg) 88.9 ± 5.0 98.7 ± 5.0 85.3 ± 2.2 129.7 ± 13.0** 101.8 ± 7.1 
RPP (HR X SBP/1000) 35.0 ± 2.4 36.3 ± 5.0 33.4 ± 1.3 48.9 ± 5.2* 39.2 ± 1.6 
Table 4.1 Baseline cardiac parameters in non-instilled, saline-instilled and DEP-instilled rats. 
Abbreviations: DEP = diesel exhaust particulate, HR = heart rate, SBP = systolic blood pressure, DBP = diastolic blood pressure, RPP = 
rate pressure product. 

























































































































































































































































Figure 4.1 Instillation of diesel exhaust particulate (DEP) does not affect 
endothelium-dependent relaxation, but impairs vasodilator response to sodium 
nitroprusside (SNP), in vivo. 
Percent change in femoral vascular conductance (FVC) from baseline in response to 
intra-arterial acetylcholine (ACh; 0.07 & 0.7 µg) and SNP (0.09 & 0.9 µg) 6 hours (a 
& c) or 24 hours (b & d) after instillation.  Responses were obtained in non-instilled 
rats (open columns), saline-instilled rats (purple columns) or DEP-instilled rats (0.5 
mg; pink columns).  Columns represent mean ± SEM (n=4-6) *P<0.05, **P<0.01, 






















instilled 96.9 ± 1.0 97.6 ± 1.1 92.3 ± 2.1 97.0 ± 0.1 98.3 ± 1.2 98.5 ± 1.5 90.5 ± 3.4 96.5 ± 1.3 
                  
6 h                 
Saline 93.9 ± 1.2 97.7 ± 1.1 90.2 ± 4.4 97.1 ± 0.1 95.9 ± 2.4 99.1 ± 2.6 88.7 ± 2.0 97.4 ± 2.4 
DEP 95.4 ± 1.2 97.8 ± 0.7 91.8 ± 3.1 97.8 ± 0.7 94.1 ± 3.1 97.1 ± 0.1 88.0 ± 1.8 97.1 ± 1.0 
                  
24 h                 
Saline 97.5 ± 1.5 102.0 ± 1.5 88.4 ± 1.4 107.7 ± 4.2 99.2 ± 1.1 95.3 ± 5.3 93.4 ± 2.9 100.2 ± 4.9 
DEP 92.7 ± 1.9 102.8 ± 3.6 91.9 ± 1.4 99.1 ± 3.9 96.3 ± 0.8 98.3 ± 1.6 94.7 ± 2.4 105.3 ± 4.6 
                  
Table 4.2 Effect of vasodilators on cardiac parameters in non-instilled, saline-instilled and DEP-instilled rats. 
Abbreviations: DEP = diesel exhaust particulate, HR = heart rate, MAP = mean arterial blood pressure. 
MAP and HR were measured immediately after intra-arterial injection.  Data are expressed as mean ± SEM (n=4-7). No significant 




4.3.3 Effects of DEP instillation on pulmonary cell count and cell 
differential 
Examination of routinely stained cytospins of BAL fluid detected macrophages 
(large circular cells with a single round nucleus) in all groups (Figures 4.2a-f).  DEP 
particles were found in or adhering to macrophages from rats at both 6 and 24 hours 
after instillation (Figures 4.2c & e).  Large numbers of neutrophils (smaller cells with 
a multi-lobed nucleus) were visible in the BAL fluid of DEP-instilled rats 6 hours 
post-exposure (Figure 4.2c), declining markedly by 24 hours (Figure 4.2e).  No 
neutrophils were observed in the lungs of non- or saline-instilled rats.   
 
The values for total and differential cell counts in BAL are shown in Figure 4.3.  The 
total number of cells recovered in BAL fluid from non-instilled rats was 10.3 ± 2.0 x 
10
5 
cells/ml.  At both time points after saline-instillation, there was no difference in 
the total number of cells compared with those in non-instilled control rats.   The total 
number of cells was increased markedly to 130.5 ± 35.0 x 10
5 
cells/ml 6 hours after 
instillation of DEP (P<0.001 compared to saline; Figure 4.3a).  By 24 hours total cell 
counts had decreased to levels that were comparable among all three groups.  
Differential analysis of BAL cells showed that the BAL from non- or saline-instilled 
rats was comprised predominately of macrophages (Figure 4.3b).  The increase in 
BAL total cell count 6 hours after instillation of DEP appeared to be attributed to 
increases in neutrophil numbers; rising from 17.3 % of the total cell count in saline-
instilled rats to 75.4% in DEP-instilled rats (Figure 4.3c).  At 24 hours after 
instillation neutrophil numbers had returned to near baseline values. 
4.3.4 Effect of DEP instillation on total protein level in BAL fluid  
Total protein in BAL fluid 6 hours after instillation of DEP was significantly higher 
than non- or saline-instilled controls (P<0.001. Figure 4.4).  In contrast, there were 





Figure 4.2 Cytospins of bronchoalveolar lavage (BAL) cells showing pulmonary 
inflammatory cell infiltration following diesel exhaust particulate (DEP) 
instillation. 
BAL cells from (a) non-instilled rats, or 6 hours after instillation with (b) 0.5 ml 
saline or (c) 0.5 mg DEP, and 24 hours after instillation with (d) 0.5 ml saline or (e) 
0.5 mg DEP.  Open arrows indicate neutrophils; arrowheads indicate alveolar 
macrophages with aggregates of DEP.  Cells stained with Diff-Quik physiological 
stain.  Magnification x 40.  The outlined area is shown at a higher magnification.  All 
images were acquired at 1x10
5
 cells/slide.  Variations in colour were likely a result of 







































































































































Figure 4.3 Instillation of diesel exhaust particulate (DEP) causes transient 
pulmonary inflammation. 
Bronchoalveolar lavage (BAL) fluid was analysed for (a) total cell count, (b) 
macrophages and (c) neutrophils.  Non-instilled (open columns), saline-instilled 
(purple columns) and DEP-instilled (0.5 mg; pink columns) rats 6 and 24 hours after 
instillation.  Columns represent mean ± SEM (n =5-8). ***P<0.001, compared to 

























Figure 4.4 Lung capillary protein leakage at 6 hours after instillation with diesel 
exhaust particulate (DEP). 
Bronchoalveolar lavage (BAL) fluid was analysed for total protein.  Non-instilled 
(open columns), saline-instilled (purple columns) and DEP-instilled (0.5 mg; pink 
columns) animals 6 and 24 hours after instillation.  Columns represent mean ± SEM 




4.3.5 Effect of DEP instillation on pro-inflammatory cytokine levels 
in BAL fluid 
The concentration of IL-6 in BAL fluid from non-instilled rats was 0.30 ± 0.07 ng/ml 
(Figure 4.5a) and was not altered by saline instillation at any time point.  However, 
the concentration of IL-6 was significantly increased 6 hours after administration of 
DEP (P<0.001compared to the saline; Figure 4.5a).  However, by 24 hours the 
concentration of IL-6 had returned to control levels (Figure 4.5a).  The concentration 
of TNFα levels was below the limit of detection in the non- and saline-instilled rats, 
but was elevated 6 hours after DEP instillation to 322 ± 190 pg/ml (Figure 4.5b).  
Within 24 hours, TNFα concentration had fallen close to the limit of detection (50 ± 
25 pg/ml; Figure 4.5b).  The concentration of CRP was below the limit of detection 
in the non-instilled rats (Figure 4.5c), but was detectable 6 hours after instillation of 
either saline or DEP (Figure 4.5c).  At 24 hours CRP was undetectable in all groups. 
4.3.6 Effect of DEP instillation on blood cell count 
The circulating white blood cell (WBC) concentration was higher (8.6 ± 0.3 x 10
3
/µl) 
6 hours after intra-tracheal instillation of DEP compared to saline (5.8 ± 0.4 x 10
3
/µl; 
P<0.05; Table 4.3).  This effect did not appear to occur at the later 24 hour time point.  
In contrast, red blood cell (RBC) and platelet counts were unaltered in all treatment 
































































































































































Figure 4.5 Elevated lung levels of cytokines at 6 hours after instillation with 
diesel exhaust particulate (DEP). 
(a) Interleukin-6 (IL-6), (b) tumour necrosis factor alpha (TNFα) and (c) C-reactive 
protein (CRP) in bronchoalveolar lavage (BAL) fluid.  Cytokines were detected by 
enzyme-linked immunosorbent assay (ELISA).  Non-instilled (open columns), 
saline-instilled (purple columns) or DEP-instilled (0.5 mg; pink columns) rats 6 and 
24 hours after instillation.  Columns represent mean ± SEM (n=4-8) ***P<0.001, 
compared to saline; ##P<0.01, ##P<0.001 compared to non-instilled; one-way 




  Group 
  Non-instilled Saline DEP 
    6 h 24 h 6 h 24 h 
WBC (x10
3
/µl)  4.6 ± 0.5 5.8 ± 0.4 4.6 ± 1.0 8.6 ± 0.3* 5.7 ± 1.4 
RBC (x10
3
/pl)  5.9 ± 0.3 5.4 ± 0.3 5.6 ± 0.3 5.6 ± 0.2 5.3 ± 0.3 
Platelets (x10
3
/µl)  358 ± 93 415± 106 525 ± 177 447 ± 49 618 ± 164 
Table 4.3 Effect of DEP instillation on blood cell numbers. 
Abbreviations: DEP = diesel exhaust particulate, WBC = white blood cell, RBP = 
red blood cell. 
Data are expressed as mean ± SEM (n=5).  *P<0.05 compared to saline at same time 
point; one-way ANOVA with Bonferroni post-hoc test. 
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4.3.7 Effect of DEP instillation on blood cytokine levels 
Plasma IL-6 concentration in non-instilled rats was 53.5 ± 11.5 ng/ml (Figure 4.6a) 
and this was not significantly altered 6 or 24 hour after saline instillation (Figure 
4.6a).  IL-6 concentrations were unchanged 6 hours after DEP instillation but were 
significantly elevated 24 hours after DEP instillation (P<0.05, compared to saline; 
Figures 4.6a).  TNFα concentrations were also increased at 24 hours but not at 6 
hours after DEP instillation (P<0.01, compared to saline; Figure 4.6b).  CRP 
concentrations were similar between all groups at both time points (Figure 4.6c). 
4.3.8 Effect of DEP instillation on plasma catecholamine levels 
Plasma catecholamine concentrations (adrenaline and noradrenaline) in non-instilled 
rats were 72.6 ± 0.9 ng/ml and were not altered 6 hours after saline or DEP 
instillation (Figure 4.7).  No data is available at 24 hours after instillation.  When 
carrying out the assay, results of the studies described above had moved the focus 






































































































































































Figure 4.6 Elevated blood levels of cytokines 24 hours after instillation with 
diesel exhaust particulate (DEP). 
Plasma (a) Interleukin-6 (IL-6), (b) tumour necrosis factor alpha (TNFα) and (c) C-
reactive protein (CRP) concentrations.  Cytokines were detected by ELISA.  Non-
instilled (open columns), saline-instilled (purple columns) or DEP-instilled (0.5 mg; 
pink columns) rats 6 and 24 hours after instillation.  Columns represent mean ± SEM 

































Figure 4.7 Instillation of diesel exhaust particulate (DEP) does not affect plasma 
catecholamine concentrations. 
Plasma catecholamine concentrations in non-instilled, saline-instilled and DEP-
instilled (0.5 mg) rats 6 hours after instillation.  Plasma catecholamine concentrations 
were detected by enzyme-linked immunosorbent assay (ELISA).  Columns represent 





The purpose of this study was to determine whether pulmonary exposure to DEP 
impairs or abolishes endothelial cell function secondary to pulmonary and systemic 
inflammation.  Moreover, the knowledge obtained would further our understanding 
of the role endothelial cell dysfunction plays in cardiac susceptibility to 
ischaemia/reperfusion (I/R) injury in later chapters of this thesis.  DEP exposure 
induced a pulmonary and systemic inflammation with no effect on endothelium-
dependent vasodilation in the rat hind-limb vasculature.  Pulmonary inflammation 
was detectable at 6 hours post-exposure.  In contrast, systemic inflammation was 
detectable at 24 hours post-exposure, by which time the pulmonary inflammation had 
mostly resolved.  
4.4.1 Influence of DEP instillation on vascular function in healthy 
male rats   
Previous studies from this laboratory have shown both short- and long-term 
impairment of endothelium-dependent dilation in humans after exposure to DE 
(Mills et al., 2007; Mills et al., 2005; Tornqvist et al., 2007).  Inhalation exposure of 
rats to DE has also been associated with endothelial dysfunction in vitro (Cherng et 
al., 2009; Knuckles et al., 2008; Kodavanti et al., 2011).  There is some indication 
that these effects are mediated by the particulate components of the DE (Lucking et 
al., 2011; Mills et al., 2011). 
 
Particles such as those generated from DE engines and ambient air have been shown 
to attenuate vascular function in various rodent models (Cozzi et al., 2006; Hansen et 
al., 2007; Kido et al., 2011; LeBlanc et al., 2009; Nurkiewicz et al., 2008; 
Tamagawa et al., 2008), although vascular impairment is not always observed 
despite the exposure to high doses of particulate (Bagate et al., 2004b; Gerlofs-
Nijland et al., 2010).  The reason for these discrepancies is likely to be multi-
factorial, being influenced by type of particle, dose and duration employed, animal 
species, the type of vessel examined and where/when the measurements were made.  
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It is also likely that negative findings may by under-represented due to the tendency 
not to report negative data.  The experiments presented in this chapter were 
specifically designed to maximise the chances of detecting alterations in vascular 
function by making measurements in vivo, in the presence of neurohormonal factors.  
In the anaesthetised rat, both the endothelium-dependent vasodilator ACh and the 
endothelium-independent vasodilator SNP induced an increase in blood flow to the 
hind-limb.  Both agents were delivered locally via the femoral artery to avoid 
reduction of systemic blood pressure and the associated reflex vasoconstriction 
(Dabisch et al., 2008; Takahashi et al., 1996).  In rats that had received DEP 6 hours 
prior to assessment of vascular function, responses to ACh in the hind-limb 
resistance bed were not different from those achieved in saline-instilled rats.  This 
contrasts with earlier clinical studies in the laboratory demonstrating a decrease in 
the vascular resistance in the human forearm after DE exposure (Mills et al., 2008; 
Mills et al., 2007; Mills et al., 2005).  It is, however, difficult to make direct 
comparisons between the in vivo pre-clinical and clinical studies.  The clinical 
studies used whole DE, comprising both a particle-phase and gas-phase.  
Additionally, the route of exposure varied between these studies (inhalation versus 
instillation).  Parallel studies in my own group explored the relaxation of femoral 
arteries ex vivo in response to ACh in DEP-instilled rats (see Appendix 2).  These 
studies found no underlying alteration in the endothelium-dependent vasodilator 
function of isolated arteries in saline- or DEP-instilled rats, supporting the in vivo 
measurements (see Appendix 2).  Similarly, DEP-instillation had no effect on ACh-
induced relaxation in the aorta (a large conduit artery) or in mesenteric resistance 
arteries ex vivo (see Appendix 2).  Using similar concentrations of DEP to those 
reported in this study, Hansen et al. (2007) reported intra-peritoneal injection of DEP 
to have no effect on endothelial function in rat aortic rings of healthy rats ex vivo.  
The passage of intra-tracheally instilled DEP from the lung to the systemic 
circulation cannot be ruled out in the current study.  However, it is clear that any 
potentially translocated particles are not altering endothelial cell function. 
 
Endothelium-independent relaxation in response to SNP ex vivo was also unaffected 
by DEP instillation, suggesting that sensitivity of the smooth muscle to SNP was not 
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compromised (see Appendix 2).  In contrast, the increase in FBF induced by SNP in 
vivo was impaired 6 and 24 hours after administration of DEP.  The reason for these 
discrepancies between the in vivo and ex vivo data are unknown and require further 
study.  With no effect of DEP instillation on SNP-related vascular responses in the 
isolated vessels, it would suggest involvement of a neurohormonal activation rather 
than altered cellular function within the arterial wall.  In the current study, arterial 
pressures (discussed in detail below) were elevated 6 hours after instillation of DEP, 
suggestive of increased sympathetic activity.  These data provide further support to 
the hypothesis that the impairment in the SNP-induced vascular response was due to 
a neurohormonal change.  Furthermore, this is also consistent with studies in animals 
(McQueen et al., 2007; Rhoden et al., 2005) and in man (Gold et al., 1999; Pope et 
al., 1999) reporting associations between baroreflex function, autonomic nervous 
system (ANS) activity and particulate air pollution.  The mechanism of these effects, 
such as the involvement of changes to sympathetic activity and baroreflex sensitivity 
is yet to be determined, although the role of the sympathetic nervous system (SNS) is 
explored in relation to myocardial infarction in Chapter 6. 
 
In summary, instillation of DEP does not impair endothelial cell function in the hind-
limb vascular bed.  Further studies are needed to determine whether the results in the 
hind-limb vascular bed extend to other vascular beds, including the coronary 
vascular bed. 
4.4.2 Pulmonary effects of DEP instillation in healthy male rats  
Inflammation has been implicated in many of the actions of DEP and other particles, 
including actions on the cardiovascular system (Seaton et al., 1995).  Much research 
has been, and is being, undertaken to characterise the exposure of pollutants on lung 
inflammation.  In the present study, lung inflammation was assessed by BAL 6 and 
24 hours after particulate exposure to validate the use of the method for delivering 
DEP to the lungs.  DEP induced a neutrophilic airway inflammation 6 hours after 
exposure, which had largely resolved by 24 hours.  Analogous results have been 
reported in rats 6 hours after intra-tracheal instillation of ultrafine carbon black (CB) 
particles (Li et al., 1997).  Airway neutrophilic inflammation has also been detected 
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at this time in healthy human volunteers exposed to DEP (Nordenhall et al., 2000; 
Salvi et al., 1999).  In contrast, levels of neutrophils in BAL fluid recovered from 
rats were significantly elevated 12 hours after intra-tracheal instillation of 1 mg/kg 
DEP and remained elevated for up to 24 hours (Yokota et al., 2008b).  Exposure to 
concentrated ambient PM has also been reported to induce pulmonary inflammation 
in mice 24 hours after intra-tracheal instillation of ambient PM (Wegesser et al., 
2008).  These results suggest that the kinetics of the inflammatory response may be 
dependent on animal species and nature of particles. 
 
In the present study, the transient lung inflammatory response to DEP may result 
from direct effects of DEP on airway cells.  Increased cytokine production has been 
reported in alveolar and bronchial epithelial cell lines after exposure to DEP and 
other air pollution particles (Boland et al., 1999; Boland et al., 2000; van Eeden et 
al., 2001).  Becher et al. (1996) reported release of IL-6 and TNFα by rat alveolar 
macrophages stimulated with PM. 
 
Rats instilled with 0.5 ml of saline showed no significant changes in the number of 
inflammatory cells in BAL fluid at 6 and 24 hours post instillation compared with the 
non-instilled control rats.   Similar findings were reported in a previous study, where 
no differences were detected between saline-instilled and non-instilled rats in cellular 
profiles in BAL fluid (Tesfaigzi et al., 2000).   Somewhat unexpectedly, BAL levels 
of CRP were significantly elevated above controls in both saline-instilled and DEP-
instilled animals at 6 hours.  This may be due to contamination of the saline.  
However, this seems unlikely given that sterile saline was used and no effects were 
noted for the other inflammatory mediators measured. 
 
To summarise, these findings suggest that the lack of effect of DEP exposure on 
endothelial cell function was not due to ineffective DEP exposure. 
4.4.3 Systemic effects of DEP instillation in healthy male rats 
It has been proposed that the adverse cardiovascular effects of air pollutants are due 
to, or exacerbated by, the release of inflammatory mediators from the lung into the 
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circulation.  Studies both in humans and in animals have shown air particles to 
increase the number of polymorphonuclear leukocytes (PMN) in the circulation by 
inducing rapid release from the bone marrow into the peripheral circulation (Ghio et 
al., 2011; Mukae et al., 2001; Suwa et al., 2002; Tan et al., 2000).  As described 
above, increased levels of IL-6 were detected in BAL 6 hours after intra-tracheal 
instillation of DEP.  IL-6 released from alveolar macrophages has been previously 
shown to enhance release of PMNs from the bone marrow (Suwa et al., 2002).  In the 
present study, circulating leukocytes were increased 6 hours, but not 24 hours after 
intra-tracheal instillation of DEP.  These findings are consistent with reports of 
higher circulating leukocyte counts 4 hours, but not 12 hours, following intra-
tracheal instillation of DEP in rats (Yokota et al., 2008b).  In contrast, to the results 
from the WBC counts in the present study, instillation of DEP did not significantly 
affect RBC count.  Other studies in the literature have been inconsistent with respect 
to RBC counts, reporting increases (Rivero et al., 2005), decreases (Seaton et al., 
1999) and no change (Nemmar et al., 2007; Ogugbuaja et al., 2001).  Exposure to 
concentrated air pollution has been reported to lower the anti-oxidative enzyme 
activities of RBCs in elderly patients (Delfino et al., 2008).  The RBCs play an 
important role in protecting cells against oxidative stress  (Tsantes et al., 2006).   
Changes in the anti-oxidative capacity of the RBCs in response to DEP exposure 
cannot be ruled out in the present study and warrants consideration in future studies. 
 
Whilst the pulmonary actions of DEP are relatively consistent in the literature, 
measures of particle-induced systemic inflammatory responses are notoriously 
variable (Gottipolu et al., 2009; Nemmar et al., 2011; Yokota et al., 2008b).  In this 
study, concentrations of the studied inflammatory mediators (IL-6, TNFα and CRP) 
were not elevated at 6 hours after DEP instillation, a time at which lung 
inflammation was detected.  Plasma IL-6 and TNFα concentrations were, however, 
markedly increased 24 hours after DEP instillation compared with the saline control.  
Similarly, IL-6 levels were highly elevated in mouse plasma 24 hours after intra-
tracheal instillation of DEP.  IL-6 and TNFα have also been shown to be elevated in 
the serum and plasma of humans 24 hours, but not 6 hours, after exposure to DE 
(Mills et al., 2005; Tornqvist et al., 2007).  Later systemic changes when the 
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pulmonary effects induced by DEP are largely resolved has been reported in mice 
exposed to coal fly ash (CFA) (Smith et al., 2006).  These investigators reported 
systemic inflammation to peak after pulmonary inflammation had already subsided.  
The time-course of these responses could suggest that these factors originate from 
the prior inflammatory response in the lung.  A recent study in mice showed that 
inflammatory mediators such as IL-6 translocate from the lung following PM 
exposure into the blood stream contributing to the systemic inflammation (Kido et al., 
2011).  Previous studies in animals (Upadhyay et al., 2010; Zhao et al., 2010) and 
man (Hertel et al., 2010; Peters et al., 2001b; Sandhu et al., 2005) have reported 
raised levels of CRP in the blood following exposure to urban particulates or 
episodes of high air pollution, yet results presented here did not demonstrate any 
changes in this mediator after air pollution.  Differences in the type and composition 
of the particulate or co-pollutant may explain these discrepancies.  It is important to 
note that the results of this study cannot rule out the possibility of that other 
biomarkers are more sensitive at detecting systemic inflammation. 
 
As noted above, this study detected elevated WBC counts and increased BAL TNFα 
concentrations 6 hours after instillation of DEP.  It is reported that TNFα can induce 
the expression of adhesion molecules on PMN and endothelial cells (Gamble et al., 
1985; Lee et al., 2006; Takahashi et al., 1996).  Adhesion molecules play an 
important role in PMN attachment and subsequent transmigration through vascular 
endothelium (Walzog et al., 2000).  PMN adhesion and transmigration play an 
important role in many inflammatory disorders, including reperfusion injury (Jordan 
et al., 1999; Saeed et al., 2005).  PMN adhesion molecule expression and function in 
response to DEP instillation requires investigation, and will be discussed in the next 
chapter.  DEP has been reported to induce interleukin-8 (IL-8) in cultured normal 
human bronchial epithelial cells (Bayram et al., 1998).  This inflammatory cytokine 
has been identified as an important PMN chemotactic factor (Standiford et al., 1990) 




To summarise, markers of systemic inflammation could be detected after 24 hours.  
The time course of these responses could suggest that these inflammatory factors 
originate from the prior inflammatory response in the lung. 
4.4.4 Haemodynamic effects of DEP instillation in healthy male rats  
During ischaemia there is an imbalance between the heart’s oxygen supply and 
demand.   RPP is a major determinant of oxygen consumption.  RPP, calculated as 
the product of SBP multiplied by HR, has been reported to be a valid and reliable 
indicator of myocardial oxygen consumption (Nelson et al., 1974).  Not all changes 
in myocardial oxygen consumption are determined by HR x SBP.  Other major 
determinants of myocardial oxygen consumption are ventricular wall stress 
(afterload) and contractility (inotropy), although it was not practical to measure these 
parameters in the present study.   At baseline, RPP was higher 6 hours, but not 24 
hours, after instillation with DEP relative to their respective saline-instilled controls.  
This was principally due to elevated systolic pressures with little or no change in HR.  
However, it is important to emphasis that calculating HR from the consecutive 
systolic peaks on the blood pressure tracing may not have been the most accurate 
approach to detect changes in HR.  A better way may have been to calculate HR 
from an ECG.  Regardless, the RPP responses to DEP in rats after intra-tracheal 
instillation lends additional support to the results of other studies showing a positive 
association between PM and RPP (Bartoli et al., 2009b; Shah et al., 2008; Urch et 
al., 2005).  However, this study did not examine the impact of DEP instillation on the 
supply of myocardial oxygen.  It would be valuable to investigate the effects of DEP 
instillation on the RPP when myocardial oxygen supply is interrupted in ischaemia.  
This will be further investigated in the next chapter. 
 
Diastolic pressures were also higher after DEP instillation.  Epidemiological studies 
and human and animal controlled exposure studies on the associations between air 
PM and blood pressure have been somewhat inconsistent (Brook et al., 2009a).  A 
study by Dvonch et al. (2009) in the Detroit metropolitan area reported a 3.2 mmHg 
increase in SBP for every 10 µg/m
3
 rise in PM.  A chamber exposure study 
conducted by our laboratory reported no change in blood pressure 6 hours following 
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exposure to DE compared to filtered air (Mills et al., 2005).  Similar haemodynamic 
results were obtained in controlled human exposure studies using concentrated 
ambient particles (CAP) (Mills et al., 2008).  Controlled animal exposure studies 
have reported similar discordant results.  This may be partly explained by differences 
in the methodologies of exposure.  Vincent et al. (2001) reported an increase in 
blood pressure 2-48 hours after nose-only inhalation exposure to diesel soot in rats.  
On the other hand, intravenous injections of DEP at doses of 0.02 – 0.5 mg/kg 
decreased blood pressure in rats 24 hours after dosing (Nemmar et al., 2007).  
Inconsistencies may also result from using different blood pressure measurement 
techniques and different PM characteristics and source type.  It is possible that the 
increased plasma IL-6 concentrations 24 hours after DEP instillation may have 
prevented increases in arterial pressure.  Indeed, Tateishi et al. (2007) reported in 
septic patients, an association between high circulating IL-6 concentrations and a 
decline in blood pressure. 
 
Several plausible mechanisms may explain this increase in blood pressure 6 hours 
after DEP instillation.  Alterations in endothelial function and subsequent changes in 
vasomotor tone may explain the pro-hypertensive response observed 6 hours after 
intra-tracheal instillation of DEP.  Sun et al. (2005) reported PM-induced 
vasoconstriction in mice to be mediated by systemic inflammatory and oxidative 
stress responses.  In the present study the blood pressure change 6 hours post 
exposure were not accompanied by changes in systemic cytokine levels.  It is, 
therefore, unlikely that the pro-hypertensive response was due to inflammation-
induced vascular dysfunction.  In further support of this conclusion, as discussed 
above there was no loss of endothelium-mediated vasodilator responses in the hind-
limb after DEP instillation.  Previous studies both in humans and in animals have 
reported endothelin-1 (ET-1)-induced haemodynamic changes following exposure to 
air pollutants (Bouthillier et al., 1998; Calderon-Garciduenas et al., 2007; Peretz et 
al., 2008b; Vincent et al., 2001).  Circulating plasma levels of ET-1, a potent 
vasoconstrictor peptide released by vascular endothelial cells, were not measured in 
the present study.  It seems more likely that the rapid and transient hypertensive 
response is mediated by an imbalance of the ANS favouring an increase in the 
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sympathetic drive.  This hypothesis is supported by animal and human studies 
showing PM-induced elevations in blood pressure to be mediated by neurohumoral 
activation (Bartoli et al., 2009b; Brook et al., 2009a).  Bartoli et al. (2008) 
demonstrated that the raised DBP during a 5 hour exposure to CAP was significantly 
attenuated by prazosin, a selective alpha 1 (α1) adrenoceptor antagonist.  
Furthermore, increased sympathetic activation has been suggested from studies 
reporting associations between air pollutants and decreased heart rate variability 
(HRV) (Brook et al., 2009a; Gold et al., 1999; Pope et al., 1999; Rivero et al., 2005; 
Schulz et al., 2005).  Interestingly, a recent observational study reported wearing a 
facemask to significantly lower SBP in healthy subjects during a 2 hour walk in 
Beijing (Langrish et al., 2009b).  The magnitude of the SBP decrease was strongly 
associated with increases in HRV, reflecting an autonomic regulation of blood 
pressure (Langrish et al., 2009b).  In the present study, there was no difference in 
plasma catecholamine levels between the groups.  However, there are many practical 
concerns (Boomsma et al., 1993; Goldstein, 2003) about the measurement of 
catecholamines (such as stability) making it difficult to draw any firm conclusions.  
A better alternative to measuring sympathetic nerve activity would have been to use 
microneurography (Nakamura et al., 2003).  Unfortunately, this was not available in 
the laboratory.  Importantly, PM exposure studies have also reported increases in 
parasympathetic tone.  Indeed, HRV has been shown to increase in response to 
particulate air pollution (Brito et al., 2010; Riediker et al., 2004).  Together, these 
studies suggest that air pollution can affect both the sympathetic and parasympathetic 
branches of the ANS.  In rats, Rhoden et al. (2005) demonstrated intra-tracheal 
instillation of CAP to increase both sympathetic and parasympathetic stimulation.  A 
similar observation has been seen in dogs exposed to CAP (Godleski et al., 2000).  
Enhancement of both sympathetic and parasympathetic tone could explain the lack of 
change in HR observed in this study. 
 
In summary, the rapid-onset of the DEP-induced elevation in blood pressure is likely 
to be principally mediated by rapid changes in ANS balance favouring SNS-




The results obtained clearly show that, instillation of DEP in rats causes both 
pulmonary and systemic inflammation, but this is not associated with impaired 
endothelial cell function at 6 and 24 hour post exposure.  However, DEP 
administration produced specific impairments in vascular response in vivo, through a 
mechanism that may involve changes in autonomic activity.  The DEP-induced 
pulmonary inflammation was observed at 6 hours post exposure and largely resolved 
by 24 hours.    Arterial blood pressure and myocardial work and oxygen consumption 
were also higher 6 hours after exposure to DEP, with less pronounced effects at the 
later time point.  While there was no indication of systemic inflammation at 6 hours 
after DEP instillation, the levels of two inflammatory mediators, IL-6 and TNF 
were increased in the plasma by 24 hours after exposure.  The time course of these 
responses could suggest that these factors originate from the prior inflammatory 
response in the lung.  The following chapter explores the effect of DEP on the 
susceptibility of rats to ischaemia and reperfusion, using a surgical model to mimic 
the effects of coronary occlusion in cardiovascular disease.  All remaining studies 
will be carried out at 6 hours post-exposure since the results presented in this study 
found pulmonary and haemodynamic changes associated with DEP exposure to be 
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There is growing clinical and experimental evidence for detrimental effects of diesel 
exhaust (DE) and particulate matter (PM) on coronary vascular function, on 
atherosclerotic plaque development and stability and on thrombosis and clot 
resolution (Kunzli et al., 2005; Nemmar et al., 2003a; Suwa et al., 2002).  While the 
coronary effects of PM increase the likelihood of heart attack occurrence there is also 
evidence that exposure to PM has deleterious effects on the myocardium itself.  
Particulates and other air pollutants increase the incidence of ventricular arrhythmias 
in patients with implantable defibrillators (Dockery et al., 2005; Peters et al., 2000; 
Vedal et al., 2004).  Experimental studies have also reported cardiac abnormalities, 
including impaired left ventricular diastolic performance and arrhythmias after in 
vivo exposure to PM (Anselme et al., 2007; Okayama et al., 2006; Wold et al., 2006; 
Yan et al., 2008).  These observations suggest that exposure to PM may also render 
the heart more vulnerable to injury following infarction.  To date, only one study has 
addressed this question directly.  Myocardial I/R injury was increased in mice 24 
hours after pulmonary instillation of concentrated ambient particles (CAP) (Cozzi et 
al., 2006).  However, the mechanism by which pulmonary exposure to pollution is 
associated with enhanced reperfusion injury is currently unclear. 
 
This chapter assessed the myocardial susceptibility to I/R injury, both in vivo and ex 
vivo, in rats that had received a single intra-tracheal exposure of DEP 6 hours earlier.  
In vivo and ex vivo animal models of myocardial I/R injury have been extensively 
used in experimental investigations (Bagate et al., 2006b; Cozzi et al., 2006; Jeanes 
et al., 2008; Wold et al., 2006).  In both models of myocardial I/R injury, ischaemia 
is induced by transient ligation of the left anterior descending (LAD) coronary artery 
followed by reperfusion.  In these experimental models, it has been shown that 
initiating reperfusion after ischaemia lasting longer than 20 minutes leads to 
irreversible myocardial damage (Park et al., 1999).  The current study used a model 
of I/R rather than one of permanent ligation to mimic more closely the clinical 
setting of reperfusion therapy in acute myocardial infarction (MI).  Indeed, these 
animal models produce changes in cardiac rhythm and contractility similar to those 
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seen in the clinic (Park et al., 1999; Yellon et al., 2007).  The inflammatory infiltrate 
that surrounds infarcted myocardium also closely resembles the human situation 
(Park et al., 1999; Yellon et al., 2007).  Using both in vivo and ex vivo models will 
enable a more accurate and thorough exploration of the molecular mechanisms 
underlying the effects of PM exposure on I/R injury, extending the previous findings 
in animal studies. 
5.1.1 Hypothesis 
Intra-tracheal instillation of DEP in healthy rats will increase the vulnerability of the 
heart to subsequent myocardial I/R injury. 
5.1.2 Aims 
The aims of the work described in this chapter were to determine whether intra-
tracheal instillation of DEP: 
v. increases susceptibility to in vivo I/R injury 
vi. increases susceptibility in ex vivo I/R injury 
vii. increases cardiac oxidative stress 
viii. influences myocardial tissue injury and may enhance circulating 





5.2.1 Pulmonary instillation of DEP 
Adult male Wistar rats (250-350 g; Charles River Laboratories) were used for all 
experiments.  Animals were instilled intra-tracheally with either DEP (0.5 mg in 0.5 
ml saline) or vehicle (saline 0.5 ml).  For details of the preparation and instillation 
process please refer to Chapters 2.2 and 2.3.  To ensure that saline instillation itself 
had no notable effects on the parameters studied, an additional group of rats received 
no instillation.  Animals were sacrificed 6 hours after instillation by exsanguination.  
This time point was chosen based on results described in Chapter 4.     
5.2.2 Coronary artery ligation 
Ischaemia induced by coronary artery ligation followed by reperfusion was carried 
out on rat hearts in vivo and ex vivo.  For details of the two animals models of 
myocardial I/R injury please refer to Chapter 2.7. 
5.2.3 Detection of reactive oxygen species (ROS) by electron 
paramagnetic resonance (EPR) spectroscopy  
In some ex vivo perfused hearts, oxygen free radical generation from the myocardium 
was assessed in perfusion fluid using spin label EPR.  Measurements were taken at 
baseline, after 0 and 30 minutes of ischaemia and after 0, 1 and 2 hours of 
reperfusion.  Please refer to Chapter 2.11 for more details. 
5.2.4 Tissue collection 
For histological analysis hearts were cut longitudinally from apex to base.  This was 
followed by fixation, processing and embedding in paraffin wax as described in 
Chapter 2.8.  For infarct size assessment the whole heart was excised and washed in 
saline to remove excess Evans Blue prior to storage at -20°C.  Wet weight was 
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recorded in some ex vivo perfused hearts following reperfusion prior to storage at -
20°C. 
5.2.5 Plasma IL-8 concentration 
Blood samples were collected as described in Chapter 2.4.  Circulating levels of IL-8 
were measured by enzyme-linked immunosorbent assay (ELISA) (Cusabio Biotech 
Co., Ltd) in plasma generated by centrifugation of whole blood for 5 minutes at 1500 
g and 4°C, as described in Chapters 2.5.3 & 2.5.4. 
5.2.6 Assessment of granulocyte adhesion and activation by flow 
cytometry 
Flow cytometry was used to evaluate changes in CD11b and CD62L expression of 
granuloctyes in whole blood.  Cells were stained with fluorochrome-conjugated 
antibodies specific for CD11b (10 µg/ml) and CD62L (0.1 mg/ml).  An isotype 
IgG2a (10 µg) was used as a negative control.  To assess granulocyte functions after 
stimulation, whole blood was stimulated with 1 µg formyl-Met-Leu-Phe-OH (fMLP).  
All data was collected on a FACS-Calibur flow cytometer and analysis performed 
using FlowJo Data Analysis Software.  Please refer to Chapter 2.10 for more details. 
5.2.7 Histology 
Sections were stained with haematoxylin and eosin (H & E) to allow for 
identification and quantification of neutrophils (cells containing distinctive 
polymorphonuclear morphology) in the left ventricle, as described in Chapter 2.9.2. 
5.2.8 2, 3, 5-triphenyltetrazolium chloride (TTC) staining 
TTC staining was used to assess myocardial viability as described in Chapter 2.9.1.  
In some studies, in hearts from DEP-instilled rats, Evans blue was unable to 
discriminate between perfused and non-perfused myocardium due to increased 
capillary leak.  In these studies, infarct size was expressed as a percentage of left 




All values are expressed as mean ± SEM.  Arrhythmias were clearly indicated by an 
abnormal change in blood pressure.  The arrhythmia duration was defined as the total 
number of minutes rats exhibited irregular blood pressure.  Relative radical 
concentrations (in arbitrary units, AU) were recorded as the signal intensity obtained 
from the peak-to-peak height of the first derivative EPR spectrum.  Baseline systemic 
haemodynamics, plasma IL-8 concentrations, the adhesion and activation of 
granulocytes, myocardial AAR and infarct size were compared between the groups 
using one-way ANOVA combined with Bonferroni’s post hoc test for multiple 
comparisons.  Differences in haemodynamic parameters over time within and 
between groups were analysed by two-way ANOVA followed by Bonferroni post 
hoc test.  An unpaired t-test was used to compare oxygen free radical generation.  




5.3.1 I/R in vivo 
5.3.1.1 Effect of DEP instillation on resting heart rate (HR), blood pressure and 
rate pressure product (RPP) 
No differences were observed in the resting HR of rats receiving no instillation or 
those 6 hours following instillation of saline  or DEP (355 ± 12, 348 ± 13 and 377 ± 
13 bpm respectively).  Neither systolic nor diastolic arterial blood pressures under 
resting conditions were different 6 hours after saline instillation to that in rats that 
had no instillation (Table 5.1).  Systolic and diastolic blood pressures were 
significantly higher in rats anaesthetised 6 hours after the instillation of DEP as 
compared to saline (Table 5.1).  The RPP (HR multiplied by systolic arterial 
pressure) was calculated to provide an indication of myocardial demand.  There was 
no difference in RPP in rats that received saline instillation compared to non-instilled 
rats (Table 5.1).  However, RPP was significantly higher in rats 6 hours after 
exposure to DEP (P<0.05 compared to saline).  Values reported here are consistent 
with those previously reported in Chapter 4.3.7. 
5.3.1.2 Effect of DEP instillation on HR, blood pressure and RPP during 
ischaemia and reperfusion in vivo 
Induction of ischaemia by coronary artery ligation resulted in a transient drop in 
mean arterial blood pressure (MAP) in all groups (Table 5.2).  This had returned to 
pre-ischaemic levels within 10-15 min for the non-instilled and saline-instilled 
animals while MAP in the DEP-instilled group continued to remain lower throughout 
the period of I/R (Table 5.2).  In all groups there was a small (7-12%), statistically 
insignificant increase in the RPP at the onset of ischaemia.  Thereafter, RPP 
remained relatively constant for the non-instilled and saline-instilled rats (Table 5.2).  
In the DEP-instilled rats RPP was significantly lower than baseline after 2 hour 




  Group 
  Non-instilled Saline DEP 
HR (beats/min) 355 ± 12 358 ± 10 389 ± 13 
SBP (mmHg) 113.0 ± 7.4 100.7 ± 7.8 148.5 ± 5.2*** 
DBP (mmHg) 101.8 ± 8.1 89.6 ± 5.7 139.3 ± 5.2*** 
RPP (HR X 
SBP/1000) 31.2 ± 3.1 32.4 ± 1.8 41.9 ± 2.5* 
Table 5.1 Baseline cardiac parameters in non-instilled, saline-instilled and DEP-
instilled rats. 
Abbreviations: DEP = diesel exhaust particulate, HR = heart rate, SBP = systolic 
blood pressure, DBP = diastolic blood pressure, RPP = rate pressure product. 
Data are expressed as mean ± SEM (n=6). ***P<0.001 compared to saline; one-way 






Baseline Onset Isc 45 min Isc 1 h Rep 2 h Rep 
Non-instilled (n=6)   
HR (beats/min) 355 ± 12 341 ± 17 324 ± 14 330 ± 19 321 ± 20 
MAP (mmHg) 105.5 ± 7.8 71.0 ± 2.6
##
 94.3 ± 4.0 90.7 ± 2.4 76.7 ± 2.6
##
 
RPP (HR X SBP/1000) 31.3 ± 3.1 35.0 ± 1.0 30.5 ± 2.0 30.1 ± 1.6 24.7 ± 0.7 
Saline (n=6)   
HR (beats/min) 358 ± 10 346 ± 10 335 ± 13 357 ± 7 342 ± 21 
MAP (mmHg) 93.0 ± 6.4 59.4 ± 4.9
###
 96.8 ± 6.6 91.5 ± 4.1 86.9 ± 5.2 
RPP (HR X SBP/1000) 32.4 ± 1.8 34.8 ± 2.0 34.0 ± 4.1 33.1 ± 1.8 28.6 ± 2.3 
DEP (n=4)   
HR (beats/min) 389± 13 365 ± 12 366 ± 16 367 ± 10 347 ± 14 
MAP (mmHg) 140.5 ± 6.2*** 82.7 ± 10.7
###




 88.6 ± 2.8
###
 
RPP (HR X SBP/1000) 41.9 ± 2.5*** 46.6 ± 6.8 38.1 ± 5.1 38.3 ± 5.4 30.2 ± 2.9
#
 
Table 5.2 Cardiac parameters at timed intervals during ischaemia and reperfusion in non-instilled, saline-instilled and DEP-
instilled rats. 
Abbreviations: DEP = diesel exhaust particulate, HR = heart rate, SBP = systolic blood pressure, MAP = mean arterial blood pressure, RPP 
= rate pressure product, Isc = ischaemia, Rep = reperfusion. 
Data are expressed as mean ± SEM (n=4-6). ***P<0.001 versus saline; #P<0.05, ##P<0.01, ###P<0.001 versus baseline in each group; 




5.3.1.3 Effect of DEP instillation on cardiac arrhythmias during 45 minutes of 
ischaemia in vivo 
Three needle electrodes were inserted subcutaneously into both hind-paws and the 
right fore-paw for electrocardiogram (ECG) measurements.  No arrhythmias were 
seen during the baseline period in any of the experimental groups (representative 
traces are shown in Figures 5.1a & b).  Characterising the specific types of 
arrhythmias was beyond the scope of this thesis.  Arrhythmias were detected within 5 
minutes of ischaemia induction (representative traces are shown in Figures 5.1c & d).  
In non-instilled rats these lasted for 7.6 ± 1.1 minutes (Figure 5.1e).  Saline 
instillation did not modify arrhythmia duration (Figure 5.1e).  In contrast, prior 
instillation of DEP significantly increased arrhythmia duration to 32.9 ± 5.0 minutes 
(P = 0.0008; Figure 5.1e).  Additionally, in the DEP-instilled rats these arrhythmias 
were poorly tolerated; ventricular arrhythmias leading to sudden cardiac death within 
15 minutes occurred in 60% (6 out of 10) of cases in the DEP-instilled group.  
Sudden cardiac death did not occur in the non-instilled and saline-instilled animals.  
There was no difference in the rate of deaths due to surgical- or anaesthetic-related 
mishaps. 
5.3.1.4 Effect of DEP instillation on myocardial infarct size after ischaemia and 
reperfusion in vivo 
The AAR, determined after ligation was not different in rats that received saline 
instillation compared to non-instilled rats (Figure 5.2a).  In DEP-instilled rats, initial 
studies indicated that Evans blue was not effectively excluded from the AAR 
indicating enhanced capillary leakage.  Ultimately infarct size was calculated as a 
percentage of LV mass.  Infarct size in non-instilled rats averaged 13.3 ± 1.0 % of 
total LV mass (Figure 5.2b) and was not changed by saline instillation.  In contrast, 
infarct size in DEP-instilled rats was increased threefold compared with that in 

























































































Figure 5.1 Arrhythmic events increased during ischaemia in the in vivo rat heart 
6 hours after instillation with diesel exhaust particulate (DEP). 
Representative traces of normal sinus rhythm showing standard PQRST waves from 
(a) saline- and (b) DEP-instilled rats at baseline.  (c) Representative trace of a saline-
instilled animal during ischaemia displaying 2
nd
 degree atrioventricular (AV) block.  
(d) Representative trace of DEP-instilled rat during ischaemia displaying ventricular 
tachycardia (VT).  (e) Duration of arrhythmias during ischaemia of surviving rats 
after no instillation, or 6 hours after instillation of saline or DEP.  Columns represent 
mean ± SEM (n = 4-6) *** P<0.001, compared to saline; one-way ANOVA with 












































































Figure 5.2 Pulmonary exposure to diesel exhaust particulate (DEP) led to 
increased infarct size after in vivo ischaemia-reperfusion. 
(a) Area at risk (AAR; expressed as a percentage of total left ventricular (LV) mass) 
after no instillation and 6 hours after instillation of 0.5 ml saline.  (b) Myocardial 
infarct size (expressed as a percentage of LV) after no instillation and 6 hours after 
instillation of saline or 0.5 mg DEP.  Columns represent mean ± SEM (n = 4-6) *** 




5.3.2 I/R ex vivo 
5.3.2.1 Effect of DEP instillation on coronary perfusion pressure (CPP), AAR 
and infarct size after ex vivo I/R 
The CPP (i.e the pressure at the coronary ostia) has been shown to be a major 
determinant of cardiac function (Broadley, 1979).  Changes in CPP have been 
reported to affect functional changes of the hearts induced by I/R (Monasterio et al., 
2004).  CPP was measured continuously at the aortic cannula using a transducer.  
There were no significant differences between the groups in baseline CPP (45.0 ± 6.1 
ml/min for non-instilled, 48.1 ± 4.1 ml/min for 6 h saline and 52.5 ± 3.0 ml/min for 6 
h DEP).  There was a tendency towards increased perfusion pressure in all groups 
during the ischaemia and reperfusion, but the increase was not significant (Table 5.3).  
Changes in CPP during ischaemia and reperfusion were not different between groups. 
 
The AAR was 73.3 ± 3.3 % in the non-instilled animals (Figure 5.3a).  This was not 
further modified by instillation, regardless of whether saline or DEP was 
administered.  Infarct size in hearts from non-instilled rats averaged 13.3 ± 1.0 % of 
total LV mass (Figure 5.3b) and was not changed in hearts from saline-instilled rats.  
In contrast, infarct size in hearts from DEP-instilled rats was increased threefold 
compared with that in control rats (P<0.001). 
5.3.2.2 Effect of DEP instillation on oxygen free radical production at baseline 
and during the ischaemia and reperfusion in the isolated perfused rat heart 
Baseline oxidant stress, determined by EPR in heart perfusate, 6 hours after 
instillation of saline was 2140.0 ± 224.0 AU (Figure 5.4a).  Free radical intensity was 
approximately 3-fold higher in hearts from DEP-instilled rats (P = 0.0035; Figure 
5.4a).  All hearts showed a small burst of oxidant stress on reperfusion but this did 
not differ between treatment groups (Figure 5.4b).  Unfortunately, there is no data 
available at this time on the free radical production in hearts from non-instilled rats 
due to time constraints. 
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5.3.2.3 Effect of DEP instillation on wet weight and wet-to-dry weight ratio after 
ex vivo I/R 
Wet heart weight, but not dry heart weight, was significantly higher from DEP-
instilled rats than those from animals instilled with saline (P = 0.0053; Figure 5.5a).  







Coronary perfusion pressure (CPP) values (mmHg) 
Baseline Onset Isc 30 min Isc 1 h Rep 2 h Rep 
Non-instilled 45.0 ± 6.1 58.8 ± 10.0 62.4 ± 8.7 62.4 ± 9.8 70.7 ± 16.7 
Saline 48.1 ± 4.1 54.4 ± 4.9 64.1 ± 15.3 60.0 ± 14.4 62.7 ± 14.8 
DEP 52.5 ± 3.0 62.0 ± 7.5 63.7 ± 9.8 58.1 ± 9.6 51.8 ± 3.0 
Table 5.3 Coronary perfusion pressures sampled at various time intervals 
during ischaemia and reperfusion in hearts isolated from non-instilled, saline-
instilled and DEP-instilled rats. 
Abbreviations: DEP = diesel exhaust particulate, Isc = ischaemia, Rep = reperfusion. 















































































Figure 5.3 Infarct size was bigger in Langendorff-perfused hearts from rats 
instilled with diesel exhaust particulate (DEP). 
(a) Area at risk (AAR; expressed as a percentage of total left ventricular (LV) mass) 
and (b) myocardial infarct size (expressed as percentage of AAR) in non-instilled 
rats and 6 hours after instillation of 0.5 ml saline or DEP (0.5 mg).  Columns 
represent mean ± SEM (n = 4-6) *** P<0.001, compared to saline; one-way 





































































































Figure 5.4 At baseline oxygen free radical formation in perfused rat hearts was 
higher in animals instilled with diesel exhaust particulate (DEP). 
Electron paramagnetic resonance (EPR) signal of the 1-hydroxy-3-carboxy-
pyrolidine (CP-H) spin adduct at (a) baseline and at (b) different times during the 
ischaemia/reperfusion (I/R) 6 hours after instillation of 0.5 ml saline or DEP (0.5 mg).  























































































































Figure 5.5 After ischaemia/reperfusion (I/R) wet weight of the isolated rat 
hearts was higher in rats instilled with diesel exhaust particulate (DEP). 
(a) Wet heart weight, (b) dry weight and (c) wet-to-dry heart weight ratio 6 hours 
after instillation of 0.5 ml saline or DEP (0.5 mg).  Columns represent mean ± SEM 
(n = 5) ** P<0.01, compared to saline; unpaired t-test. 
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5.3.3 Influence of DEP on tissue injury, cytokines and neutrophil 
activation state prior to I/R  
5.3.3.1 Effect of DEP instillation on heart wet weight 
Before I/R wet heart weight was significantly higher from DEP-instilled rats than 
non-instilled animals (Figure 5.6).  
5.3.3.2 Effect of DEP instillation on cardiac cell viability 
Staining of hearts with TTC was used to determine whether particle instillation led to 
irreversible myocardial damage.  The LV had negligible levels of damage in hearts 
from non-instilled rats or at 6 hours following saline instillation.  However, 10.1 ± 
2.6% of the LV stained brick red with TTC (TTC-positive) in hearts collected 6 
hours after instillation of DEP (Figure 5.7). 
5.3.3.3 Effect of DEP instillation on circulating IL-8 concentrations 
Plasma IL-8 concentration in non-instilled rats was 266.3 ± 28.4 pg/ml (Figure 5.8) 
and this was not significantly altered 6 hours after saline or DEP instillation (Figure 
5.8). 
5.3.3.4 Effect of DEP instillation on myocardial neutrophil tissue number 
H & E stained left ventricle sections revealed no penetration of neutrophils into the 




















Figure 5.6 Diesel exhaust particulate (DEP) instillation increased heart wet 
weight. 
Wet heart weight after no instillation and 6 hours after instillation of 0.5 ml saline or 
DEP (0.5 mg).  Columns represent mean ± SEM (n = 4) * P<0.05, compared to non-































Figure 5.7 Diesel exhaust particulate (DEP) instillation decreased cardiac cell 
viability. 
The percentage of viable myocardium in the left ventricle (LV) after no instillation 
and 6 hours after instillation of 0.5 ml saline or DEP (0.5 mg) was calculated by 
deducting the percentage of tissue stained brick with 2, 3, 5-tetrazolium chloride 
(TTC).  Columns represent mean ± SEM (n = 3) ** P<0.01, compared to saline; one-




Figure 5.8 Instillation of diesel exhaust particulate (DEP) does not affect plasma 
interleukin-8 (IL-8) concentrations. 
Plasma IL-8 concentrations in non-instilled, saline-instilled and DEP-instilled (0.5 
mg) rats 6 hours after instillation.  Plasma IL-8 concentrations were detected by 





Figure 5.9 No infiltrating neutrophils were found in rat heart 6 hours after 
pulmonary exposure to diesel exhaust particulate (DEP). 
Haematoxylin and eosin (H & E) stained sections of left ventricle (LV) 6 hours after 






























5.3.3.5 Effect of DEP instillation on whole blood flow cytometric analysis of 
granulocyte adhesion and activation 
Granulocytes were analysed after exclusion of other cells (red blood cells (RBC), 
monocytes and lymphocytes) using forward and side scatter parameters.  Two 
distinct sub-populations of CD11b expressing cells were identified, either low 
(CD11b
LOW
) or high (CD11b
HIGH
) median fluorescence intensity (MFI) (Figure 




 in blood from non-instilled rats 
was 41.7 ± 4.8 and 238.3 ± 12.4 (arbitrary units) respectively (Figures 5.11a &c).   




 populations were not 
altered in blood collected 6 hours after instillation of saline or DEP (Figures 5.11a & 
c).  In blood from all treatment groups stimulation ex vivo with fMLP caused a 
decrease in the intensity of expression of the CD11b
LOW
 populations (Figure 5.11b).  
In contrast, fMLP treatment of granulocytes in whole blood of non-instilled rats 
increased the intensity of expression of CD11b
HIGH
 (Figure 5.11d).  Neither saline 









 was not 
different between the groups (data not shown).  In all groups no CD62L expressing 


































Figure 5.10 Flow cytometric analysis of granulocyte CD11b expression. 
Representative fluorescence histogram profile of normal rat peripheral blood 





 populations readily discernible.  The 
median fluorescence intensity (MFI) measured on a logarithmic scale (in arbitrary 
units) was calculated for each peak (seen as a bracketed horizontal line).  The red 















































































































































































































































 granulocytes at baseline or after ex 
vivo stimulation. 





subsets in non-instilled rats and 6 hours after instillation of saline or DEP (0.5 mg) at 
baseline (a & c) and following 1 µM formyl-Met-Leu-Phe-OH (fMLP) stimulation (b 




The data presented here are consistent with the hypothesis that instillation of DEP 
into the lungs of rats increases the vulnerability of the heart to subsequent myocardial 
reperfusion injury.  These studies have also shown that a single exposure of the lung 
to DEP primes the heart making it more susceptible to subsequent ischaemic injury 
within as little as 6 hours following exposure. 
5.4.1 In vivo studies 
There is strong epidemiological, clinical and experimental data demonstrating 
associations between increased particulate air pollution and the triggering of 
arrhythmias(Dockery et al., 2005; Hazari et al., 2011; He et al., 2010; Liao et al., 
2010; Peters et al., 2000; Watkinson et al., 1998; Wellenius et al., 2002).  Watkinson 
et al. (1998) reported increased cardiac arrhythmia after a single intra-tracheal 
instillation of residual oil fly ash (ROFA) in normal rats.  Without a regular ECG 
assessment we could not characterise the type of cardiac arrhythmia.  Nevertheless, 
in the current study, the total duration of arrhythmias during 45 minutes of ischaemia 
was significantly longer in the DEP-instilled rats. The increased susceptibility to 
arrhythmias was associated with an increased oxygen demand during ischaemia 
(higher RPP).  This could be a reason for increased injury as increased demand 
would mean more damage when supply is limited.  It was also observed that a single 
exposure to DEP increased I/R-related mortality.  These observations point towards 
the ability of a single exposure to DEP to increase the vulnerability of the heart to 
developing arrhythmia caused by subsequent ischaemia and reperfusion.  Regarding 
DEP, Yokota et al. (2004) previously showed exacerbation of ventricular 
arrhythmias during the reperfusion period and increased reperfusion-related mortality 
24 to 48 hours after instillation of 1 mg DEP.  These investigators concluded that this 
increased susceptibility was due to increased generation of ROS by recruited 




It is well recognised that circulating neutrophils play an important role in myocardial 
I/R injury (Jordan et al., 1999).  Indeed, neutrophils migrate from the circulation into 
the ischaemic tissue via endothelial cell interactions and produce an inflammatory 
response within the first few minutes of reperfusion (Yellon et al., 2007).  The study 
in Chapter 4 of this thesis showed an increased circulating white blood cell (WBC) 
count 6 hours after instillation of DEP.  One explanation for the increased infarct size 
after DEP instillation might be increased recruitment of neutrophils into ischaemic 
myocardium.  This is supported by the finding that increased infarct size in animals 
instilled with CAP 24 hours earlier was positively associated with increased 
myocardial neutrophil tissue number (Cozzi et al., 2006).  Prior activation or priming 
of neutrophils in DEP-instilled rats might also enhance their recruitment and also 
their subsequent activation and contribution to injury.  Thus, it was considered 
worthwhile to evaluate the effect of DEP instillation on the surface expression of 
CD11b on granulocyte cells.  Under resting conditions, the CD11b subunit of the 
granulocyte adhesion molecule (β2 integrins), is mainly stored within intracellular 
granules (Mazzone et al., 1995).  CD11b surface expression on granuloctyes rapidly 
increases upon activation leading to their sequestration and adhesion to the 
endothelium.  Thereafter, activated granulocytes release ROS.  In the current study, 
there was no change in the surface expression of granulocytes 6 hours after 
instillation of DEP, indicating that pulmonary DEP did not influence the activation 
levels of systemic leukocytes.  Instillation of DEP also had no effect on CD11b 
expression of granulocytes primed with fMLP, suggesting that DEP instillation does 
not prime systemic granulocytes causing heightened response during ischaemia and 
reperfusion.  IL-8 is a potent chemotactic factor for neutrophils (Ghelfi et al., 2008).  
Plasma concentrations of IL-8 did not change after DEP instillation compared with 
rats treated with saline instillation.  This result suggests that IL-8 did not contribute 
towards the increased circulating WBC count 6 hours after instillation of DEP (see 
Chapter 4).  Similarly the plasma levels of another stimulator of neutrophils, tumour 
necrosis factor alpha (TNFα) (Benbarek et al., 2008) were not found to differ 
between groups in studies described in Chapter 4.  Other inflammatory mediators 
known to be important for the mobilisation of leukocytes include interleukin-1 beta 
(IL-1β), granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage 
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colony stimulating factor (GM-CSF) (Springer, 1994) and warrant further 
investigation.  In line with our study, no effect on CD11b expression was also 
observed by Cozzi et al. (2005) 24 hours after a single instillation of CAP in mice. 
 
It cannot be completely ruled out that the increased susceptibility to ischaemia-
induced arrhythmias was not due to a larger ischaemic zone in the DEP-instilled 
animals (Curtis, 1998).  In hearts from DEP-instilled rats, Evans blue could not 
accurately distinguish perfused from non-perfused tissue after in vivo I/R.  Upon 
visual examination the cardiac tissue from the DEP-instilled rats showed blue 
staining throughout the heart.  Assessment of AAR is important as the size of the 
ischaemic zone is the most important determinant of ultimate infarct size (Lowe et 
al., 1978).  If by chance the AAR was higher in hearts from DEP-instilled rats, then 
this alone could explain the increased infarct size.   However, this seems unlikely to 
be the case here since in the ex vivo I/R studies (discussed in detail below) the AAR 
was not different between groups but increased infarct size was still observed.  Also, 
there was reason to believe that DEP instillation caused microvascular leakage, 
thereby preventing discrimination between non- and ischaemic tissue.  The wet heart 
weight before I/R was significantly higher in those rats instilled with DEP, 
supporting the presence of oedema.  Gurgueira and co-workers reported oedema in 
the hearts of rats exposed to ambient PM in vivo (Gurgueira et al., 2002).  These 
investigators suggested that the cardiac oedema was due to an increased generation 
of ROS.  In the current study, more ROS were generated ex vivo in the hearts from 
DEP-instilled rats and this will be discussed in more detail below.  Systemic 
inflammation may also lead to oedema (Martin et al., 1988).  However, this seems 
unlikely, given that studies in Chapter 4 of this thesis did not detect increased 
circulating levels of pro-inflammatory cytokines 6 hours after the instillation of DEP.  
Since Evans blue could successfully identify the AAR in the ex vivo I/R studies, it is 
possible that neural influences in response to DEP exposure are altering 
microvascular permeability.  Further experiments are warranted to confirm whether 
DEP-instillation increases microvascular permeability and capillary leak, which in 




Another possible mechanism is that DEP alters the autonomic nervous system (ANS) 
and increases the arrhythmogenic response to ischaemia and reperfusion.  Both 
human and animal studies have reported associations between PM and triggering of 
ANS reflexes, eventually leading to arrhythmia (Godleski et al., 2000; Peters et al., 
2000; Wellenius et al., 2002).  Decreased heart rate variability (HRV, a marker of 
cardiac sympathetic activation) and increased incidence of arrhythmia have been 
reported in rats exposed to ROFA (Wellenius et al., 2002).  Ceremuzynski et al. 
(1969) reported that increased plasma catecholamine concentrations in dogs 
correlated directly with the severity of ventricular arrhythmias during ischaemia, 
lending further support to this concept.  Plasma catecholamine concentrations have 
been notoriously difficult to measure (Boomsma et al., 1993; Goldstein, 2003) and 
studies described in Chapter 4 of this thesis could not detect elevated catecholamine 
levels in the plasma of DEP-instilled rats.  Nevertheless, in the current study, DEP 
instillation caused an increase in both baseline SBP and DBP which would be 
consistent with increased sympathetic activation.  An increased sympathetic 
activation would likely explain the myocardial hypersensitivity to ischaemia-induced 
arrhythmias in the DEP-instilled rats.  Activation of the sympathetic nervous system 
(SNS) may also explain the increased irreversible myocardial damage in these 
animals (Rona, 1985).  The mechanisms by which SNS may induce myocardial cell 
damage is likely multifactorial, including ROS and Ca
2+
 overload (Rona, 1985). 
 
In summary, the data presented here showed that rats receiving a single exposure of 
DEP developed larger infarcts following I/R in vivo.  In addition, these rats were 
more susceptible to ischemia-induced arrhythmias.  Experiments using flow 
cytometry showed this increased reperfusion injury in the DEP-instilled rats was not 
due to prior neutrophil activation.  Studies in Chapter 4 of this thesis also detected no 
systemic cytokine concentration after DEP instillation.  However, the in vivo 
experiments do not allow us to determine whether the increase in infarct size is 
dependent on enhanced neutrophil recruitment or on other neurohormonal responses 
to I/R in vivo. 
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5.4.2 Ex vivo studies 
To determine the dependence of increased injury on neurohormonal influences in 
vivo and on potentially altered inflammatory cell recruitment from the blood, studies 
were therefore also performed ex vivo on hearts from saline- and DEP-instilled rats.  
An increase in infarct size after I/R was observed in hearts from rats instilled with 
DEP 6 hours previously and then buffer-perfused ex vivo.  It was also found, that at 
equivalent flow rates, CPP at baseline and during I/R did not differ between the 
DEP- and saline-instilled groups.  These findings suggest that the increase in infarct 
size in DEP-instilled rats was not, therefore, due to alterations in coronary 
endothelial function (Broadley, 1979), although further studies would be necessary to 
confirm this.  Studies in Chapter 4 of this thesis demonstrated that endothelium-
dependent vasodilation was not altered in the peripheral vascular bed of DEP-
instilled rats.  Also abnormal endothelial cell function can contribute to variations in 
the myocardial AAR.  In the present study, AAR did not differ between groups, 
showing that the increased susceptibility to reperfusion injury was not due to a larger 
ischaemic zone in the DEP-instilled group. 
 
In the current study instillation with DEP increased infarct size in the absence of 
neural or haemodynamic factors.   Together with the in vivo data, these data strongly 
suggest that instillation of DEP causes in vivo priming of hearts to subsequent injury. 
5.4.3 Implications of oxidative stress  
Possible mechanism(s) responsible for priming of the heart for subsequent injury 
were explored next.  Oxidative stress can have damaging effects on the heart.  ROS 
target all major cellular components, including proteins and lipids.  Excess 
production of ROS may ultimately lead to arrhythmia, contractile failure and cell 
death (Guo et al., 2005; Kevin et al., 2005; Kim et al., 2006; Shattock et al., 1991; 
Yu, 1994).  In the current study, oxygen-centred free radical generation from the ex 
vivo retrograde perfused heart was measured using EPR spectroscopy coupled with 
CP-H spin-trapping.  More ROS were detected in the coronary effluent of hearts 
from the DEP-instilled rats.  Previous studies of animals exposed to PM have 
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demonstrated the occurrence of oxidative stress in the heart (Gurgueira et al., 2002; 
Tankersley et al., 2008).  In the present study, it remains unclear whether this is due 
to increased ROS production and/or a reduced level of activity of anti-oxidants.  
There were no infiltrating neutrophils detectable on H & E-stained paraffin sections 
from hearts of rats instilled with DEP 6 hours previously.  Thus, it is unlikely that 
neutrophils are a major source of the excess ROS in these hearts.  Other potential 
sources of the ROS in the myocardium include mitochondria, xanthine oxidase and 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Jordan et al., 1999).  
Coronary arterioles from rats exposed to DE increased ROS generation through nitric 
oxide synthase (NOS) uncoupling (Cherng et al., 2009).  In vitro studies on alveolar 
macrophages exposed to DEP implicated the mitochondria as a major source of the 
ROS (Hiura et al., 2000).  Mo and colleagues, on the other hand found that rotenone, 
a mitochondrial inhibitor, did not alter DEP-induced ROS generation in mouse 
pulmonary microvascular endothelial cells (MPMVEC) (Mo et al., 2009).  These 
investigators showed the formation of oxygen-derived free radicals by the DEP to be 
catalysed by a membrane-bound NADPH oxidase.  Supporting evidence for the 
involvement of NADPH oxidase has recently been obtained in an animal inhalation 
study using PM (Kampfrath et al., 2011).  NADPH oxidases are of particular interest 
since these enzymes are widely distributed within heart cells (Cave et al., 2005).  In 
this regard, future studies using inhibitors of ROS-producing systems will be 
insightful.  Future studies should also include measurements of anti-oxidant enzyme 
activities using spectrophotometric methods.  The effect of exposure on anti-oxidant 
enzyme activities has been studied with conflicting results.  Anti-oxidant enzyme 
activity was significantly inhibited in vitro in rat ventricular cardiac myocytes treated 
with DEP (Okayama et al., 2006).  Others have shown decreasing anti-oxidant 
enzyme activity in the heart of rats after inhalation of carbon monoxide (CO) (Andre 
et al.; Meyer et al., 2010)  In contrast, there are reports that PM exposure generates 
an adaptive response by activating anti-oxidant defences (Gurgueira et al., 2002). 
 
At present little is known of the molecular mechanisms underlying activation of the 
ROS-generating enzymes by PM.  This might be related to the activation of pro-
inflammatory cytokines which in turn can promote the activation of ROS-generating 
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enzymes (Nakamura et al., 1998).  However, as discussed above this seems unlikely 
to have contributed to the cardiac oxidative stress in this model given that no 
systemic neutrophil or pro-inflammatory cytokine activation was detected.  Studies 
in the literature suggest that PM exposure might increase cardiac oxidants via 
autonomic activation (Ghelfi et al., 2008; Rhoden et al., 2005).  Rhoden and 
colleagues demonstrated in rats, that inhalation of CAP induced cardiac oxidative 
stress that was abolished by sympathetic and parasympathetic antagonists (Rhoden et 
al., 2005).  These investigators also showed that the increased incidence of 
spontaneous cardiac arrhythmias in CAP-exposed rats could be prevented by 
treatment with the free radical scavenger superoxide dismutase (SOD). 
 
Regardless of the mechanism, however, we have demonstrated that instillation of 
DEP leads to increased oxidant levels in the rat heart.  Hearts from DEP-instilled rats 
also had an increased area of myocardium with reduced viability, assessed by TTC 
and also an increased number of apoptotic cells (see Appendices 3 & 4).  It seems 
highly likely that this is related to the increased oxidant stress.  Okayama et al. 
(2006) found that DEP significantly decreased rat myocardial cell viability in vitro.  
This was prevented by co-incubation with anti-oxidant enzymes, including SOD and 
catalase.  In this study the authors made the assumption that the DEP can definitely 
translocate to extra-pulmonary tissues.  However, experimental evidence supporting 
the translocation of PM is still lacking and urges the need for additional studies to 
evaluate the role of oxidative stress in mediating cell death induced by DEP.  Future 
studies will, therefore, determine whether anti-oxidants abrogate the apoptosis 
induced by DEP instillation.  Furthermore, it seems likely that these phenotypic 
changes increase the severity of injuries related to I/R.  The current study may also 
help to explain why PM increased the I/R-induced infarct size but did not alter redox 
status 24 hours after instillation (Cozzi et al., 2006).  Since earlier times were not 
examined by these investigators it remains possible that the oxidative stress had 
reversed by 24 hours.  However, it is unlikely that the process of apoptosis would be 




Although not assessed in this study it is possible that DEP is inducing apoptosis via 
elevated intracellular calcium (Ca
2+
).  Increased intracellular Ca
2+
 concentrations 
have been reported in myocardial cells cultured and treated with ambient particles 
(Bagate et al., 2006a).  In vitro experiments have also shown PM to induce apoptosis 
in human epithelial cells lining the airways through an increase in Ca
2+ 
intracellular 
levels (Agopyan et al., 2004).  In addition to cell death alterations in Ca
2+ 
homeostasis contribute to both arrythmogenesis (Kihara et al., 1991; Zaugg et al., 
1996) and contractile dysfunction (Liu et al., 2008).  Alterations in Ca
2+ 
homeostasis 
may also help to explain the increased arrhythmias observed during ischaemia 6 
hours after DEP instillation.  It can also not be ruled out that the elevated oxygen free 
radicals are increasing Ca
2+ 
by damaging the proteins involved in Ca
2+ 
handling.  
Future experiments will be needed to determine wither DEP instillation influences 
intracellular Ca
2+ 
in rat myocytes using fluorescence microscopy.  Finally, it is worth 
noting that in the current study the RPP was higher 6 hours after instillation with 
DEP.  It may be that the delivery of oxygen to the heart may be obstructed 
sufficiently by the pulmonary inflammation in these animals (please refer to Chapter 
4) to cause cell death. 
 
It is well established that there is a burst of oxygen free radical generation in the 
heart at the time of post-ischaemic reperfusion (Zweier et al., 2006). In the present 
study, all hearts showed a small burst of oxidant stress on reperfusion but this did not 
differ between treatment groups.  The oxygen radicals generated are reported to play 
a pathogenetic role in arrhythmias and cell death (Bolli, 1991).  The results of the 
present study clearly indicate free radical production from non-neutrophil sources but 
the exact ROS source is as yet unknown.  Notably, in the present study there was no 
significant difference in the percentage increase in free radicals upon re-introduction 
of oxygen between the groups.  It therefore seems unlikely that the increased 
susceptibility to reperfusion injury in the hearts from the DEP-instilled animals is 
associated with the free radicals generated during the ischaemia and reperfusion.  
This demonstration that free radical generation during I/R was not different between 
groups may also suggest that the increased susceptibility to reperfusion injury in 
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hearts from DEP-instilled animals was not due to compromised cellular anti-oxidant 
capacity.  
5.4.4 Direct effects of DEP on the heart 
A direct effect of translocated DEP (or their associated constituents) cannot be 
entirely ruled out.  While some studies have demonstrated the translocation of 
nanoparticles from the lung to the systemic circulation (Brown et al., 2002; Kreyling 
et al., 2002; Oberdorster et al., 2004) there remains considerable uncertainty over 
whether this mechanism underlies the health effects of combustion-derived 
nanoparticles (Brook et al., 2004; Mills et al., 2006).  Using ultrafine iridium 
particles, studies by Kreylling et al. (2002) reported minimal (<1%) translocation of 
particles deposited in the lung to secondary target organs one week after a 1 hour 
exposure (Kreyling et al., 2002).  Therefore, if DEP did translocate from the lung it 
seems unlikely that particles would account for the full biological effects of DEP 
entering the lung. 
5.4.5 Limitations 
Several limitations need to be considered.  As discussed above, an ex vivo I/R model 
was employed to evaluate neurohormonal influences on the increased myocardial 
injury.  In these experiments, hearts were perfused at constant flow opposed to 
constant pressure.  While this allows easy measurement, it does not automatically 
alter the amount of perfusate delivered to the whole heart in response to ischaemia 
(Skrzypiec-Spring et al., 2007). 
 
Amongst other factors, variations in temperature have been reported to influence 
myocardial contractile responsiveness (Skrzypiec-Spring et al., 2007).  In this study 
hearts were enclosed in a sealed, water-jacketed chamber to maintain temperature at 
37 +/- 0.5 °C.  Other problems known to affect cardiac performance come from 
contamination of the reagent solutions and glassware.  For this reason, fresh buffers 
were prepared and the perfusion apparatus thoroughly cleaned after use.  Precautions 
were also taken to preserve hearts from ischaemic injury prior to cannulation by 
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immediately placing the heart in ice cold perfusate following excision to temporally 
arrest its motion.   Care was also taken to ensure that no air bubbles were found in 
the circuit as these may lead to significant ischaemic damage.  Additionally, 
anticoagulation by heparin administration was performed to minimise risk of thrombi 
formation in the excised heart. 
 
Future studies should also include ECG diagnostic criteria and longer-term 
assessment in both in vivo and ex vivo I/R models.  Comparing arrhythmias during in 
vivo and ex vivo electrophysiological testing will better define the mechanism for the 
increased propensity to ischaemia-induced arrhythmias in the hearts of the DEP-
instilled animals. 
5.4.6 Conclusions 
The data presented here suggest a single exposure of the lung to DEP primes the 
heart making it more susceptible to subsequent myocardial injury within as little as 6 
hours following exposure.  This may help to explain recent clinical observations that 
have identified this as a key period for increased myocardial mortality after exposure 
to PM (Bhaskaran et al., 2011).  This increased reperfusion injury was characterised 
by increased propensity to arrhythmia development during ischaemia and also to 
increased infarct size.  In these studies, instillation of DEP by itself was shown to 
induce oxidative stress and cell loss, at least in part due to increased apoptosis.  
These phenotypic changes may explain the effects of exposure to DEP on I/R-
induced injury.  Studies in Chapter 6 of this thesis will begin to examine how DEP 
initially deposited in the lung might influence injury in the myocardium, with 
particular emphasis on the ANS.  As discussed above, disturbances in ANS function 
may be related to arrhythmia, increased oxidative stress and cell death. 
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Chapter 6  
Potential role of transient receptor potential vanilloid 
1 (TRPV1) receptor and (beta 1) β1 adrenoceptor 
activation on the transmission of the influence of 





The data in Chapter 5 of this thesis clearly demonstrated that a single exposure of the 
lung to DEP leads to priming of the myocardium for ischaemia-reperfusion (I/R) 
injury.  Candidates for transmission of the effects of DEP in the lung to the periphery 
include systemic inflammation (Seaton et al., 1995) and alteration of autonomic 
outflow (Pope et al., 2004; Pope et al., 1999).  Earlier studies described in this thesis 
detected no systemic inflammation 6 hours after intra-tracheal instillation of DEP.  It 
thus seems unlikely that the damaging effects to the myocardium caused by DEP 
instillation are driven by systemic inflammation.  Interestingly, studies in Chapter 5 
did produce findings that would be consistent with sympathetic activation 6 hours 
after DEP instillation;-the most notable being increased blood pressure and increased 
incidence of ischaemia-induced arrhythmias.  Increased sympathetic activity is also 
consistent with previous human and animal studies reporting associations between 
air pollutants and decreased heart rate variability (HRV) (Brook et al., 2009a; Gold 
et al., 1999; Pope et al., 1999; Rivero et al., 2005; Schulz et al., 2005).  Likewise, 
heightened arrhythmia sensitivity and cardiac oxidative stress and injury have been 
reported to be mediated by autonomic stimulation following exposure to residual oil 
fly ash (ROFA) or concentrated ambient particles (CAPs) (Rhoden et al., 2005; 
Wellenius et al., 2002). 
 
The sympathetic adrenergic control of the heart originates from neurons found within 
the medulla.  The central nervous system (CNS) receives sensory (afferent) input 
from peripheral sensors and sensors within the brain.  The majority of afferent fibres 
innervating the lung are non-myelinated C-fibres (Coleridge et al., 1984).  These 
fibres innervate sensory receptors and transmit information from the airways to the 
nucleus tractus solitarius (NTS) through the vagus nerve.  Irritant air pollutants such 
as ozone (Lee et al., 2001), sulphur dioxide (SO2) (Wang et al., 1996), wood smoke 
(Lai et al., 1998) and diesel exhaust (DE) (Wong et al., 2003) have all been shown to 
stimulate pulmonary C-fibre afferents.  TRVP1, a non-selective cation channel, is 
widely expressed in these sensory nerve fibres (Watanabe et al., 2005).  Activation 
of TRPV1 expressed in pulmonary nerve terminals by both physical and chemical 
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stimuli leads to the release of substance P (SP) and calcitonin gene-related peptide 
(CGRP) (Bevan et al., 1994).  Moreover, it has been hypothesised that TRPV1 
activation on non-myelinated C-fibres mediates powerful autonomic reflexes which 
produce changes in the cardiovascular function (Widdicombe et al., 2001).  Whether 
stimulation of TRPV1 receptors provides a plausible link between pulmonary DEP 
and injury in distal tissues constitutes the focus of the present study.  To date, only 
one previous study has explored the association between pollution-related cardiac 
toxicities and TRPV1 stimulation (Ghelfi et al., 2008). 
6.1.1 Hypothesis 
Pulmonary instillation of DEP leads to priming of the myocardium for I/R injury via 
activation of pulmonary TRPV1 receptors and systemic 1 adrenoceptors. 
6.1.2 Aims 
The aims of the work described in this chapter were to determine whether: 
i. β1 adrenoceptor and TRPV1 receptor blockade prevents priming of the 
myocardium for I/R injury following instillation of DEP 
ii. β1 adrenoceptor and TRPV1 receptor blockade reduces the susceptibility 
to ex vivo I/R injury of hearts from DEP-instilled animals 





6.2.1 Pulmonary instillation of DEP 
Adult male Wistar rats (250-350 g; Charles River Laboratories) were used for all 
experiments.  Rats were instilled intra-tracheally with either DEP (0.5 mg in 0.5 ml 
saline) or vehicle (saline 0.5 ml).  For details of the preparation and instillation 
process please refer to Chapters 2.2 and 2.3.  Animals were sacrificed 6 hours after 
instillation by exsanguination.  This time point was chosen based on results described 
in Chapter 4. 
6.2.2 Coronary artery ligation 
Ischaemia and reperfusion were performed on rat hearts ex vivo.  For details of the 
animal model of myocardial I/R injury please refer to Chapter 2.3.2. 
6.2.3 Drug treatment studies 
For interventional studies with a β1 adrenoceptor antagonist rats were randomly 
assigned to receive either metoprolol (Metoprolol tartate salt, Sigma-Aldrich, UK; 10 
mg/kg intraperitoneal (i.p.).; Beique et al., 2000; Beril Gok et al., 2007) or vehicle 
(saline) immediately before instillation of DEP or saline.  6 hours later hearts were 
isolated for ischaemia and reperfusion as described in Chapter 2.3.2.  In an additional 
group, hearts from DEP-instilled animals underwent ex vivo I/R while being perfused 
with Tyrode’s buffer containing metoprolol (10 µM; Kovacs et al., 2009), to control 
for any direct ex vivo influence of the drug on injury.  For interventional studies with 
a TRPV1 antagonist rats were randomly assigned to receive AMG 9810 ((2E)-N-(2, 
3- Dihydro-1, 4-benzodioxin-6-yl)-3-[4-(1, 1- dimethyl)phenyl]-2-propenamide, 
Tocris, Bioscience, UK; 30 mg/kg intra-tracheal; Gavva et al., 2005) dispersed in 
DEP or saline.  6 hours later hearts were isolated for ischaemia and reperfusion as 
described in Chapter 2.3.2.  In an additional group, hearts from DEP- or saline-
instilled animals underwent ex vivo I/R while being perfused with Tyrode’s 
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containing AMG 9810 (1 µM), to control for any direct ex vivo influence of the drug 
on injury. 
6.2.4 Detection of reactive oxygen species (ROS by electron 
paramagnetic resonance (EPR) spectroscopy 
In some ex vivo perfused hearts oxygen free radical generation from the myocardium 
was assessed in perfusion fluid using spin label EPR.  Measurements were taken at 
baseline, after 0 and 30 minutes of ischaemia and after 0, 1 and 2 hours of 
reperfusion.  Please refer to Chapter 2.11 for more details. 
6.2.5 Tissue collection 
For infarct size assessment the whole heart was excised and washed in saline to 
remove excess Evans Blue prior to storage at -20°C.  Wet weight was recorded in 
some ex vivo perfused hearts following reperfusion. 
6.2.6 Assessment of pulmonary inflammation  
In a separate group of animals, a bronchoalveolar lavage (BAL) was performed (as 
described in Chapter 2.8) 6 hours after 0.5 ml saline or 0.5 mg DEP instillation alone 
and after 30 mg/kg AMG 9810 or 10 mg/kg metoprolol.  Total and differential cell 
counts were performed on the BAL fluid.  Total protein was detected using a bovine 
serum albumin (BCA) kit (Thermo Scientific Pierce).  For details of all the 
procedures please refer to Chapter 2.8. 
6.2.7 2, 3, 5-triphenyltetrazolium chloride (TTC) staining 
TTC staining was used to assess myocardial viability as described in Chapter 2.6.1.  
Infarct size was expressed as percentage of the area at risk (AAR). 
6.2.8 Statistics 
All values are expressed as mean ± SEM.  Relative radical concentrations (in 
arbitrary units, AU) were recorded as the signal intensity obtained from the peak-to-
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peak height of the first derivative EPR spectrum.  In drug intervention studies with 
AMG 9810, differences in pulmonary inflammatory markers and cardiac viability 
(before I/R) between the groups were compared by one-way ANOVA.  Myocardial 
AAR, infarct size, oxygen free radical generation and heart weight were analysed by 
two-way ANOVA.  In drug intervention studies with metoprolol, myocardial AAR, 
infarct size, oxygen free radical generation and heart weight were compared by one-
way ANOVA.  Pulmonary inflammatory markers and cardiac viability (before I/R) 
was assessed between groups by a two-way ANOVA.  The Bonferroni test was used 




6.3.1 Effect of the β1 adrenoceptor antagonist, metoprolol, on 
cardiac oxidative stress, wet weight and viability prior to I/R 
6.3.1.1 Effect of the β1 adrenoceptor antagonist, metoprolol, on the DEP-
induced cardiac oxidative stress 
Baseline oxidant stress, determined by EPR in the perfusate of hearts isolated 6 hours 
after instillation of saline was 2140.0 ± 224.0 AU (Figure 6.1).  Free radical intensity 
was significantly higher in hearts from DEP-instilled rats (P<0.01 compared to 
saline; Figure 6.1).  Administration of metoprolol (10 mg/kg i.p.) at the time of 
instillation in vivo significantly reduced the magnitude of the EPR signal of hearts 
from DEP-instilled rats (P<0.01 compared to DEP; Figure 6.1). 
6.3.1.2 Effect of the β1 adrenoceptor antagonist, metoprolol, on heart wet weight  
The wet weight of hearts did not differ between groups (Figure 6.2). 
6.3.1.3 Effect of the β1 adrenoceptor antagonist, metoprolol, on cardiac myocyte 
viability 
98.4 ± 0.8% of the left ventricle remained viable, as determined by TTC staining, 
after saline instillation.  In agreement with earlier results (see Chapter 5), cell 
viability was significantly reduced in hearts from DEP-instilled compared to saline-
instilled rats (P<0.001; Figure 6.3).  In vivo metoprolol delivery had no effect on 
cardiac myocyte viability in hearts from saline-instilled rats (Figure 6.3).  However, 
hearts from DEP-instilled rats that received metoprolol (10 mg/kg i.p.) at the time of 

































Figure 6.1 β1 adrenoceptor blockade in vivo prevented the diesel exhaust 
particulate (DEP)-induced increase in cardiac oxidative stress. 
Electron paramagnetic resonance (EPR) signal of the 1-hydroxy-3-carboxy-
pyrolidine (CP-H) spin adduct at baseline in hearts isolated 6 hours after instillation 
with 0.5 ml saline or 0.5 mg DEP alone (open columns) or in hearts from DEP-
instilled rats that received metoprolol at the time of instillation in vivo (10 mg/kg, 
intraperitoneal, hatched columns).  Columns represent mean ± SEM.  Numbers in 
brackets represent n for each group.  **P<0.01 versus saline; ##P<0.01 versus DEP; 

























Figure 6.2 β1 adrenoceptor blockade had no effect on wet heart weight. 
Wet weight of hearts isolated 6 hours after instillation with 0.5 ml saline or 0.5 mg 
DEP alone (open columns) or in hearts from rats that received metoprolol at the time 
of instillation in vivo (10 mg/kg, intraperitoneal, hatched columns).  Columns 






































Figure 6.3 β1 adrenoceptor blockade in vivo prevented the diesel exhaust 
particulate (DEP)-induced decrease in cardiac cell viability. 
The percentage of viable myocardium in the left ventricle in hearts isolated 6 hours 
after instillation with 0.5 ml saline or 0.5 mg DEP alone (open columns) or in hearts 
from rats that received metoprolol at the time of instillation in vivo (10 mg/kg, 
intraperitoneal, hatched columns) was calculated by deducting the percentage of 
tissue stained positive with 2, 3, 5-tetrazolium chloride (TTC).  Columns represent 
mean ± SEM.  Numbers in brackets represent n for each group.  *** P<0.001 versus 




6.3.2 I/R ex vivo 
6.3.2.1 Effect of the β1 adrenoceptor antagonist, metoprolol, on the increased 
susceptibility to ex vivo I/R injury of hearts from DEP-instilled animals  
There were no significant differences between the groups in baseline coronary 
perfusion pressure (CPP) (Table 6.1) 
 
The AAR was not different between groups (Figure 6.4a).  Infarct size in saline-
instilled rats averaged 14.7 ± 2.6 % of AAR (Figure 6.4b).  In agreement with earlier 
results (see Chapter 5), infarct size was larger in hearts from DEP-instilled compared 
to saline-instilled rats (P<0.001; Figure 6.4b).  Administration of metoprolol (10 
mg/kg i.p.) at the time of instillation in vivo had no effect on infarct size in hearts 
from saline-instilled rats (Figure 6.4b).  However, hearts from DEP-instilled rats that 
received metoprolol in vivo did not exhibit increased sensitivity to I/R injury 
(P<0.001; Figure 6.4b).  Metoprolol had no effect on injury in hearts from DEP-
instilled rats when applied only ex vivo in the organ bath (Figure 6.4b). 
6.3.2.2 Effect of the β1 adrenoceptor antagonist, metoprolol, on oxygen free 
radical production during ischaemia and reperfusion in the isolated perfused 
rat heart 
In all groups the free radical intensities as measured by EPR did not change 
significantly during any period of ischaemia or reperfusion (Table 6.2). 
6.3.2.3 Effect of the β1 adrenoceptor antagonist, metoprolol, on heart wet weight 
after ex vivo I/R 
The wet weight of hearts from rats receiving saline was 1.1 ± 0.1 g (Figure 6.5) and 
this was significantly increased in hearts from DEP-instilled rats (P<0.01; Figure 6.5).  
In vivo metoprolol delivery had no effect on the wet weight of hearts from saline-
instilled rats (Figure 6.5).  The increased wet weight of hearts from DEP-instilled rats 
was reversed when metoprolol was administered at the time of DEP instillation in 





Coronary perfusion pressure (CPP) values (mmHg) 
Baseline Onset Isc 30 min Isc 1 h Rep 2 h Rep 
Saline   
Control (n=4) 52.7 ± 5.4 58.4 ± 4.9 63.1 ± 15.3 60.0 ± 14.4 62.7 ± 14.8 
10 mg/kg metoprolol 
(intraperitoneal) (n=5) 51.8 ± 6.5 53.1 ± 5.4 54.2 ± 5.0 49.0 ± 4.1 52.0 ± 4.0 
DEP           
Control (n=6) 52.5 ± 3.0 56.6 ± 6.8 63.7 ± 9.7 58.1 ± 9.6 51.8 ± 3.0 
10 mg/kg metoprolol 
(intraperitoneal) (n=5) 59.8 ± 2.6 63.0 ± 3.9 55.5 ± 5.7 58.7 ± 4.1 56.9 ± 4.0 
10 µM metoprolol 
(ex vivo) (n=4) 60.5 ± 3.4 65.5 ± 8.9 64.3 ± 9.8 53.3 ± 5.7 57.5 ± 6.7 
Table 6.1 Coronary perfusion pressures (CPP) sampled at various time intervals during ischaemia and reperfusion from hearts 
isolated 6 hours after instillation with saline or DEP alone and after 10 mg/kg (intraperitoneal) or 10 µM metoprolol (in vitro). 
Abbreviations: DEP = diesel exhaust particulate, Isc = ischaemia, Rep = reperfusion. 

























































































Figure 6.4 β1 adrenoceptor blockade in vivo, but not in vitro, prevented the 
diesel exhaust particulate (DEP)-induced increase in infarct size. 
 (a) Myocardial area at risk (AAR; expressed as a percentage of total left ventricular 
(LV) mass) and (b) infarct size (expressed as a percentage of AAR) in hearts isolated 
6 hours after instillation with 0.5 ml saline or 0.5 mg DEP alone (open columns); in 
hearts from rats that received metoprolol at the time of instillation in vivo (10 mg/kg, 
intraperitoneal, hatched columns); or in hearts from DEP-instilled rats perfused ex 
vivo with Tyrode’s solution containing metoprolol (10 µM, vertical columns).  
Columns represent mean ± SEM.  Numbers in brackets represent n for each group.  
***P<0.001 versus saline; ###P<0.001 versus DEP; one-way ANOVA followed by 





























Figure 6.5 β1 adrenoceptor blockade in vivo prevented the diesel exhaust 
particulate (DEP)-induced increase in wet heart weight. 
Wet weight of hearts isolated 6 hours after instillation with 0.5 ml saline or 0.5 mg 
DEP alone (open columns); in hearts from rats that received metoprolol at the time of 
instillation in vivo (10 mg/kg, intraperitoneal, hatched columns); or in hearts from 
DEP-instilled rats perfused ex vivo with Tyrode’s solution containing metoprolol (10 
µM, vertical columns).  Numbers in brackets represent n for each group.  **P<0.01 




Electron paramagnetic resonance (EPR) signal (arbitrary units) 
Baseline Onset Isc 30 min Isc Onset Rep 1 h Rep 2 h Rep 
Saline   
Control (n=4) 2140.0 ± 224.7 2322.3 ± 812.8 5342.0 ± 1712.9 7714.0 ± 2048.0 4366.0 ± 1420.3 4279.0 ± 1996.8 
DEP             
Control (n=5) 6393.6 ± 755.2 6196.8 ± 499.4 7857.6 ± 1564.5 9264.0 ± 1123.7 6811.2 ± 2059.0 4944.0 ± 1062.8 
10 mg/kg metoprolol 
(intraperitoneal) (n=4) 2690.7 ± 43.9 2621.3 ± 23.2 4392.0 ± 120.0 5701.3 ± 1820.2 4728.0 ± 432.0 4744.0 ± 1168.0 
Table 6.2 Electron paramagnetic resonance (EPR) intensity in samples taken at different time points during ischaemia and 
reperfusion from hearts isolated 6 hours after instillation with saline or DEP alone and after 10 mg/kg (intraperitoneal) or 10 µM 
metoprolol  (ex vivo). 
Abbreviations: DEP = diesel exhaust particulate, Isc = ischaemia, Rep = reperfusion. 




6.3.3 Effect of the β1 adrenoceptor antagonist, metoprolol, on the 
DEP-induced pulmonary inflammation 
The values for total and differential cell counts in BAL are shown in Figure 6.6.  The 
total number of cells recovered in BAL fluid from saline-instilled rats was 11.0 ± 1.5 
x 10
5 
cells/ml (Figure 6.6a).  The total number of cells was increased markedly to 
77.7 ± 9.5 x 10
5 
cells/ml 6 hours after instillation of DEP (P<0.001 compared to 
saline; Figure 6.6a).  Administration of metoprolol (10 mg/kg i.p.) at the time of 
instillation had no effect on the BAL total cell count of saline-instilled rats (Figure 
6.6a), but reduced the total number of cells recovered in BAL fluid from DEP-
instilled rats (P<0.01 compared to DEP; Figure 6.6a).   Differential analysis of BAL 
cells showed that the BAL from saline-instilled animals was comprised 
predominately of macrophages (Figure 6.6b).  In vivo metoprolol delivery had no 
effect on the macrophage number in the BAL fluid recovered from saline-instilled 
rats (Figure 6.6b), but significantly increased the number of macrophages recovered 
in BAL fluid from DEP-instilled rats (P<0.001; Figure 6.6b).  The increase in BAL 
total cell count 6 hours after instillation of DEP appeared to be attributed to increases 
in neutrophil numbers (P<0.001 compared to saline; Figure 6.6c).  In vivo metoprolol 
delivery had no effect on the neutrophil number in the BAL fluid recovered from 
saline-instilled rats (Figure 6.6c), but significantly reduced the number of neutrophils 
recovered in BAL fluid from DEP-instilled rats (P<0.001; Figure 6.6c). 
 
Total protein in BAL fluid 6 hours after instillation of DEP was significantly higher 
than saline-instilled controls (P<0.01. Figure 6.6d).  In vivo metoprolol delivery had 
no effect on the protein levels in BAL fluid recovered from saline- or DEP-instilled 










































































































































































Figure 6.6 β1 adrenoceptor blockade altered the inflammatory cell profile of 
lungs from rats 6 hours after instillation of diesel exhaust particulate (DEP). 
Bronchoalveolar lavage (BAL) fluid was analysed for (a) total cell count, (b) 
macrophages, (c) neutrophils and (d) total protein in hearts isolated 6 hours after 
instillation with 0.5 ml saline or 0.5 mg DEP alone (open columns) or in hearts from 
rats that received metoprolol at the time of instillation in vivo (10 mg/kg, 
intraperitoneal, hatched columns).  Columns represent mean ± SEM (n = 4) 
**P<0.01, ***P<0.001 versus saline; ##P<0.01, ###P<0.001 versus DEP; two-way 
ANOVA followed by Bonferroni post-hoc test. 
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6.3.4 Effect of the TRPV1 antagonist AMG 9810 on cardiac 
oxidative stress, wet weight and viability prior to I/R  
6.3.4.1 Effect of the TRPV1 antagonist AMG 9810 on the DEP-induced cardiac 
oxidative stress  
Baseline oxidant stress, determined by EPR in the perfusate of hearts isolated 6 hours 
after instillation of saline was 2140.0 ± 224.0 AU (Figure 6.7).  Free radical intensity 
was approximately 3-fold higher in hearts from DEP-instilled rats (Figure 6.7).  
However, the difference did not reach statistical significance possibly due to a lack 
of power.  Values reported here agree with those previously reported in Chapter 
5.3.10.  In vivo AMG 9810 delivery did not affect the magnitude of the EPR signal of 
hearts from saline-instilled rats (Figure 6.7).  Free radical generation from DEP-
instilled hearts appeared to be increased further when AMG 9810 was co-
administered with DEP in vivo, but this failed to reach statistical significance (Figure 
6.7).  AMG 9810 had no effect on the generation of free radicals measured in hearts 
from saline-instilled rats when applied only ex vivo in the organ bath (Figure 6.7).  
However, hearts from DEP-instilled rats exhibited significantly higher levels of free 
radical production when AMG 9810 was applied only ex vivo in the organ bath 
(P<0.05; Figure 6.7). 
6.3.4.2 Effect of the TRPV1 antagonist AMG 9810 on heart wet weight  
The wet weight of hearts did not differ between groups (1.0 ± 0.1 g for 6 hour saline, 
1.1 ± 0.0 g for 6 hour DEP and 1.1 ± 0.0 g for 6 hour DEP with 30 mg/kg AMG 
9810). 
6.3.4.3 Effect of the TRPV1 antagonist AMG 9810 on cardiac myocyte viability 
As noted in Chapter 5.3.12, instillation of DEP reduced cardiac myocyte viability as 
assessed by TTC staining.  85.0 ± 2.1 % of the left ventricle was considered viable in 
hearts from DEP-instilled rats (Figure 6.8).  Co-administration of the TRPV1 
antagonist AMG 9810 in vivo with DEP into the lung was found to prevent the loss 


































Figure 6.7 Oxidative stress was increased in hearts from diesel exhaust 
particulate (DEP)-instilled rats when AMG 9810 was applied only ex vivo in the 
organ bath. 
Electron paramagnetic resonance (EPR) signal of the CPH spin adduct at baseline in 
hearts isolated 6 hours after instillation with 0.5 ml saline or 0.5 mg DEP alone (open 
columns); in hearts from rats that received AMG 9810 at the time of instillation in 
vivo (30 mg/kg, intra-tracheal, hatched columns); or in hearts from instilled rats 
perfused in vitro with Tyrode’s solution containing AMG 9810 (1 µM, vertical 
columns).  Columns represent mean ± SEM.  Numbers in brackets represent n for 
each group.  *P<0.05 versus saline; #P<0.05 versus DEP; two-way ANOVA 




































Figure 6.8 Instillation of a transient receptor potential vanilloid 1 (TRPV1) 
antagonist with diesel exhaust particulate (DEP) prevented DEP-induced 
decrease in cardiac cell viability. 
The percentage of viable myocardium in the left ventricle (LV) 6 hours after 
instillation with 0.5 ml saline (purple columns) or 0.5 mg DEP alone (pink columns) 
or in hearts from rats that received AMG 9810 at the time of DEP instillation in vivo 
(30 mg/kg, intra-tracheal, pink hatched columns) was calculated by deducting the 
percentage of tissue stained brick red with 2, 3, 5-tetrazolium chloride (TTC).  
Columns represent mean ± SEM.  Numbers in brackets represent n for each group.  




6.3.5 I/R ex vivo 
6.3.5.1 Effect of the TRPV1 antagonist AMG 9810 on the increased 
susceptibility to ex vivo I/R injury of hearts from DEP-instilled animals 
There were no significant differences between the groups in baseline CPP (Table 6.3).  
There was a tendency towards increased perfusion pressure during the ischaemia and 
reperfusion, but the increase was not significant (Table 6.3). 
 
The AAR was not different between groups (Figure 6.9a).  Infarct size in saline-
instilled rats averaged 14.6 ± 2.8 % of AAR (Figure 6.9b).  In agreement with earlier 
results (see Chapter 5), infarct size was larger in hearts from DEP-instilled compared 
to saline-instilled rats (P<0.001; Figure 6.9b).  In vivo AMG 9810 delivery had no 
effect on infarct size in hearts from saline-instilled rats (Figure 6.9b).  However, 
hearts from DEP-instilled rats that received AMG 9810 in vivo did not exhibit 
increased sensitivity to I/R injury (P<0.001; Figure 6.9b).  AMG 9810 had no effect 
on injury in hearts from saline- or DEP-instilled rats when applied only ex vivo in the 
organ bath (Figure 6.9b). 
6.3.5.2 Effect of the TRPV1 antagonist AMG 9810 on oxygen free radical 
production during ischaemia and reperfusion in the isolated perfused rat heart 
In all groups the free radical intensities measured by EPR did not change 
significantly during any period of ischaemia or reperfusion (Table 6.4).  
Nevertheless, the observed EPR data did show relatively large variation between- 
and within-groups.  This may have been due to the EPR not being sensitive enough 
to detect differences.  Alternatively, the current study may have been underpowered 
to identify a significant difference. 
6.3.5.3 Effect of the TRPV1 antagonist AMG 9810 on wet weight after ex vivo 
I/R 
The wet weight of hearts from rats receiving saline was 1.1 ± 0.1 g (Figure 6.10) and 
this was significantly increased in hearts from DEP-instilled rats (P<0.01; Figure 
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6.10).  In vivo AMG 9810 delivery increased the wet weight of hearts from saline-
instilled rats but the increase did not reach statistical significance, perhaps due to the 
small numbers (Figure 6.10).  AMG 9810 had no effect on the wet weight of hearts 
from saline-instilled rats when applied only ex vivo in the organ bath (Figure 6.10).  
The increased wet weight of hearts from DEP-instilled rats was reversed when AMG 
9810 was co-administered with DEP in vivo and when applied only ex vivo in the 





Coronary perfusion pressure (CPP) values (mmHg) 
Baseline Onset Isc 30 min Isc 1 h Rep 2 h Rep 
Saline           
Control (n=4) 49.1 ± 9.3 62.8 ± 9.2 55.9 ± 5.1 50.8 ± 14.9 48.2 ± 11.0 
30 mg/kg AMG 9810 (intratracheal) (n=3) 39.7 ± 3.9 47.5 ± 1.3 35.3 ± 3.5 39.7 ± 4.7 45.3 ± 6.4 
1 µM AMG 9810 (ex vivo) (n=3) 45.4 ± 9.0 52.8 ± 8.1 36.3 ± 7.7 41.5 ± 3.8 37.6 ± 3.1 
DEP           
Control (n=5) 41.6 ± 5.7 49.2 ± 5.4 40.8 ± 7.2 41.1 ± 4.0 40.2 ± 6.6 
30 mg/kg AMG 9810 (intratracheal) (n=5) 55.4 ± 2.2 64.1 ± 0.1 55.6 ± 2.4 54.9 ± 5.8 50.8 ± 7.5 
1 µM AMG 9810 (ex vivo) (n=3) 45.2 ± 8.2 60.0 ± 9.8 59.2 ± 9.8 46.8 ± 12.5 57.0 ± 3.8 
Table 6.3 Coronary perfusion pressures sampled at various time intervals during ischaemia and reperfusion from hearts isolated 6 
hours after instillation with saline or DEP alone and after 30 mg/kg (intra-tracheal) or 1 µM AMG 9810 (in vitro). 
Abbreviations: DEP = diesel exhaust particulate, Isc = ischaemia, Rep = reperfusion. 























































































Figure 6.9 Instillation of a transient receptor potential vanilloid 1 (TRPV1) antagonist 
with diesel exhaust particulate (DEP) in vivo, but not incubation in vitro, prevented the 
DEP-induced increase in infarct size. 
(a) Myocardial area at risk (AAR; expressed as a percentage of total left ventricular (LV) 
mass) and (b) infarct size (expressed as a percentage of AAR) in hearts isolated 6 hours after 
instillation with 0.5 ml saline or 0.5 mg DEP alone (open columns); in hearts from rats that 
received AMG 9810 at the time of instillation in vivo (30 mg/kg, intra-tracheal, hatched 
columns); or in hearts from instilled rats perfused in vitro with Tyrode’s solution containing 
AMG 9810 (1 µM, vertical columns).  Columns represent mean ± SEM.  Numbers in 
brackets represent n for each group.  *P<0.05, ***P<0.001 versus saline; ###P<0.001 versus 




























Figure 6.10 Instillation of a transient receptor potential vanilloid 1 (TRPV1) antagonist 
with diesel exhaust particulate (DEP) in vivo prevented the DEP-induced increase in wet 
heart weight. 
Wet weight in hearts isolated 6 hours after instillation with 0.5 ml saline or 0.5 mg DEP alone 
(open columns); in hearts from rats that received AMG 9810 at the time of instillation in vivo 
(30 mg/kg, intra-tracheal, hatched columns); or in hearts from instilled rats perfused in vitro 
with Tyrode’s solution containing AMG 9810 (1 µM, vertical columns). Columns represent 
mean ± SEM.  Numbers in brackets represent n for each group.  **P<0.01 versus saline; two-




Electron paramagnetic resonance (EPR) signal (arbitrary units) 
Baseline Onset Isc 30 min Isc Onset Rep 1 h Rep 2 h Rep 
Saline   
Control (n=4) 2140.0 ± 224.7 2322.3 ± 812.8 5342.0 ± 1712.9 7714.0 ± 2048.0 4366.0 ± 1420.3 4279.0 ± 1996.8 
30 mg/kg AMG 9810 
(intra-tracheal) (n=3) 1280.0 ± 341.8 1656.0 ± 360.0 3528.0 ± 312.0 3952.0 ± 395.9 8016.0 ± 840.0 3032.0 ± 529.5 
1 µM AMG 9810 (ex 
vivo) (n=3) 3088.0 ± 604.4 4902.0 ± 476.2 11304.0 ± 5604.3 13764.0 ± 6619.3 13782.0 ± 7346.0 7116.0 ± 5509.4 
DEP   
Control (n=5) 6393.6 ± 755.2 6196.8 ± 499.4 7857.6 ± 1564.5 9264.0 ± 1123.7 6811.2 ± 2059.0 4944.0 ± 1062.8 
30 mg/kg AMG 9810 
(intratracheal) (n=4) 9144.0 ± 2589.6 13881.0 ± 3325.0 10545.0 ± 3417.1 20169.0 ± 6681.0 16011.0 ± 6270.3 7516.0 ± 3627.4 
1 µM AMG 9810 (ex 
vivo) (n=3) 16208.0 ± 7928.1 15432.0 ± 7363.2 14824.0 ± 7412.5 18640.0 ± 7872.9 7544.0 ± 3457.1 3520.0 ± 2277.5 
Table 6.4 Electron paramagnetic resonance (EPR) intensity in samples taken at different time points during ischaemia and 
reperfusion from hearts isolated 6 hours after instillation with saline or DEP alone and after 30 mg/kg (intra-tracheal) or 1 µM 
AMG 9810 (in vitro). 
Abbreviations: DEP = diesel exhaust particulate, Isc = ischaemia, Rep = reperfusion. 
Data are expressed as mean ± SEM.  Numbers in brackets represent n for each group
6.3.6 Effect of the TRPV1 antagonist AMG 9810 on DEP-induced 
pulmonary inflammation 
The values for total and differential cell counts in BAL are shown in Figure 6.11.  
The total number of cells recovered in BAL fluid from saline-instilled rats was 11.0 
± 1.5 x 10
5 
cells/ml (Figure 6.11a).  The total number of cells was increased 
markedly to 77.7 ± 9.5 x 10
5 
cells/ml 6 hours after instillation of DEP (P<0.05 
compared to saline; Figure 6.11a).  In vivo AMG 9810 delivery caused a small, non-
significant decrease in the total number of cells in BAL from DEP-instilled rats 
(Figure 6.11a).   Differential analysis of BAL cells showed that the BAL fluid 
recovered from saline-instilled rats was comprised predominately of macrophages 
(Figure 6.11b).  The increase in BAL total cell count 6 hours after instillation of DEP 
appeared to be attributed to increases in neutrophil numbers; rising from 3.1 ± 1.9 x 
10
5 
cells/ml in the saline-instilled rats to 62.3 ± 7.5 x 10
5 
cells/ml in DEP-instilled 
rats (P<0.05; Figure 6.11c).  In vivo AMG 9810 delivery had no effect on the 
neutrophil number in BAL fluid recovered from DEP-instilled rats (Figure 6.11c). 
 
Total protein in BAL fluid 6 hours after instillation of DEP was significantly higher 
than saline-instilled controls (P<0.01. Figure 6.11d).  In vivo AMG 9810 delivery 
caused a small, non-significant decrease on the protein levels in BAL fluid recovered 














































































































































































Figure 6.11 Instillation of a transient receptor potential vanilloid 1 (TRPV1) 
antagonist with diesel exhaust particulate (DEP) had no effect on DEP-induced 
pulmonary inflammation. 
Bronchoalveolar lavage (BAL) fluid was analysed for (a) total cell count, (b) 
macrophages, (c) neutrophils and (d) total protein 6 hours after instillation with 0.5 
ml saline or 0.5 mg DEP alone (open columns) or when AMG 9810 was co-
administered with DEP in vivo (30 mg/kg, intra-tracheal, hatched columns).  
Columns represent mean ± SEM (n = 4) *P<0.05, compared to saline; one-way 




In Chapter 5 it was demonstrated that a single exposure of the lung to DEP leads to 
priming of the myocardium for increased I/R injury.  In the current study, this 
heightened sensitivity to reperfusion injury was shown to be abrogated both when the 
β1 adrenoceptor antagonist, metoprolol, and when the TRPV1 antagonist, AMG 9810 
were administered in vivo at the time of instillation.  Together, these results suggest 
the possibility that a TRPV1-dependent neuronal reflex response triggered by DEP 
deposition in the lung contributes to the increased sensitivity to I/R injury by causing 
secondary activation of systemic 1 adrenoceptors. 
6.4.1 Role of 1 adrenoceptors in DEP-induced increased sensitivity 
to I/R injury  
The research described in Chapter 5 demonstrated that the ability of the myocardium 
to withstand ischaemic conditions was additionally compromised when normal 
healthy rats were exposed, by intra-tracheal instillation, to DEP.  Sensitisation of the 
rat myocardium occurred within 6 hours of exposure, which correlates well with a 
recent clinical study identifying this as the period of greatest risk for myocardial 
infarction (MI) associated hospitalisation after exposure to atmospheric pollution 
(Bhaskaran et al., 2011).  Deaths during this period were due to ischaemia-evoked 
arrhythmia, while ischaemia-induced injury was also increased.  Furthermore, 
experiments performed in isolated perfused rat hearts 6 hours after DEP exposure 
demonstrated that exposure primed the hearts for subsequent injury and that 
enhancement of inflammatory cell recruitment was not required.  Priming was 
associated with increased myocardial oxidative stress, accompanied by a loss in 
cardiomyocyte viability. 
 
Sympathetic drive is a key regulator of cardiac rhythm and decreases in HRV, 
indicative of increased sympathetic tone, have been reported both in humans and in 
animals after exposure to various components of air pollution (Brook et al., 2009a; 
Gold et al., 1999; Pope et al., 1999; Rivero et al., 2005; Schulz et al., 2005).  
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Catecholamines also have been reported to exert toxic effects on the heart, including 
oxidative stress and apoptosis (Communal et al., 1998; Izem-Meziane et al., 2012; 
Romeo et al., 2000), both features of hearts collected after DEP exposure (see 
Chapter 5).  As β1 adrenoceptor signalling pathways have been implicated in 
mediating these effects (Communal et al., 1998; Park et al., 1999; Romeo et al., 
2000), the ability of β1 adrenoceptor blockade to modify DEP induced injury and 
sensitisation to reperfusion injury was investigated.  In the current study, 
administration of metoprolol (10 mg/kg i.p.), which targets β1 adrenoceptors, at the 
time of instillation in vivo was found to prevent enhancement of ex vivo reperfusion 
injury associated with DEP instillation.  This result suggests an autonomic shift 
towards increased sympathetic drive after exposure to DEP making the heart more 
susceptible to subsequent myocardial injury.  Of note, the raised blood pressure and 
increased sensitivity to arrhythmias during ischaemia observed in the DEP-instilled 
animals are supportive of the hypothesised increase in sympathetic activity (see 
Chapter 5). 
 
The present study, supporting an autonomic component in particle mediated cardiac 
toxicity is consistent with other experimental studies (Ghelfi et al., 2008; Hazari et 
al., 2011; Rhoden et al., 2005; Wellenius et al., 2002).  Ghelfi et al. (2008) reported 
particulate matter (PM)-induced changes in ventricular depolarisation and 
repolarisation to be mediated by sympathetic activation.   These conduction 
abnormalities have been implicated in predisposing the heart to drug-induced 
arrhythmia (Hazari et al., 2009; Hazari et al., 2011).  Importantly, exposure to PM 
alters not only sympathetic but also parasympathetic control of the heart (Ghelfi et 
al., 2008; Rhoden et al., 2005).  For example, Rhoden and colleagues observed co-
activation of both autonomic branches following exposure to CAP (Rhoden et al., 
2005).  More recently, a single inhalation exposure to transition metal-rich PM in rats 
resulted in a reduced ratio of low-frequency to high-frequency power (measure of 
HRV), suggesting parasympathetic dominance (Farraj et al., 2011).  Future studies 
should be extended to evaluate whether parasympathetic antagonists also ameliorate 
the effects of DEP exposure on the heart.  Moreover, measurement of HRV will 
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strengthen understanding of the changes in the regulation of the autonomic nervous 
system (ANS) elicited by DEP exposure. 
 
The exact mechanism by which the β1 adrenoceptor antagonist influences 
susceptibility to subsequent myocardial injury in the present study is unclear, but 
may be due to reduced oxidative stress and cell death.  This is in line with a previous 
study that found administration of a sympathetic antagonist to effectively block 
CAP-induced cardiac oxidative stress (Rhoden et al., 2005).  Nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase distributed within heart cells (Cave et al., 
2005) was discussed in Chapter 5 as a potential intracellular source of the increased 
ROS production in DEP-instilled rats.  In vitro studies have shown that alpha 1 (α1) 
adrenoceptor stimulation induces ROS in adult rat ventricular myocytes, at least 
partially, through the activation of NADPH oxidase (Shattock et al., 1991).  Future 
studies using inhibitors of the NADPH oxidase complex could be useful in 
determining a possible linkage of β1 adrenoceptor stimulation to cardiomyocyte 
apoptosis through NADPH oxidase.  It cannot, however, be entirely ruled out that the 
increased myocardial viability, as assessed by TTC, and the reduced number of 
apoptotic cells (see Appendix 5), were the result of metoprolol’s anti-inflammatory 
effects on the tissue.  In vitro studies have demonstrated that tumour necrosis factor 
alpha (TNFα) induces apoptosis in cardiac myocytes (Dabisch et al., 2004).  
Metoprolol has been shown to reduce myocardial expression of this and other 
inflammatory cytokines including, interleukin-6 (IL-6) and interleukin-1 beta (IL1β) 
in rat models of both microembolisation (Lu et al., 2011) and coronary artery ligation 
(Cheng et al., 2005).  However, as reported in Chapter 5 there were no infiltrating 
neutrophils detectable on haematoxylin and eosin (H & E) stained paraffin sections 
from hearts of animals instilled with DEP 6 hours previously, suggesting that anti-
inflammatory effects of metoprolol are unlikely to be of major importance.  Although 
not studied here, a decrease in blood pressure may provide another possible 
explanation for the decreased I/R sensitivity in DEP-instilled rats that received 
metoprolol in vivo.  In previous studies in rats, short-term administration of 
metoprolol to spontaneously hypertensive (SH) rats resulted in decreases in arterial 
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blood pressure (Åblad et al., 1984).  Determining the in vivo effects of metoprolol on 
blood pressure clearly requires further investigation. 
 
A note of caution must be exercised in interpreting the findings from the current 
study.  It is unclear whether DEP targets the NTS, which regulates outgoing 
autonomic signals to the heart, through afferent fibres of the vagus nerve (discussed 
in more detail below) or indirectly via the circulation.  As discussed below DEP-
induced pulmonary inflammation was not completely abrogated by administration of 
metoprolol in vivo at the time of instillation.  Moreover, no up-regulation of 
neutrophil adhesion or circulating pro-inflammatory cytokines was detected after 
DEP exposure in the studies outlined in Chapters 4 and 5.  Collectively these results 
point towards autonomic imbalance and increased sensitivity to I/R injury by DEP 
through nerve impulses transmitted from lung to brain rather than indirect effects of 
inflammation. 
 
Finally, in the present study neither metoprolol nor AMG 9810 (discussed in more 
detail below) appeared to affect CPP at baseline or during I/R when compared with 
DEP-instilled animals.  These findings suggest that alterations in coronary 
endothelial cell function (Broadley, 1979) were not a cause of the reduced infarct 
size demonstrated with the adrenoceptor and TRPV1 antagonists, although further 
studies would be necessary to confirm this.  Additionally, in the present study AAR 
did not differ between groups, showing that the reduced infarct size was not due to a 
smaller ischaemic zone. 
6.4.2 Role of 1 adrenoceptors in DEP-induced pulmonary 
inflammation 
Surprisingly, administration of metoprolol (10 mg/kg i.p.) in vivo at the time of 
instillation resulted in a reduction in total cell and neutrophil numbers in BAL fluid 
recovered from DEP-instilled rats.  The reasons for this are unclear but could be, in 
part, due to the expression of β1 adrenoceptors on rat lung (Xue et al., 1983).  
Landiolol, a short-acting selective β1 adrenoceptor-blocking agent has been reported 
to attenuate acute lung injury in a rat model of endotoxin-induced sepsis (Hagiwara 
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et al., 2009).  The increased lung macrophage number in the present study may be 
due to recruitment of macrophages from the circulation to engulf apoptotic 
neutrophils during the resolution of inflammation (Gilroy et al., 2004).  It is 
important to note that not all pulmonary inflammatory effects (BAL total protein) of 
DEP were abolished by administration of metoprolol in vivo at the time of instillation. 
Thus the cardiovascular changes in response to DEP cannot entirely be attributed to 
secondary effects of inflammation. 
 
In summary, the heightened sensitivity to ex vivo I/R injury in DEP-instilled rats was 
abrogated when the β1 adrenoceptor antagonist, metoprolol was administered in vivo 
at the time of instillation.  This antagonist was also effective in blocking the DEP-
induced cardiac oxidative stress and cell death.  However, further studies are needed 
to fully establish whether these effects are primarily credited to metoprolol’s anti-
inflammatory effects on DEP-induced pulmonary inflammation. 
6.4.3 Role of TRPV1channels in DEP-induced increased sensitivity 
to I/R injury  
The experimental evidence discussed above strongly suggests that activation of the 
SNS following DEP exposure is central to the priming of the myocardium for 
increased I/R injury.  It has been suggested that lung C-fibre receptor activation 
modifies sympathetic and parasympathetic output via feedback to the CNS.  TRPV1 
has been found to be expressed both at mRNA and protein levels in C-fibre neurons 
innervating the lung and airways (Groneberg et al., 2004; Ni et al., 2006; Seki et al., 
2006; Watanabe et al., 2005).  A more recent study has shown activation of neuronal 
TRPV1 receptors in vitro by DEP (Deering-Rice et al., 2011).  In the current study 
co-instillation of AMG 9810 with DEP in vivo was found to prevent enhancement of 
ex vivo reperfusion injury associated with DEP instillation.  These data suggest an 
initiating role for TRPV1 in mediating the increased sensitivity of hearts to ex vivo 
I/R injury associated with DEP exposure.  Prior research has reported that triggering 
of TRPV1-mediated autonomic reflexes in the lung may, at least in part, explain 
adverse cardiovascular responses to pollutants (Ghelfi et al., 2008).  A direct effect 
of translocated DEP (or its associated constituents) on TRPV1 receptors in extra-
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pulmonary tissues can also not be ruled out.  Indeed, the presence of TRPV1 
receptors has been reported in tissues other than the lung including, pancreas, liver, 
and heart (O'Neil et al., 2003; Zahner et al., 2003).  However, as discussed in the 
previous chapter, if DEP did translocate into the systemic circulation it seems 
unlikely that particles would account for the full biological effects of DEP entering 
the lung.  Of note, there is evidence from pharmacological (Hu et al., 2002; Rang et 
al., 2004) and gene knockout (KO) studies (Wang et al., 2005) that activation of 
TRPV1 receptors on the heart can trigger protective mechanisms that may attenuate 
I/R injury.  For example, Wang and colleagues demonstrated TRPV1 gene deletion 
to impair post-ischaemic recovery in isolated mouse hearts (Wang et al., 2005).  
Thus, activation of TRPV1 receptors in the heart would have been expected to afford 
protection from the increased sensitivity to I/R injury by DEP.  Moreover, AMG 
9810 had no effect on I/R injury in hearts when applied only ex vivo in the organ bath.  
Collectively, these results point towards TRPV1 receptors in the lung, but not in the 
heart, conveying the increased sensitivity to I/R injury induced by exposure to DEP.  
 
As discussed in Chapter 5, exposure to DEP significantly reduced cardiac cell 
viability due to apoptotic cell death.  The loss of viable cardiac tissue, as assessed by 
TTC, was prevented by co-instillation of AMG 9810 with DEP in vivo.  Moreover, 
inhibition of TRPV1 receptors in the lungs was also shown to prevent apoptotic 
myocyte loss induced by DEP (see Appendix 5).  Previous in vitro studies have 
demonstrated the importance of TRPV1 in mediating PM-induced apoptosis 
(Agopyan et al., 2004; Agopyan et al., 2003).  In human airway epithelial cell lines 
Agopyan and colleagues reported that the influx of extracellular calcium (Ca
2+
) 
through TRPV1 causes the PM-induced cell death (Agopyan et al., 2004; Agopyan et 
al., 2003).  However, others have shown removal and chelation of Ca
2+
 to be 
ineffective in ameliorating cell death (Reilly et al., 2005; Reilly et al., 2003).  It is 
worth noting that in these studies the authors have made the assumption that PM can 
definitely translocate to extra-pulmonary tissues.  However, as discussed in earlier 




In the preceding chapter, it was hypothesised that cardiac oxidative stress plays a 
causal role in the cardiac cell death associated with DEP exposure.  It was predicted, 
therefore, that the increased oxidative stress in hearts would be prevented by 
blocking TRPV1 receptors in the lungs at the time of DEP exposure.  Surprisingly, 
co-instillation of AMG 9810 with DEP in vivo had no influence on the oxidative 
stress generation.  In contrast, pre-treatment with the TRPV1 antagonist capsazepine 
(CPZ, delivered by aerosol inhalation) was found to prevent enhanced cardiac 
oxidative stress induced by CAP (Ghelfi et al., 2008).  This disparity may be due to 
use of a different TRPV1 receptor antagonist in the current study from the above-
cited study by Ghelfi et al. (2008).  This is supported by studies reporting CPZ to 
have low TRPV1 specificity (Behrendt et al., 2004) and poor pharmacokinetic 
properties (Valenzano et al., 2004).  Thus, it is unknown whether the adverse cardiac 
effects demonstrated in the previous study by CAP are truly mediated by TRPV1 or 
independent of TRPV1 binding.  Compared with CPZ, AMG 9810 used in the 
current study has been demonstrated to exhibit greater potency, affinity and 
selectivity for TRPV1 (Gavva et al., 2005). 
 
It is also worthwhile noting that distinct pools of TRPV1 within cells have been 
linked to different downstream effects (Reilly et al., 2005) and may provide a 
possible explanation to why the TRPV1 antagonist could not protect the heart from 
DEP-induced oxidative stress.  It is currently unclear whether AMG 9810 blocked all 
sub-cellular pools of TRPV1.   We can also not rule out the possibility that AMG 
9810 leaves the lungs and enters the circulation.  Blocking TRPV1 receptors in 
sensory nerve fibres innervating the heart might, in turn, negate possible anti-oxidant 
effects of blocking its activity in the lung.  A possible role of cardiac TRPV1 
receptors in protecting the heart from I/R injury was discussed above.  At present the 
mechanisms underlying TRPV1-induced cardiac protection are unclear.  There is 
limited evidence to suggest that such protection is mediated by sensory 
neuropeptides released on TRPV1 activation (Li et al., 1996; Wang et al., 2005).  
Intriguingly, NADPH oxidase-derived ROS have been implicated in the protection 
afforded by these sensory neuropeptides (Starr et al., 2008).  Based on this, one 
would have expected co-instillation of AMG 9810 with DEP in vivo to decrease 
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rather than increase ROS formation in hearts.  Of note, addition of AMG 9810 to the 
heart perfusate ex vivo significantly increased ROS generation, suggesting that 
activation of TRPV1 receptors on the heart do not contribute to the increased ROS 
generation in hearts of rats exposed to DEP. 
 
To summarise these data strongly imply that DEP-induced cardiac cell death was not 
secondary to oxidative stress.  This is strengthened by other lines of evidence 
showing anti-oxidants to be ineffective in decreasing the number of dead cells after 
PM exposure in epithelial cell lines (Li et al., 2002).  Additionally, these findings 
suggest that more than one target may be involved in mediating the heightened 
myocardial injury associated with DEP.  In vitro studies have shown that neutral 
synthetic polymer microsphere (SPM)-mediated IL-6 release was only partially 
inhibited by pre-treatment of CPZ in dorsal root ganglia (DRG) neurons and 
epithelial cells (Oortgiesen et al., 2000). 
6.4.4 Effect of TRPV1 blockade on DEP-induced pulmonary 
inflammation 
So far, this discussion has focussed primarily on the activation of TRPV1 receptors 
in pulmonary C-fibres transmitting signals to the CNS.  However, activation of 
TRPV1 receptors in pulmonary C-fibre sensory nerves may also trigger the release of 
neuropeptides (e.g. SP and CGRP) through a local-axon reflex, resulting in an 
inflammatory response (neurogenic inflammation) (Holzer, 1988).  Moreover, 
TRPV1 receptors localised in non-neuronal cells such as airway epithelial cells and 
mast cells (Biro et al., 1998; Veronesi et al., 2006) can initiate and enhance the 
inflammatory response by releasing cytokines.  In vitro studies have demonstrated 
TRPV1-mediated pro-inflammatory cytokine production in several human 
respiratory epithelial cell lines (Reilly et al., 2003; Seki et al., 2007).  In vivo studies 
with rats have also reported respiratory inflammation in response to inhalation of the 
TRPV1 agonist, capsaicin (Reilly et al., 2003).  Conflicting results have been 
reported in studies evaluating a causal relationship between TRP channels and PM-
induced airway inflammation (Oortgiesen et al., 2000; Veronesi et al., 1999b; Witten 
et al., 2005; Wong et al., 2003).   In the human epithelial cell line BEAS-2B-
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increased generation of IL-6 by ROFA was inhibited by CPZ pre-treatment 
(Veronesi et al., 1999b).  Similar results have been reported on isolated mouse vagal 
pulmonary sensory neurons (Veronesi et al., 2000).  Other studies have, however, 
concluded that lung C-fibre activation does not play a dominant role in pollution-
induced pulmonary inflammation and injury (Wong et al., 2003; Zweier et al., 2006).  
Studies in Chapter 4 demonstrated pro-inflammatory cytokine concentrations as well 
as neutrophil counts to be higher in BAL fluid of rats instilled with DEP.  Results 
described in this chapter show that the cardiovascular responses to DEP cannot be 
entirely attributed to an inflammatory response following TRPV1 activation.  While 
there was a tendency towards reduced lung inflammation, as measured by 
inflammatory indices in BAL fluid, in DEP-instilled rats that received AMG 9810 in 
vivo this did not reach statistical significance, perhaps due to the relatively small 
sample size.  This result suggests that the adverse cardiovascular responses to DEP 
are, at least in part, directly related to centrally-mediated reflexes.  It will be 
important, however, for future experiments to determine whether the deleterious 
effects of DEP are related to endogenous release of SP and CGRP, via activation of 
TRPV1 receptors, with the use of antagonists of the SP and CGRP receptor. 
 
In summary, co-instillation of AMG 9810 with DEP in vivo prevented the heightened 
sensitivity to ex vivo I/R injury associated with DEP instillation.  Moreover, studies 
assessing the pulmonary inflammatory response of AMG 9810 suggest DEP 
deposition in the lung triggers TRPV1-mediated central reflexes, which in turn 
renders hearts more sensitive to I/R injury. 
6.4.5 Future studies and limitations 
There are a number of limitations to be noted regarding this study and several 
questions remain unanswered. 
 
β1 adrenoceptor protein expression has been reported in several tissues other than 
heart, including the liver and kidney (Hellgren et al., 2000), to mediate a diverse 
array of cellular responses.  Therefore, methods such as microneurography, HRV and 
baroreflex sensitivity assessment should be used to confirm increased sympathetic 
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activity by pulmonary exposure to DEP.  It will also be necessary to investigate the 
effects of TRPV1 blockade on the ANS function in DEP-instilled rats. 
 
The present study is also limited in that it did not address the potential contribution 
of other TRP channels in mediating the heightened sensitivity to myocardial injury 
following exposure to DEP.  Activation of TRP ankyrin 1 (TRPA1), in addition to 
TRPV1, by DEP was recently reported in primary cultures of DRG neurons 
(Deering-Rice et al., 2011).  Other studies have shown DEP to increase activation of 
TRPV4 in primary human respiratory epithelial cell lines (Deering-Rice et al., 2011).  
This may help explain the apparent discrepancies between the cytotoxicity and 
oxidative data, and the inability of AMG 9810 to block oxidative stress.  Future 
studies using genetic ablation of TRP channels and/or pharmacological channel 
inhibition are therefore warranted. 
 
Experimental studies are also needed to evaluate TRPV1 blockade and 1 
adrenoeceptor blockade on I/R injury in vivo following exposure to DEP.  Previous 
studies reported in Chapter 5 demonstrated the ability of a single exposure to DEP to 
increase the vulnerability of the heart to developing arrhythmia during in vivo 
ischaemia and reperfusion.  Although it was not studied here we predict that TRPV1 
mediates the heightened sensitivity to arrhythmia during ischaemia.  Pre-treatment 
with a TRPA1 antagonist prevented the heightened sensitivity to aconitine-induced 
cardiac arrhythmias reported in rats after exposure to whole diesel exhaust (wDE) 
(Hazari et al., 2011).  A similar effect was observed following sympathetic 
modulation with guanethidine (Hazari et al., 2011). 
 
Furthermore, the mechanism of activation of TRPV1 by PM is not completely 
understood.  Agopyon et al. (2003) and others (Oortgiesen et al., 2000) have 
demonstrated that the effect of PM on TRPV1 is strongly dependent on PM carrying 
a net-negative surface charge.  Neutral SPM was markedly less effective than its 
charged counterparts in increasing intracellular Ca
2+
 and IL-6 in the mouse DRG 
(Oortgiesen et al., 2000).  Electrophilic components of DEP have been reported to 
bind to TRPA1 via the formation of reversible covalent bonds with cysteine residues 
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present in the ion channel (Deering-Rice et al., 2011).  These receptors can also be 
activated by ROS that are produced in the lung when inflammation accompanies 
exposure to PM (Bessac et al., 2008).  In cultured DRG (Story et al., 2003) and 
trigeminal ganglia (TG) (Jordt et al., 2004) cells, TRPA1 has been shown to co-
localise with TRPV1.  Moreover, it has been reported that TRPV1 is activated 
secondary to TRPA1 perhaps due to Ca
2+
 influx or cytokine production (Skrzypiec-
Spring et al., 2007). 
 
Lastly, the effects of DEP instillation on TRPV1 expression were not investigated 
here.  Polymerase chain reaction (PCR) studies have shown that TRPV1 mRNA 
expression in lungs increases after PM exposure in vivo (Costa et al., 2011) and in 
vitro (Veronesi et al., 2003).  Moreover, increases in the level of TRPV1 expression 
has been shown to correlate with increased sensitivity of TRPV1 to noxious stimuli 
(Reilly et al., 2005).  Whether DEP instillation increases the expression of TRPV1 
mRNA and receptor protein and potentially decreases tolerance during subsequent 
exposures warrants investigation. 
6.4.6 Conclusion 
Collectively the data presented here suggest that a TRPV1-dependent neuronal reflex 
response triggered by DEP deposition in the lung contributes to the increased 









Exposure to air pollution has been associated with increased cardiovascular mortality 
and morbidity (Bhatnagar, 2006; Brook et al., 2003; Dockery et al., 1993).  These 
associations are strongest for the particulate matter (PM) in air pollution (Brook, 
2008; Mills et al., 2009).  Ultrafine particles (UFP; or nanoparticles) are of specific 
concern because their small size allows them to penetrate deep into the respiratory 
tract and also engenders them with a large surface area (Oberdorster, 2001).  Exhaust 
from diesel engines is especially rich in nanoparticles and, therefore, may contribute 
greatly to the health effects of PM in urban environments (Baulig et al., 2003; 
Lucking et al., 2011). 
 
There are numerous clinical and experimental observations showing detrimental 
effects of diesel exhaust (DE) and other PM on coronary vascular function, on 
atherosclerotic plaque development and stability and on thrombosis and clot 
resolution (Kunzli et al., 2005; Nemmar et al., 2003a; Suwa et al., 2002).  A 
previous study in this laboratory demonstrated enhancement of myocardial ischaemia 
in patients with stable coronary heart disease during acute exposure to DE (Mills et 
al., 2007).  While the coronary vascular and pro-thrombotic effects of PM increase 
the likelihood of heart attack, there is also evidence that exposure to PM has 
deleterious effects on the myocardium itself.  Peters et al., (2000) and others 
(Dockery et al., 2005; Rich et al., 2005) have reported that exposure to PM increases 
the incidence of ventricular arrhythmias in patients with implantable defibrillators.  
Experimental studies have also reported cardiac abnormalities, including impaired 
left ventricular diastolic performance and arrhythmias after in vivo exposures to PM 
(Anselme et al., 2007; Yan et al., 2008).  These observations suggest that pulmonary 
exposure to PM may also render the heart more vulnerable to injury following 
infarctions.  To date, only one study has addressed this question directly:- myocardial 
ischaemia/reperfusion (I/R) injury was increased in mice 24 hours after pulmonary 
instillation of concentrated ambient particles (CAP) (Cozzi et al., 2006).  However, 
the mechanism by which pulmonary exposure to pollution is associated with 




The work described in this thesis was designed to investigate the hypothesis that 
intra-tracheal instillation of diesel exhaust particulate (DEP) in rats would increase 
the vulnerability of the heart to subsequent I/R injury.  Furthermore, markers of 
inflammation, and of endothelial and autonomic function, were assessed in order to 
elucidate potential mechanisms of actions.  Changes in all these parameters have 
been proposed as potential mechanisms linking air pollution with adverse 
cardiovascular events (Brook, 2008; Brook et al., 2004). 
7.1 Exposure to DEP increases arterial blood pressure 
Blood pressure was higher 6 hours, but not 24 hours, after instillation with DEP 
relative to saline-instilled controls (Chapter 4).  The higher blood pressure in the 
DEP-instilled rats was not associated with a systemic inflammatory response (no 
change in circulating interleukin-6 (IL-6), C reactive protein (CRP) or tumor necrosis 
factor alpha (TNFα)).  Additionally, alterations in endothelial function and 
subsequent changes in vasomotor tone are unlikely as acetylcholine (ACh)-induced 
dilation was not altered in the hind-limb vascular bed (Chapter 4).  Based on data 
generated showing DEP-induced cardiac injury (oxidative stress and cell death) 
could be prevented by a beta 1 (β1) adrenoceptor antagonist (Chapter 6), a more 
likely explanation is that the increase in blood pressure was due to an increase in 
sympathetic tone.  In support of this, previous animal and human studies have 
reported PM-induced elevations in blood pressure to be mediated by neurohumoral 
activation (Bartoli et al., 2009b; Brook et al., 2009a).  Bartoli et al. (2008) 
demonstrated that the raised diastolic blood pressure (DBP) during a 5 hour exposure 
to CAP was significantly attenuated by prazosin, a selective alpha 1 (α1) 
adrenoceptor antagonist.  Thus, studies with α adrenoceptor antagonists are needed to 





7.2 DEP exposure does not impair endothelial cell function 
ex vivo or in vivo 
Experiments performed on the intact hind-limb vasculature in vivo, revealed 
exposure to DEP to have no effect on the vasodilator responses to the endothelium-
dependent vasodilator ACh, at 6 or 24 hours post-exposure (Chapter 4).  These in 
vivo measurements were supported by a lack of effect of DEP on vascular function 
ex vivo (Appendix 2).  In Chapter 4, these results were discussed in detail in relation 
to other studies using DEP and other PM. 
 
Collateral blood flow is an important determinant of infarct size (Reimer et al., 1981).  
Endothelial cell dysfunction in vivo following DEP instillation may make the heart 
more prone to reperfusion injury, perhaps by compromising blood flow and 
enhancing inflammatory cell infiltration.  Of note, the present data evaluating 
endothelial cell function in the rat hind-limb vascular bed cannot be directly 
extrapolated to the heart.  Nevertheless, studies have established a close relation 
between the endothelial cell function of the peripheral circulation and that of the 
coronary circulation (Anderson et al., 1995).  Therefore, the in vivo endothelial cell 
function data may indicate that impairment of endothelial function in coronary 
collateral vessels does not play a key role in the increased ischaemic vulnerability of 
the heart in rats exposed to DEP by instillation (Chapter 5).  In further support of this 
conclusion, endothelial cell dysfunction would have been expected to induce changes 
in coronary perfusion pressure (CPP).  As described in Chapter 5, CPP was not 
different in hearts isolated from DEP exposed compared to vehicle treated rats. 
 
It is also important to mention that endothelial cell function was preserved at times 
when there was significant pulmonary (6 hour) and systemic (24 hour) inflammation.  
It has been reported that inflammation after PM exposure plays a role in mediating 
cardiovascular responses (Seaton et al., 1995).  Consistent with previous work 
(Madden et al., 2000; Nemmar et al., 2003a), pulmonary inflammation was detected 
at 6 hours after DEP exposure.  In contrast, systemic inflammation was only 
detectable at 24 hours, when pulmonary inflammation had resolved.  The time course 
of these responses could suggest that these factors originate from the prior 
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inflammatory response in the lung.  Furthermore, these data show that inflammation 
alone is unlikely to account for the cardiovascular actions of inhaled particulates.  
This was further supported by the observation that sensitisation to myocardial I/R-
induced injury could be reproduced in the isolated Langendorff-perfused rat heart. 
 
Unlike the responses to ACh, the relaxation produced by the endothelium-
independent vasodilator sodium nitroprusside (SNP) in vivo was impaired both 6 and 
24 hours after administration of DEP (Chapter 4).  The preserved dilator response to 
SNP ex vivo (Appendix 2) strongly suggests that autonomic alterations likely 
contribute to the impaired dilator responses observed in vivo.  Changes in autonomic 
and baroreceptor activity have been reported following PM exposure (Gold et al., 
1999; McQueen et al., 2007; Pope et al., 1999; Rhoden et al., 2005; Wellenius et al., 
2002).  It is possible, therefore, that the reduced vasodilator response to SNP in the 
DEP-instilled rats was due to baroreflex-induced vasoconstriction in response to 
SNP-induced hypotension.  The decrease in mean arterial pressure caused by SNP 
was not different between the saline and DEP group.  The latter suggests that 
exposure to DEP may lead to reduced baroreceptor sensitivity and increased 
vasoconstriction, thereby opposing the vasodilator effect of SNP.  Baroreceptor 
sensitivity should be assessed in future studies, for example by the assessment of 
changes in blood pressure against heart rate (HR) induced by intravenous bolus 
injections of phenylephrine (Chang et al., 1986). 
7.3 DEP exposure causes myocardial oxidative stress and 
cell death 
As mentioned above, exposure to DEP caused pulmonary inflammation at 6 hours, 
which had largely resolved by 24 hour post-exposure.  This observation, coupled 
with the previous demonstrations that blood pressure and circulating inflammatory 
cytokines were also elevated at 6 hours, led to this time-point being selected for 
subsequent investigations. 
 
Instillation of DEP alone was associated with increased myocardial oxidative stress, 
as measured by an increase in the relative electron paramagnetic spin resonance 
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(EPR) signal of isolated rat hearts (Chapter 5).  This is in line with previous studies 
of animals exposed to PM (Gurgueira et al., 2002; Rhoden et al., 2005).  The DEP-
instilled rats also showed a greater loss of viable myocardium prior to the induction 
of ischaemia, as determined by 2, 3, 5-triphenyltetrazolium chloride (TTC) staining 
(Chapter 5).  Parallel experiments confirmed that the loss of viability observed by 
TTC was due to apoptosis (Appendix 4).  The abrogation of the DEP-induced cardiac 
oxidative stress and cell death by pre-treatment with metoprolol, a β1 adrenoceptor 
antagonist, supports the involvement of β1-adrenoceptors in eliciting the observed 
response (Chapter 6).  This agrees with previous studies that have shown that 
enhanced adrenoceptor signaling induces oxidative stress and cell death in cardiac 
myocytes (Communal et al., 1998; Park et al., 1999; Romeo et al., 2000).  In the 
heart β1-adrenoceptors predominate and participate in efferent sympathetic cardiac 
regulation (Grimm et al., 2010; Wallukat, 2002).  Sympathetic nerve activity was not 
measured directly and needs to be confirmed in subsequent experiments (for example 
by microneurography (Nakamura et al., 2003)).  No significant differences were 
found for plasma catecholamine levels measured 6 hours after the instillation of DEP 
compared with saline control rats (Chapter 4).  The accurate measurement of 
catecholamines is, however, notoriously difficult and all animals were likely stressed 
from the handling and moving of cages (Kvetnansky et al., 1978).  Direct effects of 
blood-borne particles on the heart and/or from indirect consequences of DEP-
induced pulmonary inflammation cannot be completely ruled out.  The later 
explanation seems unlikely since there was no evidence that DEP induced plasma 
cytokines or granulocyte activation or priming (Chapters 4 & 5).  Similarly, direct 
effects of DEP on the heart are unlikely based on previous calculations of the amount 
of UFP that could access the bloodstream (<1%) (Kreyling et al., 2002).  Instead it 
seems a lot more likely based on the participation of β1-adrenoceptors, coupled with 
the lack of effect of DEP exposure on systemic inflammation or on the oxygen 
carrying capacity of the blood (no change in red blood cell (RBC) count), that 
sympathetic activation is a major determinant of the cardiac oxidative stress and cell 
death.  Furthermore, the abrogation of both DEP-induced cardiac oxidative stress and 
cell death by metoprolol pre-treatment provides support that the oxidative stress and 
reduction in cell viability are closely linked events.  Indeed oxidative stress is well 
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recognized as a major contributing factor to the induction of apoptosis (Akki et al., 
2009). 
 
Data from Rhoden and colleagues showed that short-term exposure to CAP increased 
oxidative stress in the rat heart, which could be prevented by pre-treatment with 
atenolol (a β1 adrenoceptor antagonist) (Rhoden et al., 2005).  These results further 
indicate that cardiac oxidative stress may result from an imbalance in cardiac 
autonomic activity in response to deposition of PM in the lung.  Reactive oxygen 
species (ROS) have been shown to be mediators in this pathway (Rhoden et al., 
2005).  ROS levels in the systemic circulation were not measured in the current study.  
However, granulocytes, and especially neutrophils, are a major source of ROS.  In 
the present study, although the number of white blood cells (WBC) increased 6 hours 
after DEP exposure, granulocytes were not activated (CD11b expression) (Chapter 5).  
Moreover, ROS are known to induce cytokines and vice versa (Stocker et al., 2004; 
van Eeden et al., 2002; Yoshida et al., 1999).  As mentioned above, there was no 
increase in circulating cytokine levels found in rats 6 hours after exposure to DEP.  
Collectively, these data suggest that ROS in the systemic circulation does not 
contribute to the occurrence of cardiac oxidative stress following DEP exposure.  It 
would be useful in future studies to measure oxidative stress indicators, such as 
glutathione (GSH) in blood.  An alternative approach would be to evaluate whether 
pre-treatment of rats with an anti-oxidant, such as N-acetyl-cysteine (NAC), could 
prevent the cardiac oxidative stress. 
  
It should be emphasised that it remains unclear whether the increased cardiac 
oxidative stress is due to increased ROS production and/or a reduced level of activity 
of anti-oxidants.  The lack of neutrophil infiltration on haematoxylin and eosin (H & 
E)-stained paraffin sections from hearts of rats instilled with DEP 6 hours previously 
did, however, rule out neutrophils as major sources of ROS.  Based on the results 
discussed above, it would be interesting to evaluate the effects of nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase inhibition, a major source of ROS 
(Jordan et al., 1999), on the DEP-induced cardiac oxidative stress.  NADPH oxidase 
is widely distributed within the heart (Cave et al., 2005) and increased NADPH 
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oxidase-derived ROS production has been reported upon alpha 1 (α1) adrenoceptor 
activation (Xiao et al., 2002).  Furthermore, the involvement of NADPH oxidase in 
PM-induced oxidative stress has been reported both in vivo (Kampfrath et al., 2011) 
and in vitro (Mo et al., 2009).  Using pharmacological inhibitors of NADPH oxidase 
would also help to verify whether an oxidative mechanism is involved in the 
myocardial apoptosis. 
 
In this study, multiple lines of evidence pointed towards impaired modulation of 
autonomic regulation, partly as a result of activation of vagal afferent C-fibers 
innervating the lung rather than as a consequence of DEP-induced pulmonary and 
systemic inflammation.  Blocking the β1-adrenoceptors did not completely abrogate 
the DEP-induced pulmonary inflammation (Chapter 6).  As already mentioned above, 
exposure to DEP did not enhance the adhesive properties of neutrophils or increase 
levels of circulating pro-inflammatory cytokines.  Finally, the β1-adrenocpetor-
mediated myocardial cell death following DEP exposure was also prevented by pre-
treatment with the transient receptor potential vanilloid 1 (TRPV1) inhibitor AMG 
9810 (Chapter 6 and Appendix 5).  Activation of sensory receptors in the airways has 
been reported to modify sympathetic and parasympathetic output via feedback to the 
central nervous system (CNS) (Widdicombe et al., 2001).  Indeed, pharmacological 
studies support a role for TRP receptor activation in vivo to PM-induced cardiac 
oxidative stress and electrophysiological changes (Ghelfi et al., 2008).  Rather 
unexpectedly, the TRPV1 inhibitor AMG 9810 did not prevent the DEP-induced 
cardiac oxidative stress (Chapter 6).  The reasons for this are not obvious but may 
simply be a reflection of insufficient statistical power to detect a meaningful 
difference.  Here it is worth mentioning that it is not clear if AMG 9810 blocks all 
pools of TRPV1.  Indeed, distinct pools of TRPV1 within cells have been linked to 
different downstream effects (Reilly et al., 2005).  However, replication studies with 
a larger sample size are needed before any firm conclusions can be drawn. 
 
It is also noteworthy, that pharmacological blockade of TRPV1 had partial, but 
significant, effects on DEP-induced lung inflammation (Chapter 6).  This may be 
explained by attenuation of the local axon reflex-mediated neurogenic inflammation 
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in the lung (Holzer, 1988) by blocking the activation of TRPV1.  This strongly 
suggests that the inflammation elicited by DEP is due, in part, to neurogenic 
inflammation.  Conflicting results have suggested that the C-fibre-mediated axon 
reflex plays no major role or plays the primary role in PM-induced inflammation 
(Oortgiesen et al., 2000; Veronesi et al., 1999b; Witten et al., 2005; Wong et al., 
2003).  These findings also reveal insight into whether TRPV1 detects DEP directly 
or indirectly (via inflammatory mediators).  The inflammatory response in 
association with PM exposure has been reported to activate TRP receptors (Bessac et 
al., 2008).  However, the abrogation of DEP-induced injury as well as sensitisation to 
reperfusion injury suggests that DEP may be able to bind and activate TRPV1 
directly.  This conclusion is supported by a recent study showing that DEP directly 
activates TRPV1 (Deering-Rice et al., 2011).  Direct activation of TRPA1 by DEP 
was also confirmed (Deering-Rice et al., 2011) highlighting the need to address the 
potential contribution of other channels in mediating the observed effects on cardiac 
injury. 
7.4 DEP exposure increases susceptibility to myocardial 
I/R injury both ex vivo and in vivo 
A single exposure of the lung to DEP 6 hours prior to I/R increased myocardial 
sensitivity to I/R injuries, most notably characterised by increased susceptibility to 
ischaemia-induced arrhythmias and arrhythmic death as well as an increase in the 
infarct size (Chapter 5).   This study is clinically relevant, particularly in light of the 
recent clinical study reporting an increased risk for myocardial infarction (MI)-
associated hospitalisation in the first 6 hours after exposure to atmospheric pollution 
(Bhaskaran et al., 2011).  The increased susceptibility to arrhythmias may be 
associated with increased cardiac metabolic demand during ischaemia (increased rate 
pressure product (RPP); Chapter 4).  Alternatively, the oxidative stress induced by 
DEP before I/R may have decreased the capacity of the heart to deal with the 
arrhythmogenic effect of a subsequent ischaemia.  It has been reported that pre-
treatment with the anti-oxidant NAC was capable of blocking arrhythmias in vivo 
following exposure to DEP (Kim et al., 2012).  Furthermore, these investigators 





)/calmodulin kinase II (CaMKII) activation (Kim et al., 2012).  β1 
adrenoceptor-evoked increases in intracellular Ca
2+
 has also been associated with 
arrhythmias via activation of CaMKII (Anderson, 2007; Grimm et al., 2010).  
Moreover, sympathetic drive is a key regulator of cardiac rhythm and the SNS has 
been implicated in mediating alterations in heart rate variability (HRV) (Ghelfi et al., 
2008; Hazari et al., 2011).  Increased aconitine-induced arrhythmia sensitivity after 
whole diesel exhaust (wDE) exposure was fully prevented by guanethidine (a 
sympathetic blocking drug) (Hazari et al., 2009).  Future studies using β 
adrenoceptor blockers are necessary to establish whether SNS activation contributes 
to the increased susceptibility to ischaemia-induced arrhythmias in DEP-instilled rats.  
In addition to sympathetic activation, Hazari and colleagues also demonstrated a role 
for transient receptor potential ankyrin 1 (TRPA1) in mediating the heightened 
arrhythmia sensitivity following inhalation of wDE (Hazari et al., 2011).  In the 
present study, pre-treatment with a TRPV1 antagonist completely abrogated DEP-
induced loss of cell viability, as well as sensitisation to injury ex vivo (69% inhibition 
in infarct size).  Treatment of rats with TRPV1 inhibitors before DEP exposure is 
needed to ascertain the role of TRPV1 in the ischaemic arrhythmias.  It will also be 
necessary to investigate the effects of TRPV1 blockade on the ANS function in DEP-
instilled rats.  Furthermore, assessing arrhythmias in ex vivo perfused hearts of DEP-
instilled rats will specifically determine whether in vivo mechanisms affect the 
incidence of arrhythmias during the ischaemia and reperfusion. 
 
It has been reported that granulocyte (especially neutrophil) infiltration plays an 
important role in the development of arrhythmia and cell death due to I/R (Jordan et 
al., 1999).  Based on the flow cytometry data (Chapter 5), DEP exposure did not alter 
the activation or priming responses of granulocytes.  Although not assessed in this 
study, neutrophil recruitment to the myocardium during I/R may underlie the 
increased arrhythmogenic susceptibility, as has been shown by others (Yokota et al., 
2004; Yokota et al., 2008a).  I/R conducted on isolated hearts from rats exposed to 
DEP did, however, show that neutrophil infiltration during I/R was not essential for 
mediating the increased infarct size.  The heightened sensitivity to I/R-induced injury 
in vivo and ex vivo also demonstrated that hearts are primed in vivo following 
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exposure to DEP.  Additionally, studies using pharmacological inhibitors of β1 
adrenoceptors and TRPV1 confirmed that activation of pulmonary TRPV1 and 
systemic β1 adrenoceptors are central to the heightened sensitivity to I/R-triggered 
cell death ex vivo.  As mentioned above both these receptors were shown to be 
implicated in the heart injuries (oxidative stress and cell death) induced by DEP 
exposure alone.  Collectively, these data confirm that this priming effect upon 
exposure to DEP was associated with increased oxidant stress generation from the 
heart, accompanied by loss of cardiomyocyte viability.  Furthermore, activation of 
pulmonary TRPV1 and systemic β1 adrenoceptors appear to be necessary for priming 
of the heart for subsequent injury.  As mentioned above DEP-induced lung 
inflammation was not completely blocked by the TRPV1 antagonist revealing that 
the mechanism by which hearts are primed is at least partially independent of lung 
inflammation.  This was further confirmed by a complete reversal of the heightened 
sensitivity to myocardial reperfusion injury, but not lung inflammation, in DEP-
exposed animals by blockade of β1 adrenoceptors.  Repeating the drug intervention 
studies using an in vivo model of I/R is needed to confirm or refute whether β1 
adrenoceptor blockade and/or TRPV1 blockade prevents the increased I/R-triggered 
cell death in the DEP-instilled rats. 
7.5 General considerations 
All studies used DEP.  The physiochemical properties of DEP vary depending on the 
fuel used and the engine type and running conditions.  The work described in this 
thesis used widely available ‘standard’ DEP from the National Institute of Standards 
and Technology (NIST), a frequently used source of DEP that acts as a benchmark 
for comparisons of the biological effects of DEP between studies.  It is important to 
acknowledge that although the dose used was lower than that used in other studies 
(Yokota et al., 2004; Yokota et al., 2008a) it was substantially higher than that 
expected from real-world exposures.  The total dose delivered to the alveolar surface 
was approximately 30-fold higher than the comparable alveolar deposition from a 24 
hour inhalation of 100 µg/m
3
 in man (multiple path particle dosimetry (MPPD) 
model, adjusted rat lung surface area) (Cassee et al., 2002).  Nevertheless, this does 
not, for instance, take into consideration peak PM levels which occur regularly, 
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particularly in large cities, or the increased PM deposition during exercise (e.g., brisk 
walking, cycling or jogging) (Daigle et al., 2003).  The research described in this 
thesis was conducted in healthy rats.  It is unclear whether biological responses will 
be evident at lower doses among specific sub-groups of the population, such as those 
with pre-existing cardiovascular disease.  Indeed it has been reported that certain 
sub-groups of the population are more susceptible to health effects from exposure to 
PM (Daigle et al., 2003; Miller et al., 2007). 
 
Lastly, intra-tracheal instillation was used to deliver particulate to the lungs of rats.  
This approach has been successfully used previously to investigate the health effects 
of DEP on the cardiovascular system (Madden et al., 2000; Murphy et al., 1998; Yan 
et al., 2008; Yokota et al., 2004; Yokota et al., 2008a; Yokota et al., 2005; Yokota et 
al., 2008b).  Although intra-tracheal instillation is less physiological than inhalation, 
it has been widely accepted as a reliable technique to administer particles directly to 
the respiratory tract in a quantitative and reproducible manner (Driscoll et al., 2000; 
Miyabara et al., 1998).  In comparison to inhalation exposure, instillation results in 
better dispersion of particles throughout the lobes of rodent lungs and across the 
alveolar surface (Driscoll et al., 2000; Miyabara et al., 1998).  The nasal passages of 
rodents are more complex than humans and serve as a filter for the inhaled particles.  
This filtering of particulates reduces the quantity of particles able to reach the alveoli 
and limits dose reproducibility (Driscoll et al., 2000; Miyabara et al., 1998).  
Additionally, PM has been reported to induce similar increases in bronchoalveolar 
lavage (BAL) fluid cell counts for both methods of exposure (Driscoll et al., 2000; 
Henderson et al., 1995; Miyabara et al., 1998). 
7.6 Main conclusions 
Airway inflammation, characterised by increased protein permeability, neutrophil 
infiltration and increased production of inflammatory cytokines, was detectable at 6 
hours after exposure to DEP.  At this time-point, hearts from DEP exposed rats were 
more sensitive to I/R injury in vivo, indicated by increased susceptibility to 
ischaemia-induced arrhythmias and arrhythmic death as well as an increase in infarct 
size.  No endothelial dysfunction or systemic inflammation was detected 6 hours 
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after exposure and, thus, these processes are unlikely to be causally related to the 
increased ischaemic vulnerability.  Isolation of hearts 6 hours following exposure to 
DEP demonstrated that exposure primed the hearts for subsequent injury and that 
enhancement of inflammatory cell recruitment was not required.  Priming was 
associated with increased oxidant stress generation from the heart, accompanied by 
loss of cardiomyocyte viability.  Co-administration in vivo of a β1 adrenoceptor 
antagonist completely abrogated the DEP-induced cardiac injury as well sensitisation 
to injury ex vivo, suggesting that activation of the SNS was key in the priming 
mechanism.  The increased blood pressure 6 hours after DEP exposure was also most 
probably due to increased sympathetic activation.  Sensory transduction involving 
TRPV1 channels in the lungs feeds back to the CNS inducing changes in autonomic 
outflow to the heart (Widdicombe et al., 2001).  A role for this pathway was strongly 
supported by the observation that myocardial priming by DEP could be prevented 
when pulmonary TRPV1 receptors were blocked using a selective antagonist.  
Together these data implicate activation of a sensory feedback loop by DEP in the 
lung leading to increased sympathetic outflow and priming of the heart for increased 
ischaemic injury (Figure 7.1).  This mechanism may also provide a plausible 
explanation for recent reports associating short-term increases in exposure to PM 
(within 1-6 hours) with ‘short-term displacement’ of myocardial events rather than 




Figure 7.1 Schematic of proposed mechanism for the transmission of effects of 
diesel exhaust particulate (DEP) in the lung to the heart. 
Airway activation of transient receptor potential vanilloid 1 (TRPV1) sends an 
afferent signal to the nucleus tractus solitaries (NTS) in the brain stem,  and in turn, 
increases efferent sympathetic outflow to the heart.  The sympathetic nervous system 
(SNS) acts via beta 1 (β1) adrenoceptors to induce oxidative stress and cell death that 
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Appendix 1: Supplemental materials and methods 
 
Ex vivo vascular function using myography 
The thoracic aorta, a region of un-injured femoral artery and 3
rd
 order mesenteric 
resistance arteries were isolated from animals 6 or 24 hours after instillation of diesel 
exhaust particulate (DEP, 0.5 mg in 0.5 ml saline) or vehicle (saline 0.5 ml), and 
cleaned of connective tissue. Segments of aorta (~5 mm length), femoral and 
mesenteric arteries (both 1-2 mm length) were mounted in a multi-myograph system 
(610M; Danish Myo Technology, Aarhus, Denmark) (Miller et al., 2009), using 40 
µm diameter wire for smaller vessels. Vessels were submerged in Krebs buffer 
(composition in mM: 118.4 NaCl, 25 NaHCO3, 11 glucose, 4.7 KCl, 1.2 MgSO4, 1.2 
KH2PO4, 0.027 ethylenediaminetetraacetic acid, 2.5 CaCl2) bubbled with 5% 
CO2/95% O2 at 37
o
C before a baseline tension of 14.7 mN (aorta), 8 mN (femoral) or 
4 mN (mesenteric) was gradually applied over 10 minutes and vessels were allowed 
to equilibrate for a further 30 minutes. Preliminary experiments showed that these 
pre-tension levels produced optimal contraction and dilatation responses. Data from 
force transducers were processed by a MacLab/4e analogue-digital converter 
displayed through Chart
TM
 software (AD Instruments, Sussex, UK). 
 
Vessel viability was confirmed by a contractile response on addition of 80 mM KCl, 
repeated 3 times (aorta) or serial addition of high K
+ 
Krebs (Krebs with substitution 
of 4.7 mM NaCl and 118.4 mM KCl) together with 10 M noradrenaline (femoral 
and mesenteric arteries). Concentration-response curves to phenylephrine (PE; 1 nM 
– 10 M) were obtained and a concentration that produced 80% maximum 
contraction (EC80; 0.1-1 M) was chosen for each individual arterial segment. 
Following sub-maximal contraction with the appropriate concentration of PE, 
cumulative concentration-response curves were obtained for acetylcholine (ACh; 1 
nM - 10 M), sodium nitroprusside (SNP; 0.1 nM - 3 M) and a nitric oxide-
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independent vasodilator (isoprenaline; 0.1 nM - 10 M).  A 30 minute washout was 
allowed before application of subsequent drugs. 
 
Results are expressed as percentage of the pre-contraction to EC80 PE, where positive 
values represent vasodilatation and 100% vasodilatation represents a complete 
abolition of PE-induced tone. Statistical comparisons were performed by two-way 
ANOVA using the Bonferroni post-hoc test. 
 
Immunohistochemistry using TACS® 2 TdT-Blue Label in 
situ Apoptosis Detection Kit 
Apoptosis in heart tissue samples were evaluated using a Terminal Deoxynucleotidyl 
Transferases dUTP Nick End Labeling (TUNEL) assay according to the 
manufacturer’s instructions (TREVIGEN®, Gaithersburg, USA).  Briefly, heart tissue 
was collected from rats after no instillation and 6 hours after intra-tracheal 
instillation of DEP (0.5 mg in 0.5 ml saline) or vehicle (saline 0.5 ml) alone or from 
rats that had received metoprolol (10 mg/kg, intraperotineal) or AMG 9810 (30 
mg/kg, intra-tracheal) at the time of instillation in vivo.  The hearts were fixed for 24 
hours in 10% neutral buffered formalin prior to further processing and paraffin wax 
embedding as described in Chapter 2.8.  Paraffin wax-embedded hearts were 
sectioned at 5 μm thickness, then deparaffinized and rehydrated.  Please refer to 
Chapter 2.9.2 for more details.  Sections were then incubated for 10 minutes in 
phosphate buffer saline (PBS).  Slides were placed in a magnetic immunology 
staining tray and covered with 50 µl Proteinase K solution for 30 minutes at 37°C.  
After washing in deionised water (2 changes of 2 minutes), sections were immersed 
in Quenching solution (5 minutes) followed by washes in PBS (3 changes of 1 
minute).  Sections were then placed in terminal deoxynucleotidyl transferase (TdT) 
labeling buffer for 5 minutes and covered with 50 µl of labeling reaction mix to 
allow TdT-mediated dUTP nick end labeling.  After incubation for 1 hour at 37°C, 
the reaction was stopped by incubation in TdT stop buffer for 5 minutes.  Following 
washes in PBS (2 changes of 5 minutes), modified nucleotides were visualized under 
a light microscope using TACS- Blue Label™ (approximately 3 minutes for colour 
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development).   After washing in deionised water (2 changes of 2 minutes), sections 
were counterstained with Nuclear Fast Red (2 minutes), followed by a wash in 
deionised water and dehydration through a graded series of alcohol (74% ethanol for 1 
minute twice, 100% ethanol for 1 minute).  Finally, a cover slip was mounted using 
DPX mounting media. A negative control was included by omitting TdT from the 
reaction mixture. 
 
TUNEL-positive cells were viewed with an Image Pro6.2, Stereologer Analyser 6 
MediaCybernetics (Buckinghamshire, UK).  For quantification, sections were tiled at 
x100 magnification (using a 100x objective).  The entire left ventricle (LV) was 
identified as an area of interest using the Image Pro6.2 computer programme after 
image acquisition.  30 randomly selected areas of 2 mm
2
 per section were examined.  
Results are expressed as the mean number of TUNEL-positive cells per 2 mm
2 
± 
SEM.  One tissue section per rat heart was counted.  Data was analysed using one-
way ANOVA combined with Bonferroni’s post hoc test for multiple comparisons.    
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Appendix 2: Ex vivo vascular function 
 
 
Instillation of diesel exhaust particulate (DEP) has no effect on vascular 
responses ex vivo.  
(a) Contraction to phenylephrine (PE), and relaxation to (b) acetylcholine (ACh), (c) 
sodium nitroprusside (SNP) and (d) isoprenaline (ISP) in the thoracic aorta. 
Responses to ACh in (e) femoral artery and (f) 3
rd
 order mesenteric arteries. Data 
from saline-instilled animals (open symbols) and DEP-instilled animals (closed 
symbols) sacrificed at 6 hours (circles, solid line) or 24 hours (triangles, dashed line) 
after instillation. Results are expressed as mean ± SEM (n=6-10). No significant 
differences were found between saline- or DEP-instilled animals at either time points 
for all vessels (two-way ANOVA). 
235 
 
Appendix 3: Left ventricle TUNEL staining of 
DEP- and saline-instilled rats: microscopic images 
6 h Saline 6 h DEP
 
Representative images of TUNEL-stained left ventricular sections showing 
positive apoptotic cells collected 6 hours after instillation with diesel exhaust 
particulate (DEP). 
Left ventricle (LV) myocyte TUNEL staining 6 hours after instillation of saline or 
DEP (0.5 mg).  (Scale bar = 25 µm).    
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Appendix 4: Left ventricle TUNEL staining from 









































Diesel exhaust particulate (DEP) instillation increased cardiac myocyte 
apoptosis. 
TUNEL-positive cell numbers per 2 mm
2
 in the left ventricle (LV) of hearts from 
non-instilled, saline-instilled and DEP-instilled (0.5 mg) rats 6 hours after instillation.  
Columns represent mean ± SEM (n=3-4) *P<0.05, compared to saline; one-way 
ANOVA with Bonferroni post-hoc test.  
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Appendix 5: Effects of drug intervention on 
apoptosis of hearts from DEP-instilled rats  

















































The β1 adrenoceptor antagonist metoprolol and the TRPV1 receptor antagonist 
AMG 9810 prevented diesel exhaust particulate (DEP)-induced cardiac myocyte 
apoptosis.  
TUNEL-positive cell numbers per 2 mm
2
 in the left ventricle (LV) of hearts isolated 
6 hours after instillation with DEP (0.5 mg) alone (open columns); in hearts from rats 
that received metoprolol at the time of instillation in vivo (10 mg/kg, intraperotineal, 
hatched columns); or in hearts from rats that received AMG 9810 at the time of 
instillation in vivo (30 mg/kg, intra-tracheal, vertical columns).  Columns represent 
mean ± SEM (n=3-4) **P<0.01, compared to saline; one-way ANOVA with 
Bonferroni post-hoc test.  
 
